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ABSTRACT 
 
 
Accumulation of ectopic fat in liver and pancreas are seen as key indicators of the metabolic 
syndrome affecting over a third of the population in the western world. Deposition of these 
ectopic fat depots is linked to insulin resistance, a major risk factor in the development of type 
2 diabetes.  
 
Quantifying ectopic fat deposition, without the use of biopsy, has always been a challenge. 
Magnetic resonance (MR) techniques have emerged as the gold-standard for estimating overall 
fat deposition. However, little is known on the regional variation of fat deposition in liver and 
pancreas in human subjects.  The aim of this project was to determine, using an in vivo Multi-
Echo MR imaging technique, regional variations in ectopic fat deposition in liver and pancreas 
and assess the potential impact of environmental factors, including BMI, age, and gender. 
 
The overall ranges in liver and pancreas fat ranged from 0.69- 32.27 % and 0.40 - 24.18% 
respectively. There was a strong correlation between liver fat, body weight, waist-to-hip ratio 
and waist circumferences. A significant correlation between pancreatic fat and waist-to-hip 
ratio, particularly in men, was also observed. The relationship between liver and pancreatic fat 
was surprisingly weak, suggesting different mechanism of accumulation. 
 
Regional variations in liver and pancreatic fat were assessed by using surgical segmentations 
as anatomical markers, resulting in 8 anatomical segments for the liver and 3 for the pancreas.   
 
Intra-abdominal adipose tissue and age had the largest effect on liver and pancreatic fat 
deposition.  
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Relative physical activity influenced the overall levels of liver ectopic fat content but did not 
significantly affect regional distribution in the pancreas. No gender differences in fat 
distribution in the liver were detected but a strong correlation with pancreas and men was 
detected. 
 
Life-style interventions, such as weight loss programs, showed significant reduction in overall 
liver and pancreatic fat content. As for bariatric interventions, more significant reduction of 
overall ectopic fat in liver was seen with an increase in total and regional pancreas fat content.  
 
In conclusion, I have shown, utilising an anatomical compartmentalisation of the liver and 
pancreas, that there are significant heterogeneity in fat deposition in the pancreas, and that 
different regions respond variably to lifestyle interventions. There is a more homogeneous fat 
deposition in the liver, which is more consistently modulated in response to lifestyle changes.  
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Chapter I: Introduction 
 
1.1 Obesity 
 
The increased occurrence of obesity has focused attention on a worldwide crisis that is not one 
of famine or infection, but one of surplus.(Kahn, Hull et al. 2006) Obesity is defined as a 
multifactorial disease caused by abnormal or excessive adipose tissue accumulation. (Keys, 
Karvonen et al. 1972, WHO 2005, Shea, Diamandis et al. 2012) 
 
Numerous reviews and academic books have been published on the causes, health 
consequences, and pathophysiological aspects of obesity. (Bray 2003, Haslam and James 2005, 
Kahn, Hull et al. 2006, Poirier, Giles et al. 2006, Van Gaal, Mertens et al. 2006) Unfortunately, 
the epidemic is increasing at an alarming rate and with it the occurrence of a number of 
comorbidities, including cardiovascular disease, type 2 diabetes and certain types of cancers. 
(Finucane, Stevens et al. 2011, Shea, Diamandis et al. 2012) 
 
An individual's body weight and body composition are determined by interactions between the 
environment and genetics.(Loos 2012) The environment's influence on obesity relies on 
behaviours that increase the risk of positive energy balance, which in turn increases body mass 
in order to restore the energy balance.(Foreyt and Goodrick 1995, Hill and Peters 1998) Some 
individuals can avoid obesity in an unaccommodating environment by maintaining a pattern of 
healthy behaviours.(Klem, Wing et al. 1997, Hill and Peters 1998) 
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1.2 Obesity and Genetics 
 
‘the genetic background loads the gun, but the environment pulls the trigger’.(Bray 2004) 
 
Genetic makeup plays a part in regulating the strength of an individual's physiological 
resistance against gaining and maintaining body fat levels. (Sonnenberg, Krakower et al. 2004, 
Hebebrand, Bammann et al. 2010, Rhee, Phelan et al. 2012) There are a few theories that aim 
to explain this, such as the thrifty gene hypothesis, the fetal programming hypothesis, the 
sedentary lifestyle hypothesis and the ethnic shift hypothesis.(Walley, Asher et al. 2009, Heber 
2010) All of these various theories offer a partial explanation regarding the impact of genes on 
body fat content, though none offer a full explanation. 
 
Genetic contribution to obesity has been recognised through family, twin, and adoption studies. 
Twin studies have shown that genetic factors may be a factor of >40% of the variation in Body 
Mass Index (BMI) while lower heritability has been shown in families (>20%) and adoption 
(>20%) studies. (Stunkard, Foch et al. 1986, Stunkard, Sorensen et al. 1986, Turula, Kaprio et 
al. 1990, Hjelmborg, Fagnani et al. 2008) 
 
The strongest obesity-related traits remains the association with variants within FTO (the fat-
mass and obesity-related) gene.  
 
FTO is expressed in many tissues, particularly in the hypothalamus and the liver.(Gerken, 
Girard et al. 2007, Fredriksson, Hagglund et al. 2008, Wang, Yang et al. 2011) 
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However, the molecular mechanism by which FTO variants influence obesity and thus lead to 
type 2 diabetes is still elusive.(Dina, Meyre et al. 2007, Frayling, Timpson et al. 2007, Scuteri, 
Sanna et al. 2007, Yeo and O'Rahilly 2012)  
 
It has been recognised that obesity affects the endocrine function of adipose tissue by altering 
the secretion of adipokines, such as adiponectin and leptin, which have been related to ectopic 
fat accumulation, insulin sensitivity, and diabetes risk in epidemiological studies. (Soodini and 
Hamdy 2004, Perseghin, Lattuada et al. 2007) 
 
Leptin is a multifunctional hormone produced mainly by the adipose tissue, and is involved in 
the regulation of food intake and energy homeostasis through its key actions.(Friedman and 
Halaas 1998) Athough leptin receptors (LepR) are abundantly expressed in the brain, they are 
also present in peripheral tissues, indicating that leptin can exert peripheral actions.(Muoio and 
Dohm 2002, Paz-Filho, Mastronardi et al. 2012) 
 
A more recent study from Bravard et al. (Bravard, Vial et al. 2014) have demonstrated a link 
between leptin receptor-signal transducers, activators of transcription 3 (LepR-STAT3) 
signalling pathway and the FTO gene, revealing a new role of FTO in the regulation of hepatic 
leptin action and glucose metabolism .  
 
Other additional loci associated with obesity include TMEM18, 
KCTD15, SH2B1, MTCH2, NEGR1, GNPDA2 and MC4R. (Willer, Speliotes et al. 2009, 
Vimaleswaran and Loos 2010) Several reviews have assessed the implications of those loci to 
the development of human obesity.(Walley, Asher et al. 2009, McCarthy 2010, Vimaleswaran 
and Loos 2010) 
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Nevertheless, an acceptable consensus in the field is still lacking. It should be emphasized that 
whilst heritable factors are acknowledged in clarifying greatly the individual variation in risk 
of obesity, large genome-wide association studies identified so far <2% of common single 
nucleotide polymorphisms (SNPs) associated with BMI variability. (Bogardus 2009, Loos 
2009, Hebebrand, Volckmar et al. 2010, Cheung and Mao 2012, Loos 2012)  
 
1.3 Obesity Outbreak  
 
The obesity outbreak seemed to begin almost simultaneously in most high-income countries in 
the 1970s and 1980s. (F Sassi 2009) Since then, coinciding growths in obesity in nearly all 
countries seem to be driven mainly by changes in the global food system. 
 
This produces an unlimited supply of processed, highly palatable, energy-dense, affordable, 
and effectively marketed food. (Hill and Peters 1998, Swinburn, Sacks et al. 2011) These foods 
coupled with low levels of habitual physical activity have greatly contributed to the rise in 
global obesity. 
 
1.3.1 Food System 
 
The association between the global food system and shifts in obesity and related co-morbidities 
most notably diabetes, was first observed in high- and middle-income countries .(Popkin 2002)  
 
This is now commonly seen in lower-income countries too, (Popkin and Slining 2013) although 
the relationship is not yet fully understood. (Monteiro, Moubarac et al. 2013) Perhaps this is 
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due to the underestimation of the full impact of industrialized food processing on dietary 
patterns and environments.(Monteiro, Moubarac et al. 2013)   
 
Ever since the improvement of methods of preservation, such as smoking and fermentation, 
(Monteiro, Moubarac et al. 2013) the processing of food has enabled the evolution, adaptation 
and increase of humankind and of settled populations.(Ludwig 2011, Wrangham 2013) 
However, a more recent revolutionary development in the global food system and  an 
acceleration in food science techniques can be dated as from the 1980s, (Monteiro, Moubarac 
et al. 2013) where transitional changes has been made from individual to mass provision thus
“lowering the time price of food consumption”. (Cutler, Glaeser et al. 2003) 
 
This ‘Food’ has been identified as ‘ultra-processed’; (Monteiro, Moubarac et al. 2013) It is 
ready-to-consume and is entirely or mostly made from industrial ingredients and additives such 
as sugar, fats, salt, and flavour enhancers, which makes it extremely profitable. (Godfray, Crute 
et al. 2010, Monteiro, Moubarac et al. 2013, Moodie, Stuckler et al. 2013) Food is now cheaper, 
hyper-palatable, processed and more readily available, than possibly at any time in human 
history.(Godfray, Crute et al. 2010, Monteiro and Cannon 2012, Stuckler, McKee et al. 2012, 
Monteiro, Moubarac et al. 2013, Moodie, Stuckler et al. 2013) 
 
This increase in choice and abundance makes it difficult in reducing 
overconsumption. (Swinburn, Sacks et al. 2011) Additionally, marketing these processed food 
and beverages have been associated with increasing obesity rates.(Goris, Petersen et al. 2010) 
and is especially effective among children.(Gortmaker, Swinburn et al. 2012)  
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1.3.2 Active Living 
 
Suggestions on changes in total daily physical activity and the prevalence of obesity are weak 
and a complex enterprise.(Brownson, Boehmer et al. 2005, Wareham, van Sluijs et al. 2005, 
Bauman, Allman-Farinelli et al. 2008, Allman-Farinelli, Chey et al. 2010, Luke and Cooper 
2013) There are no objective measurements of energy expenditure shown across the time frame 
of the rise of the epidemic. (Luke and Cooper 2013) 
 
The extent of the change in population levels of physical activity over time is largely driven by 
the role the built environment and sedentary behaviour play in decreased energy 
expenditure.(Day and Cardinal 2007, Gebel, Bauman et al. 2007, Sallis, Linton et al. 2009, 
Ding and Gebel 2012, Luke and Cooper 2013) 
 
Data from cross-sectional studies and recent reviews have shown associations between 
environmental attributes, such as presence of sidewalks and proximity to parks in relation to 
outcomes such as physical activity and body mass.(McCormack, Giles-Corti et al. 2004, 
Kaczynski and Henderson 2008, Casagrande, Whitt-Glover et al. 2009) Furthermore, the 
existing environments within a country (the built environment, transport systems, active 
recreation opportunities, cuisines and food culture, and culture around body size) can have 
powerful effects and help to explain much of the differences in obesity prevalence between 
populations.(Swinburn, Sacks et al. 2011)  
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Undoubtedly, to consume a particular food or beverage or to exercise or not, is an individual 
decision. However, many of these decisions are automatic or subconscious.(Cohen 2008, 
Swinburn, Sacks et al. 2011) triggering a trend to consider influences on behaviour that are 
outside the person, such as the built environment. 
 
In addition, the literature implies that sedentary behaviours or sitting may be associated with 
obesity independent of physical activity.(Sugiyama, Healy et al. 2008, Dunton, Berrigan et al. 
2009, van Uffelen, Wong et al. 2010, Mozaffarian, Hao et al. 2011, Proper, Singh et al. 2011, 
Thorp, Owen et al. 2011) Working adults spend about one half of their workday sitting 
down.(Mummery, Schofield et al. 2005, Jans, Proper et al. 2007, Ki, Pouliou et al. 2011) 
Adults also spend hours sitting in their leisure-time (e.g. TV viewing, using a computer, 
transports etc.) (Salmon, Owen et al. 2003, Dunstan, Salmon et al. 2005, Proper, Cerin et al. 
2007, Ki, Pouliou et al. 2011) This has fairly significant public health implications, even 
though some adults could meet physical activity recommendations, they may sit for extended 
periods each day in different settings which could affect their health.(Chau, van der Ploeg et 
al. 2012) 
 
1.4 Obesity and Economic Effects 
 
By 2008, 502 million adults were classified as obese, a number that is expected to double by 
2015. (Finucane, Stevens et al. 2011, Shea, Diamandis et al. 2012) One estimate, predicted that 
in 2030 an expected 2.16 billion adults worldwide will be overweight and 1.12 billion will be 
obese.(Kastorini, Milionis et al. 2011) 
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Consequently, the financial burden of obesity on healthcare worldwide is estimated to be about 
3% or more of total healthcare expenditures. Bearing in mind that medical costs for obese 
individuals are extensively higher than for non-obese.(Finkelstein, Fiebelkorn et al. 2004, 
Shea, Diamandis et al. 2012) 
 
Analysis of the patterns of the obesity epidemic in the past four decades is limited by the 
absence of representative data from different countries.(Wang and Lobstein 2006) 
Nevertheless, there is an evidence for a non-linear, stepwise increase of the prevalence over 
time. (Prentice and Jebb 1995, Olds and Harten 2001, Keith, Redden et al. 2006, Rokholm, 
Baker et al. 2010) 
 
In low-income and middle-income countries such as Brazil, China, India and Mexico; groups 
of high socioeconomic status in urban areas tend to be the first to have high obesity prevalence, 
but the burden of obesity shifts to low socioeconomic status groups and rural areas as a 
country's gross domestic product (GDP) increases.(Monteiro, Moura et al. 2004, Mendez, 
Monteiro et al. 2005) 
 
In addition, Popkin et al. (Popkin and Slining 2013) and Razak et al. (Razak, Corsi et al. 2013) 
support a potential rising shift in the BMI level among those who are already overweight and 
obese.  
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In recent years, interventions such as increasing the price of unhealthy food and beverages, 
(Mytton, Gray et al. 2007, Brownell and Frieden 2009, Sacks, Veerman et al. 2011) or 
decreasing the price of healthy foods, (Ni Mhurchu, Blakely et al. 2010) have been considered.  
 
However there has been very little research in the effect and resolution of sociocultural 
determinants such as food choices, physical activity, and body-size perception.(McCabe and 
Ricciardelli 2001) These determinants ought to be a priority for studies examining the high 
prevalence of obesity in specific ethnic groups,(Ogden, Carroll et al. 2006) given that 
prevalence of adverse body fat patterns associated with adverse effects are higher in 
populations from Asia, Latin America, the Middle East and Africa .(Barba, Cavalli-Sforza et 
al. 2004, Tuan, Adair et al. 2009) 
 
1.4.1 Obesity in the Gulf Regions 
 
Since the discovery of oil in the Arabian Gulf region in the 1960s, the countries that make up 
the Gulf Cooperation Council (GCC) – United Arab Emirates (UAE), Bahrain, Kuwait, Qatar, 
Oman and Saudi Arabia have experienced continued growth in population, per capita income 
and wealth.(Ng, Zaghloul et al. 2011)  
 
Along with the rapid socio-economic growth of the GCC and change in lifestyle,(Malik and 
Razig 2008) there have been rises in nutritional health problems and related diseases.(Ng, 
Zaghloul et al. 2011)This is often referred to as a ‘nutrition transition’, which was first 
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perceived in developed countries, but has swiftly spread to growing economies and developing 
nations in the past two decades.(Popkin 2006)  
 
Recent estimates on the prevalence of obesity in the GCC states are astonishing; particularly 
in Kuwait, Qatar, Saudi Arabia and Bahrain where between two-thirds to three-quarters of 
adults and 25–40% of children and adolescents are overweight or obese. These levels in some 
cases, may be exceeding, that of some developed countries.(Popkin 2006, Mabry, Reeves et al. 
2010, Ng, Zaghloul et al. 2011) 
 
Furthermore, there appears to be a gender difference where obesity is more prevalent among 
women than men (Women in Saudi Arabia ~79.2% vs. Men in Saudi Arabia ~74.5%). (Al-
Mahroos and Al-Roomi 2001, Al-Riyami and Afifi 2003, Bener, Al-Suwaidi et al. 2004, 
Ministry of Health 2005) 
 
Saudi Arabia seems to be the leading country globally in terms of diabetes prevalence 
worldwide, (Kamran, Bener et al. 2007, Al-Lawati, Mabry et al. 2008, Mabry, Reeves et al. 
2010) with the highest recorded expenditure on diabetes consuming 21% of the country’s total 
health expenditure, with no data available on the health expenditure of  obesity. (Farag and 
Gaballa 2011, Al-Rubeaan, Youssef et al. 2013) 
  
 
 
45 
 
1.5 Obesity and Measurement 
 
In clinical practice, obesity has been commonly measured by expressing body weight as a 
function of height, the so called BMI, calculated as weight in kilograms divided by height in 
meters squared. (Keys, Karvonen et al. 1972, Consultation 2000, Barba, Cavalli-Sforza et al. 
2004) This has long been used as an index of obesity, since it was originally described by 
Quetelet in 1869.  (Quételet 1869) 
 
Population studies have consistently reported a J-shaped relationship between the BMI and 
morbidity/mortality risk.(Yusuf, Hawken et al. 2004, Prospective Studies, Whitlock et al. 
2009, Berrington de Gonzalez, Hartge et al. 2010) 
 
At present, several organizations use categories of BMI to define underweight, normal weight, 
overweight, and various classes of obesity, (Consultation 2000, Barba, Cavalli-Sforza et al. 
2004) although it must be noted that these classifications by BMI do not apply to trained 
athletes.(Bray 2005) (Figure 1.0) Its limitations however, such as not distinguishing fatness 
from muscularity, and not taking into account the site where fat is deposited on the body, have 
left health professionals limited by the fact that obesity is a fairly a heterogeneous condition. 
(Keys, Karvonen et al. 1972, Despres, Lemieux et al. 2001, Tchernof and Despres 2013) 
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Figure 1.0 WHO (Consultation 2000) Classification  
 
Accordingly, there has been a tendency for some time to adopt a one-size-fits-all approach to 
the management of obesity; interest has focused on detrimental characteristics of excess 
adipose tissue only considering the primary functions of this tissue i.e. storage and release of 
metabolic fuel.(Raz, Eldor et al. 2005) 
 
However, adipose tissue is not simply a storage reservoir of excess energy in the form of fat 
but an active endocrine organ that plays multiple roles in the body. The metabolic role of 
adipocytes changes as they enlarge with increasing obesity and also according to their location. 
Indeed, they can be associated with a low-grade state of inflammation as a consequence of the 
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secretion of pro-inflammatory cytokines leading to metabolic complications.(Calabro, Golia et 
al. 2009, McQuaid, Hodson et al. 2011) 
 
While it is acknowledged that obesity is the result of a positive imbalance between energy 
intake and output, the pathophysiology underlying the failure of energy homoeostasis remains 
unclear. (Tan and Vidal-Puig 2008) 
 
1.6 Adipose Tissue Distribution 
 
Epidemiological and metabolic studies conducted over the past several years have re-
highlighted the concept introduced in the mid-forties by French physician Dr Jean Vague, 
(Vague 1947) who pointed out that the disease-causing complications that have been 
traditionally associated with obesity were more directly related to where the excess fat was 
rather than to excess weight per se.(Vague 1947, Krotkiewski, Bjorntorp et al. 1983, Kissebah, 
Freedman et al. 1989, Terry, Stefanick et al. 1991, Despres, Lemieux et al. 2001, Tchernof and 
Despres 2013) 
 
Since then, recent studies have found that a high proportion of adipose tissue located in the 
abdominal part of the human body or a male type (upper body) “android obesity” has a harmful 
effect on a variety of important metabolic factors relative to peripheral or premenopausal 
female type (lower body) or “gynoid obesity”. (Kissebah, Vydelingum et al. 1982, Lapidus, 
48 
 
Bengtsson et al. 1984, Blair, Kohl et al. 1989, Kissebah, Freedman et al. 1989, Seidell, 
Bjorntorp et al. 1989, Pouliot, Despres et al. 1990)  
 
This android obesity is known to increase the risk of cardiovascular diseases, type 2 diabetes, 
hypertension, certain types of cancers and related mortality. (Kissebah, Vydelingum et al. 
1982, Lapidus, Bengtsson et al. 1984, Blair, Kohl et al. 1989, Kissebah, Freedman et al. 1989, 
Seidell, Bjorntorp et al. 1989, Pouliot, Despres et al. 1990, Shuster, Patlas et al. 2012) 
 
1.6.1 Adipose Tissue Depots 
 
Whole body adipose tissue has commonly been subdivided in two main components: 
subcutaneous and internal adipose tissue.(Tchernof and Despres 2013) (Figure 1.1) 
 
Subcutaneous adipose tissue is usually defined as the layer found just below the skin 
(hypodermis) and some evidence even suggests it might be protective, particularly in the 
gluteofemoral area. (Ross, Leger et al. 1992, Thomas, Saeed et al. 1998, Shen, Wang et al. 
2003, Snijder, Visser et al. 2005, Porter, Massaro et al. 2009, Bays, Fox et al. 2010, Tchkonia, 
Thomou et al. 2013) 
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Figure 1.1 Anatomy of Major Fat Depots in Humans taken from (Tchkonia, Thomou et al. 
2013) 
 
The main areas for subcutaneous fat deposition are the gluteal/leg regions, back, and anterior 
abdominal wall. In normal weight adults, ~ 80% of total body fat is found in the subcutaneous 
region.(Wajchenberg 2000, Ibrahim 2010, Tchoukalova, Koutsari et al. 2010, Tchkonia, 
Thomou et al. 2013) (Figure 1.2) 
 
Internal adipose tissue on the other hand, comprises ~ 10% of total body fat, (Abate, Garg et 
al. 1995) and can be divided into intra-abdominal and non-abdominal sites. Visceral or intra-
abdominal fat is mainly composed of omental, mesenteric and retroperitoneal depots. Non-
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abdominal fat includes cardiac and inter-muscular depots. (Wajchenberg 2000, Ibrahim 2010, 
Item and Konrad 2012, Thomas, Fitzpatrick et al. 2013) (Figure 1.2) 
 
 
Figure 1.2 Schematic Diagram showing Adipose Tissue Depots taken from (Thomas, 
Fitzpatrick et al. 2013) 
 
Within the upper body, Scarpa’s fascia separates superficial and deep abdominal subcutaneous 
fat. Deep abdominal subcutaneous fat accumulation is interconnected with visceral fat 
accumulation, (Kelley, Thaete et al. 2000) showing that it may well present morphological and 
functional characteristic similar to visceral adipose tissue. (Walker, Verti et al. 2007) Although, 
Jensen et al. (Jensen, Sarr et al. 2003) observed that  deep and superficial abdominal 
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subcutaneous fat behaved quite similarly with respect to meal fat storage, implying  that these 
subdivisions may not be that functionally diverse.(Ebbert and Jensen 2013) 
 
Fat accumulation and distribution varies extensively between sexes, among individuals and 
families, between different ethnicities, with aging and several disease conditions, as well as 
side effects to drugs and hormones. (Borkan, Gerzof et al. 1982, Enzi, Gasparo et al. 1986, 
Forbes and Brown 1989, Bouchard 1997, Wajchenberg 2000, Thomas, Parkinson et al. 2012, 
Tchernof and Despres 2013, Tchkonia, Thomou et al. 2013)  
 
In young- to middle-aged subjects the upper limit of a normal and healthy body fat per cent 
(BF%) is ~ 25–30% in males and 35–40% in females.(WHO 1995) 
 
As for determining the presence of abdominal obesity, Waist (WC) and Waist/Hip (WHR) ratio 
are used as markers where WC is >102 cm for men and >88 cm for women (Adult Treatment 
Panel III criteria).(Logue, Smucker et al. 1995, Expert Panel on Detection and Treatment of 
High Blood Cholesterol in 2001) This has allowed scientists to show that extra accumulation 
of fat in the visceral region gives rise to metabolic complications.(Lapidus, Bengtsson et al. 
1984, Wajchenberg 2000, Lakka, Lakka et al. 2002, Despres and Lemieux 2006, Alligier, 
Gabert et al. 2013, Tchernof and Despres 2013, Tchkonia, Thomou et al. 2013) Though the  
explanation for this association is not fully understood.(Ebbert and Jensen 2013) 
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Intra-abdominal adipose tissue seems to play a major role in the pathogenesis of insulin 
resistance, diabetes, dyslipidemia, inflammation, hypertension and cardiovascular diseases. 
Whereas the metabolic consequences of subcutaneous adipose tissue are less well-
defined.(Goldstone, Thomas et al. 2001, Despres 2006, Kuk, Katzmarzyk et al. 2006) Even 
though it had been linked to features of the metabolic syndrome independently of intra-
abdominal fat.(Goodpaster, Thaete et al. 1997) 
 
Whilst the distinct importance of visceral fat depot versus subcutaneous fat depot dysfunction 
has been challenged.(Frayn 2000) There is mounting evidence to suggest that visceral 
adipocytes are phenotypically dissimilar from subcutaneous adipocytes.(Perrini, Laviola et al. 
2008, Tchkonia, Thomou et al. 2013) A recent study from Chau et al.(Chau, Bandiera et al. 
2014) used genetically modified mice to confirm just that.  
 
The research showed that the majority of visceral fat depots in the body can be traced back to 
a single type of cell in the developing embryo. These ‘bad’ fat originator cells, express a gene 
called Wt1 and are not found in the subcutaneous fat. (Chau, Bandiera et al. 2014) The highest 
number of these cells were found in the fat depots around the heart and stomach, which are 
known to be the most common places that give rise to metabolic complications. 
 
Compatible with these functional differences a variation in lipid synthesis was found between 
fat depots due to fat cell size. (Ostman, Arner et al. 1979, Bjorntorp 1990, Edens, Fried et al. 
1993, VanHarmelen, Lonnqvist et al. 1997, P.Arner 1998, Barakat, Hickner et al. 2002, Caesar, 
Manieri et al. 2010, Koutsari, Ali et al. 2011) Subcutaneous fat tissue enlargement in 
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response to overfeeding is due to an increase in cell number, not size, the opposite is true for 
abdominal fat gain. (DiGirolamo, Fine et al. 1998) Visceral fat mass changes principally 
through adjustments in adipocyte size, rather than number, regardless of sex and degree of 
adiposity. (Tchernof and Despres 2013) As well as a distinction in the expression of adipogenic 
genes and the secretion of adipocytokines. (Motoshima, Wu et al. 2002, Vohl, Sladek et al. 
2004, Tchkonia, Giorgadze et al. 2006, Kim, van de Wall et al. 2007, Yamamoto, Gesta et al. 
2010) 
 
Moreover, portal and systemic lipid kinetics in human subjects differ between these fat regions 
(Nielsen, Guo et al. 2004), suggesting that the release of lipids from subcutaneous fat depots 
are drained systemically. This indicates a less harmful effect than visceral (omental and 
mesenteric) fat depots, where lipids and pro-inflammatory cytokines are mostly drained by the 
portal vein, which is then transported directly to the liver leading to the impediments of ectopic 
fat. (Bjorntorp 1990, Bjorntorp 1991, Klein 2004, Nielsen, Guo et al. 2004, Jensen 2008, Item 
and Konrad 2012)  
 
1.7 Ectopic fat 
 
Human physiology needs to be well adapted to manage major disruptions in both the supply of 
and demand for energy. Adipose tissue is an important “energy bank” and requires an 
adaptability to have ‘a clear capacity to utilize lipid and carbohydrate fuels and to transition 
between them’. (Kelley, He et al. 2002, Sanyal 2005) Such ability exemplifies a healthy state 
and can be termed ‘metabolic flexibility’.  
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Furthermore, most tissues have a small intracellular reserve of lipids as a source for vital 
‘housekeeping’ functions such as preservation of membrane structure, fluidity and intracellular 
signalling. (Rasouli, Molavi et al. 2007)  
 
However, when adipose tissue stores, whether peripheral or central, become saturated either 
due to failure to develop sufficient adipose tissue mass (lipodystrophy), or to expand these 
stores suitably to contain increased energy intake (metabolic inflexibility),  (Storlien, Oakes et 
al. 2004, Raz, Eldor et al. 2005, Tan and Vidal-Puig 2008, Virtue and Vidal-Puig 2010, Snel, 
Jonker et al. 2012) lipids may ‘overflow’ into other non-adipose tissues such as in the  liver, 
pancreas, skeletal muscle, heart and kidneys. (Heilbronn, Smith et al. 2004, McQuaid, Hodson 
et al. 2011, Cohen, Syme et al. 2013) The storage of lipid droplets in these organs  is known 
as an ‘ectopic fat’ storage.(Snel, Jonker et al. 2012) (Figure 1.3) 
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Figure 1.3 Lipid Overflow in Non-adipose Tissues leading to Several Diseases in the 
Metabolic Syndrome taken from (Tchernof and Despres 2013) 
 
Ectopic fat accumulation appears to have clinical consequences; ectopic fats seem to disrupt 
metabolic processes and impair organ function and are closely related to the development of 
insulin resistance, type 2 diabetes mellitus, cardiovascular diseases and the metabolic 
syndrome.(Unger 2003, Montani, Carroll et al. 2004, Rasouli, Molavi et al. 2007, Snel, Jonker 
et al. 2012, Cohen, Syme et al. 2013) 
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These local fat availability and depositions are likely to be influenced by different genetic and 
environmental factors such as increased energy intake and physical inactivity, and appear to 
have varying metabolic implications.(Bachmann, Dahl et al. 2001, Stannard, Thompson et al. 
2002, Kabir, Catalano et al. 2005, Schrauwen-Hinderling, Kooi et al. 2005, Bergman, Kim et 
al. 2006, Cohen, Syme et al. 2013) (Figure 1.3) 
 
The effects of ectopic fat accumulation is dependant on the specific organ. However, the 
mechanisms leading to the disruption of organ function are quite similar at the cellular level. 
(Snel, Jonker et al. 2012) Lipids can diffuse intercellularly or accumulate intracellularly. 
Intercellular lipid accumulation could impair organ function via paracrine effects of throught 
the release of adipokines. Though, it is mostly intracellular lipid accumulation that is associated 
with decreased insulin sensitivity.(Snel, Jonker et al. 2012) 
 
Free fatty acids are usually taken up by the cell via specific transport proteins in the cell 
membrane along with passive diffusional uptake. (Glatz, Bonen et al. 2002) Inside the cell, 
Long-chain fatty acyl-CoA goes through β-oxidation and further degradation through the 
tricarboxylic acid cycle in the mithochondria. This may lead to an outcome of continuous 
supply of free fatty acids (FFAs) (caused by enhanced lipolysis and adipocyte dysfunction) 
together with an impairment in FFA oxidation in the mitochondria, resulting to intracellular 
lipid accumulation. 
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Metabolites such as long-chain acyl-CoA and ceramides are the ones that appear to be toxic to 
cells and not the FFAs themselves. These fatty acid metabolites induce a sustained activation 
of serine/threonine kinases such as protein kinase C isoforms which phosphorylate insulin-
receptor substrates on serine residues. (Morino, Petersen et al. 2006) The subsequent defects 
in insulin signaling lead to a decrease in cellular function that depends on the cell type. (Morino, 
Petersen et al. 2006, Szendroedi and Roden 2009) 
 
Correspondingly, it has been observed that that peripheral subcutaneous depots appear to play 
the role of a metabolic sink, buffering lipids to limit their deposition in other organs as well as 
maintaining the homeostasis of daily lipid fluxes. (Frayn 2002, Tan and Vidal-Puig 2008, 
Porter, Massaro et al. 2009) While visceral depot is more established as being part of the 
complex phenotype of adipose tissue storage dysfunction and ectopic lipid accumulation in 
several sites especially in the liver. (Despres 2011) 
 
1.7.1 Ectopic fat in the Liver 
 
The ectopic fat deposition in the liver, also known as intra-hepatocellular lipids (IHCL), in the 
absence of excessive alcohol ingestion leads to a spectrum of changes in the liver associated 
histologically with fat accumulation within the cytoplasm of hepatocytes. (Hamer, Aguirre et 
al. 2006, Oliva, Mortele et al. 2006) Common patterns of fat infiltration in the liver include 
diffuse fat accumulation, diffuse fat accumulation with focal sparing, and focal fat 
accumulation in an otherwise normal liver. (Hamer, Aguirre et al. 2006)  
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This spectrum encompasses non-alcoholic hepatic steatosis, also known as non-alcoholic fatty 
liver disease (NAFLD), a clinical condition predisposing to cirrhosis, liver failure and 
hepatocellular carcinoma.(Powell, Cooksley et al. 1990, Teli, James et al. 1995, Angulo, Keach 
et al. 1999, Matteoni, Younossi et al. 1999, Angulo 2002, Bugianesi, Leone et al. 2002, 
McCullough 2002, Dam-Larsen, Franzmann et al. 2004, Oliva, Mortele et al. 2006, Vauthey, 
Pawlik et al. 2006) (Figure 1.4) 
 
 
Figure 1.4 Spectrum of NAFLD taken from http://www.hku.hk/press/news_detail_8345.html 
 
Fatty infiltration of the liver is not a new occurrence, like civilization itself, it manifested in the 
agricultural revolution of the Fertile Crescent of Mesopotamia, where there was enough food 
being produced and less physical work to go around.(Charlton 2007)  
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In antiquity, the practice of fattening the liver of animals through overeating of figs derived 
from ancient Egypt, where Egyptians have noted that the liver of migrating geese and ducks, 
owing to the experience of overfeeding and inactivity these animals had before starting the 
migration, was delicious to eat.(K.F. Kiple 2000, Leuschner, James et al. 2001, Riva, Riva et 
al. 2011) Thus, on the grounds that both are inevitable in requiring overfeeding and inactivity, 
the concrete similarities between the French delicatesse ‘foie gras’ and human NAFLD are 
self-evident. (Leuschner, James et al. 2001) 
 
However, until the last few decades, NAFLD was considered to be a somewhat benign 
condition. (Zelman 1952, Westwater and Fainer 1958, Mehta, Thomas et al. 2008) In 1980, 
Ludwig and colleagues introduced the term “non-alcoholic steatohepatitis” (NASH) to describe 
these histological findings in patients who did not consume alcohol. (Ludwig 1980) The 
mechanisms leading to hepatic fat accumulation remain, to this day, multifactorial and poorly 
understood.(Adams and Angulo 2005, Sanyal 2005)  
 
The liver synthesizes circulating  free fatty acids (FFA)s which  are derived from lipolysis of 
triglycerides within adipose tissue, diet or de novo lipogenesis into triglycerides (TG)s. (Sanyal 
2005, Ibrahim, Kohli et al. 2011) Once seized by the liver, FFAs can either be oxidised in the 
mitochondria to form adenosine triphosphate (ATP), or esterified into neutral TGs for storage, 
or combined into very low density lipoprotein (VLDL) particles.(Angulo 2002, Adams, Angulo 
et al. 2005, Mehta, Thomas et al. 2008) 
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Triglycerides accumulate in the liver when their synthesis surpasses their 
export via VLDL.(Angulo 2002, Adams, Angulo et al. 2005) Therefore they may serve as a 
probable biomarker for the flux of FFAs delivered to the liver. The total volume of circulating 
FFA is a critical index of the severity of the disease and degree of hepatocyte lipo-
apoptosis.(Nehra, Angulo et al. 2001, Feldstein, Canbay et al. 2003, Ibrahim, Kohli et al. 2011) 
 
In addition to its impact on liver injury, hepatic steatosis increases hepatic insulin resistance as 
well as peripheral insulin resistance in skeletal muscle and adipose tissue. (Canbay, Taimr et 
al. 2003, Marchesini, Bugianesi et al. 2003, Korenblat, Fabbrini et al. 2008), furthering the 
development of diabetes. (Kotronen, Westerbacka et al. 2007, Kotronen and Yki-Jarvinen 
2008) It is also recognized as a pathogenic link between obesity and its metabolic 
complications independent of age, gender, and BMI. (Wanless and Lentz 1990, Garg and Misra 
2002, Stranges, Dorn et al. 2004, Thomas, Hamilton et al. 2005, Kotronen, Westerbacka et al. 
2007, Dunn, Xu et al. 2008, Kotronen and Yki-Jarvinen 2008, Alberti, Eckel et al. 2009, 
Almeda-Valdes, Cuevas-Ramos et al. 2009, Fabbrini, deHaseth et al. 2009) 
 
Incidences of NAFLD are underreported and are highly variable with only a minority of 
patients ~3% progressing to cirrhosis. (Vernon, Baranova et al. 2011, Schuppan and 
Schattenberg 2013) Although it has been stated to affect over 20% to 30% of the general 
population in the western world.(Mehta, Thomas et al. 2008) 
 
Numerous findings have now confirmed that both excessive intra-abdominal and hepatic fat 
accumulation are critical contributors to the development of the metabolic syndrome and type 
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2 diabetes. (Alberti, Zimmet et al. 2005, Thomas, Hamilton et al. 2005, Eguchi, Eguchi et al. 
2006, Verrijken, Francque et al. 2008) Although they tend to occur together (Jakobsen, 
Berentzen et al. 2007) their measurable mutual relationship and roles as well as all the factors 
influencing ectopic fat accumulation in the metabolic syndrome remains unclear.(Thomas, 
Hamilton et al. 2005, Jakobsen, Berentzen et al. 2007) 
 
However, the abnormalities of insulin secretion and insulin resistance that trigger type 2 
diabetes have a convincing hypothesis of a single, common aetiology, i.e. excess lipid 
accumulation in the liver and pancreas. (Taylor 2008, Lim, Hollingsworth et al. 2011) 
 
1.7.2 Ectopic fat in the Pancreas 
 
Less is known about the human pathophysiological consequences of lipid accumulation in the 
pancreas, also known as intra-pancreatic cellular lipids (IPCL) with regards to the metabolic 
syndrome. (R. Paul Robertson 2004, Rossi, Fantin et al. 2011, Sepe, Ohri et al. 2011) 
Deposition of fat inside and around pancreas has been shown to be linked with a higher risk of 
diabetes. (Lee, Hirose et al. 1994, Nolan, Madiraju et al. 2006)  It has also been suggested that 
it follows a similar process to NASH and is termed non-alcoholic steato-pancreatitis (NASP) 
or fatty pancreas. (N. S. Patel 2013)  
 
β-cells are usually present with other endocrine cells in the Islets of Langerhans which are 
scattered throughout the exocrine pancreas. (R. Paul Robertson 2004) It has been suggested 
that excess ectopic pancreatic fat accumulation deteriorates β-cell function, exocrine 
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dysfunction and decreases insulin secretion. (Lee, Hirose et al. 1994, Kahn, Hull et al. 2006, 
Mathur, Marine et al. 2007, Tushuizen, Bunck et al. 2007, Hannukainen, Borra et al. 2011) 
 
Pancreatic fat is normally present several years before type 2 diabetes is diagnosed and has 
been proposed as a potential marker to identify individuals at risk.(Kahn, Hull et al. 2006, van 
Herpen and Schrauwen-Hinderling 2008, Lingvay, Esser et al. 2009). 
 
This excess in accumulation may be achieved through a number of mechanisms including local 
free fatty acid release, triglyceride metabolite accumulation, oxidative stress, and release of 
pro-inflammatory factors and cytokine production, all of which stimulate β-cell injury. (R. Paul 
Robertson 2004) 
 
In obese individuals, increased lipolysis contributes to high levels of circulating non esterified 
FAs , (McGarry 2002) subsequently, various mechanisms including the formation of reactive 
long-chain fatty acyl-CoAs and toxic metabolites, such as ceramide, may contribute to 
apoptosis and the decline of β-cell mass. (Shimabukuro, Zhou et al. 1998, Kharroubi, Ladriere 
et al. 2004, R. Paul Robertson 2004) Experimental and autopsy data have shown that fatty 
infiltration of the pancreas may add to a decrease in β-cell mass and function, by the local 
release of non estereified FAs and by adipocyte-derived proinflammatory and vasoactive 
factors. (R. Paul Robertson 2004, Newsholme, Keane et al. 2007) 
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However, the literature regarding the associations of pancreatic fat accumulation with β-cells 
function are scarce and less conclusive, with conflicting results, (Maarten E. Tushuizen 2007, 
Pinnick, Collins et al. 2008, Lingvay, Esser et al. 2009, Heni, Machann et al. 2010) leading to 
the fact that interaction of pancreatic fat with glucose regulation is somewhat complex.(N. S. 
Patel 2013) 
 
In animal studies, adipocyte expansion and triglyceride accumulation increased in parallel in 
both exocrine and endocrine pancreatic regions. This leads to the eventual β-cell dysfunction, 
leading to lipoapoptosis and impaired insulin secretion as the animals develop pre-diabetes and 
diabetes. (Joseph L. Milburn 1995, Lingvay, Esser et al. 2009, Y Lee 2010)  
 
Of late, studies have similarly demonstrated additional associations with fatty pancreas 
including hepatic steatosis, increased risk of pancreatic cancer, visceral fat accumulation and 
obesity. (Lee, Kim et al. 2009, Lingvay, Esser et al. 2009, Sijens, Edens et al. 2010) 
 
1.7.3 Other ectopic fat stores 
 
Whilst beyond the scope of this thesis there are other ectopic fat depots that need mention for 
the purpose of context. These other depot sites are the muscle, heart and kidneys. 
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1.7.3.i Muscle 
 
Accumulation of fat can be found stored within muscle cells – intra-myocellular lipids (IMCLs) 
and increased amounts of this ectopic depot have been linked to insulin resistance, type 2 
diabetes and visceral adiposity. (Phillips, Caddy et al. 1996, Pan, Lillioja et al. 1997, Jacob, 
Machann et al. 1999, Snel, Jonker et al. 2012)  
 
However, elevated IMCL has been reported in endurance-trained athletes, despite being highly 
insulin sensitive, an effect referred to as the ‘athlete’s paradox’. (Goodpaster, He et al. 2001, 
van Loon, Koopman et al. 2004) 
 
IMCL is usually measured by skeletal muscle biopsies or using magnetic resonance 
spectroscopy (MRS).(Krssak, Falk Petersen et al. 1999, Perseghin, Scifo et al. 1999)  
 
1.7.3.ii Heart 
 
Pericardial fat is the adipose tissue surrounding the heart. It consists of two layers: epicardial 
fat (i.e the true visceral fat depot of the heart) originating from mesothelial cells and 
surrounding the heart by 80% (Iacobellis, Corradi et al. 2005, Rabkin 2007, Sacks and Fain 
2007, Snel, Jonker et al. 2012) and paracardial fat, originating from mesenchymal cells and 
comprising 20% of total heart weight. (Sacks and Fain 2007, Snel, Jonker et al. 2012) 
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Epicardial fat plays a dichotomous role, both unfavorable and protective and has been 
attributed to cardiovascular diseases. (Iacobellis and Barbaro 2008) This is due to its anatomic 
and functional proximity to the myocardium and the fact that it shares a common blood supply 
with the latter and encloses intense metabolic activity.(Iacobellis and Willens 2009, Ghosh 
2014) Nevertheless, its physiology in animals and humans is not completely clear. (Iacobellis 
and Willens 2009) 
 
1.7.3.iii Kidneys 
 
Ectopic fat accumulation in the kidney especially around the renal sinus affects kidney function 
by compressing blood vessels as they exit the kidney, (Montani, Carroll et al. 2004)leading to 
hypertension and chronic renal disease.(Foster, Hwang et al. 2011, Ghosh 2014) Fatty kidneys 
have also been frequently seen in concurrence with abdominal obesity. (Ghosh 2014) 
 
1.8 Body Composition Measurement 
 
In order to fully understand the relationship between adiposity, ectopic fat and obesity related 
health risk, we must be able to accurately measure body fat content and distribution, as well 
as characterize regional fat distribution vis-à-vis ectopic fat without particularly relying on 
invasive histological and biochemical approaches. Consequently, there are two non-invasive 
methods to measure body fat content and ectopic fat: Indirect and Direct. 
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1.8.1 Indirect Methods 
 
A number of technique have been developed to assess adiposity.(Bergman 2012) Indirect 
methods include: BMI, anthropometry, skinfold thickness, bioelectrical impedance, 
underwater weighing, and body water dilution. (Ayvaz, Kilinc et al. 2011, Bergman 2012, 
Thomas, Fitzpatrick et al. 2013) 
 
While these methodologies do provide useful information, particularly at a population 
level,(Thomas, Fitzpatrick et al. 2013) they cannot be generalized among different ethnic 
groups.(Garrido-Chamorro, Sirvent-Belando et al. 2009, Rahman and Berenson 2010, Thomas, 
Fitzpatrick et al. 2013) and are often impossible to preform in individuals with extreme body 
types such as athletes or obese subjects.(Bergman 2012, Thomas, Fitzpatrick et al. 2013)  
 
In addition, they give little information on different fat depots (van der Kooy and Seidell 1993, 
Pouliot, Despres et al. 1994, Kyle, Bosaeus et al. 2004, Shuster, Patlas et al. 2012) with no 
information concerning ectopic fat levels and distribution.(Thomas, Fitzpatrick et al. 2013)  
 
1.8.2 Direct Methods 
 
The fact that different fat depots and ectopic fats within the body appear to impact, to a varying 
extent, the risk of developing chronic diseases such as the metabolic syndrome, has made it 
clear that measuring total body fat content alone was not sufficient. 
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This lead to the development and implementation of new techniques that are continuously 
being perfected, and could accurately measure in-vivo adipose tissue content and distribution 
as well as fat depots in specific organs. 
 
1.8.2. i Ultrasound 
 
Ultrasound (US) is an important diagnostic tool that uses sound waves to create images of 
organs and structures inside the body. (Erikson, Fry et al. 1974)It is non-invasive, easy to use, 
safe, inexpensive and widely available.(Ricci, Longo et al. 1997, Strauss, Gavish et al. 2007, 
Roldan-Valadez, Favila et al. 2008) 
 
It is also a suitable technique for estimating different adiposity depots. Although the time 
needed for a single measurement is very short, reproducibility and accuracy are 
poor.(Armellini, Zamboni et al. 1993, Suzuki, Watanabe et al. 1993) Moreover, care should be 
taken when interpreting ultrasound measurements as they are often subjective to the experience 
and abilities of the operator.(Mehta, Thomas et al. 2008, Shuster, Patlas et al. 2012)  
 
Although a constant matter of debate, (Schwenzer, Springer et al. 2009) various studies have 
reported sensitivities and specificities for the detection of ectopic fat deposition with US, 
particularly in severe cases of fatty Liver.(Needleman, Kurtz et al. 1986, Joseph, Saverymuttu 
et al. 1991, Fishbein, Castro et al. 2005, Vernon, Baranova et al. 2011) It has been stated that 
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US had an acceptable level of sensitivity (60%–100%) (Angulo 2002, Saadeh, Younossi et al. 
2002) but is is unable to provide precise determination and change of hepatic fat content. 
(Marchal, Verbeken et al. 1989, Mehta, Thomas et al. 2008, Sepe, Ohri et al. 2011) 
 
Referring to a three point scoring system (‘mild,‘moderate’and‘severe steatosis’ ) based 
on hyperechogenic liver tissue, the increased discrepancy of echo amplitude between liver and 
kidney and the loss of echoes from the walls of the portal system, (Saverymuttu, Joseph et al. 
1986, Hamaguchi, Kojima et al. 2007) grading of hepatic fat content using ultrasound,  tend to 
be somewhat subjective.(Mehta, Thomas et al. 2008) 
 
Ectopic fat in the pancreas, on the other hand, cannot be fully imaged with trans-abdominal US 
because of superimposing air in the stomach and small intestine (Sepe, Ohri et al. 2011), except 
when placing an endoscopic ultrasound (EUS) next to the pancreas parenchyma, where EUS 
can provide detailed image of fatty pancreas for analysis.(Al-Haddad, Khashab et al. 2009, 
Sepe, Ohri et al. 2011) 
 
1.8.2. ii Computerized Tomography  
 
Computed Tomography (CT) allows for the quantification and distribution of total adipose 
tissue content, as well as individual adipose tissue depots such as intra-abdominal and 
subcutaneous adipose tissue depot.(Borkan, Gerzof et al. 1982, Baumgartner, Heymsfield et 
69 
 
al. 1988, Kvist, Chowdhury et al. 1988, Gallagher, Kuznia et al. 2005, Thomas, Fitzpatrick et 
al. 2013)  
 
It can also be applied in inter-muscular depots, and other internal tissues and organs. 
(Baumgartner, Heymsfield et al. 1988, Kvist, Chowdhury et al. 1988, Gallagher, Kuznia et al. 
2005, Thomas, Fitzpatrick et al. 2013) However the main drawback of CT scanning is the 
radiation dose it emits, which limits significantly its application in longitudinal studies and in 
paediatric populations. (Mehta, Thomas et al. 2008, Thomas, Fitzpatrick et al. 2013) 
 
Contrast-unenhanced CT provides an accurate, reliable and more visible visualization of the 
whole liver in hepatic steatosis than contrast-enhanced CT. (Bydder, Kreel et al. 1980, Park, 
Kim et al. 2006) Not only diffuse but also focal fatty infiltrations of the liver parenchyma can 
be observed. (Schwenzer, Springer et al. 2009)This is done by measuring the difference in liver 
and spleen attenuation values in Hounsfield units (HU).(Piekarski, Goldberg et al. 1980) 
 
Normal healthy liver has an attenuation value of about 50–57 HU which is about 8–10 HU 
higher than the one of spleen .(Piekarski, Goldberg et al. 1980)  Reduction in values of the liver 
which are less than 40 HU or 10 HU smaller than those of the spleen, can predict the occurrence 
of hepatic steatosis. (Hamer, Aguirre et al. 2005, Park, Kim et al. 2006) The image in the liver 
parenchyma appears darker than the spleen and even darker than the content of the hepatic 
vessels.(Schwenzer, Springer et al. 2009) 
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Lipid droplets in the pancreas are primarily in the interlobular septa. This results in a 
heterogeneous pattern on CT scans, making quantification of tissue density (fat) by using 
Hounsfield units unreliable and inaccurate.(Marks, Filly et al. 1980, Paivansalo 1984) 
Although, scans can be used to image the pancreas in its entirety. 
 
1.8.2.iii  Magnetic Resonance Imaging  
 
Magnetic resonance imaging (MRI) is a medical imaging technique that uses strong magnetic 
fields and radiowaves to form images of the body. It allows measurement of fat and water 
proton signals and is considered one of the most accurate non-invasive technique for assessing 
adipose tissue content and distribution as well as assessing ectopic fat. (Siegelman and Rosen 
2001, Cassidy, Yokoo et al. 2009) (Figure 1.5) 
 
Image contrast in the MRI may be weighted to demonstrate different anatomical structures. 
This is measured by assessing how quickly tissues return to their equilibrium state after 
excitation by the independent processes of longitudinal T1 (spin-lattice) and transverse T2 
(spin-spin) relaxation. (Haacke 1999) Signal intensities on T1 and T2 weighted images relate 
to specific tissue characteristics. 
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Figure 1.5 Methods in measuring Different Body Fat Content and Distribution  
 
MRI has been validated against weighing of adipose tissue from human cadavers, with a 
reported difference of  less than 5% .(Abate, Burns et al. 1994) 
 
The first studies utilising MRI to measure adipose tissue content and distribution in humans 
were published in the mid-1980s. (Foster, Hutchison et al. 1984, Kvist, Sjostrom et al. 1986, 
Seidell, Oosterlee et al. 1987, Baumgartner, Heymsfield et al. 1988) Since then, the technique 
has become the gold standard methodology for accurate and reproducible measurements of 
adipose tissue content and distribution in relation to health and disease.(Seidell, Bakker et al. 
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1990, Ross, Leger et al. 1992, Bonora, Micciolo et al. 1995, Thomas, Saeed et al. 1998, Stolk, 
Wink et al. 2001, Winsley, Fulford et al. 2005, Brambilla, Bedogni et al. 2006, Thomas, 
Collins et al. 2010, Thomas, Fitzpatrick et al. 2013) 
 
Whole-body scanning provides a detailed quantitative map of adipose tissue content and 
distribution. However, this technique is very time-consuming, both in terms of MRI data 
acquisition (between 5 and 10 min) and image analysis (between 3 and 12 h) and is currently 
used by small groups world-wide. (Thomas, Fitzpatrick et al. 2013) 
 
The standard protocol for full body scan, taken from the original publication by Ross et al. 
(Ross, Leger et al. 1992) involved the acquirement of a large dataset (>110  transverse slices) 
with small inter-slice gaps of 10 mm from head to toe, representing an excellent definition of 
the intra-abdominal fat depots and internal organs.(Thomas, Saeed et al. 1998, Machann, 
Thamer et al. 2005) 
 
Moreover, whole-body imaging has other potential benefits; it can measure other tissues and 
determine organ volumes including skeletal muscle, liver, kidney, heart, pancreas and bone 
marrow.(Bosy-Westphal, Kossel et al. 2009, Lee, Kim et al. 2011, Watson, Pride et al. 2012)  
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Several alternatives to whole-body imaging have been suggested, either to overcome the 
technical short-comings of scanners and/or to shorten examination and analysis time while still 
giving full information on abdominal adiposity. (Thomas, Fitzpatrick et al. 2013)  
 
CT has proven to be one technique that is widely available with lower cost and shorter 
examination time than MRI, its spatial resolution remains superior to the latter and is less 
susceptible to patient’s movements. (Earls 2000) 
 
However, its ionizing radiation as stated previously limits significantly its application in 
longitudinal studies and in paediatric populations. Most significantly, studies have shown that 
patients with complicated disease and symptoms referable to hepatic, adrenal, and pancreatic 
disease may be best served by initial evaluation with MRI, which is more sensitive and specific 
in detecting and characterizing particular symptoms. (Earls 2000, Noone, Semelka et al. 2004, 
Mehta, Thomas et al. 2008, Thomas, Fitzpatrick et al. 2013) 
 
US is another technique that is widely used for determining abdominal adiposity and may be 
the most cost-effective with a more common availability of the modality, level of optimization 
of the modality, staffing, and ease of patient handling.(Noone, Semelka et al. 2004) Although 
as mentioned previously reproducibility and accuracy are poor.(Armellini, Zamboni et al. 
1993, Suzuki, Watanabe et al. 1993) Moreover, they are often subjective to the experience and 
abilities of the operator.(Mehta, Thomas et al. 2008, Shuster, Patlas et al. 2012)  
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Alternatively, this has led some groups to adopt a single-slice imaging technique with MRI for 
a compromise between accuracy and cost, where the anatomical landmark tends to be at the 
level of L4–L5. (Ross, Shaw et al. 1994, Abate, Garg et al. 1997, Shen, Wang et al. 2003, 
Thomas and Bell 2003, Kuk, Church et al. 2006, Kuk, Katzmarzyk et al. 2006, Maislin, Ahmed 
et al. 2012, So, Sasai et al. 2012) (Figure 1.5) 
 
Similarly, acquisition of images from the abdominal region of the body, mainly visceral 
adipose tissue and hepatic ectopic fat, from multi-slice protocols has also been suggested.(Ross, 
Leger et al. 1992, Heymsfield, Wang et al. 1997, Thomas and Bell 2003, Gallagher, Kuznia et 
al. 2005, Yim, Heshka et al. 2007, So, Sasai et al. 2012) 
 
Despite the fact that whole body MRI is the gold standard in terms of accuracy, in practice, 
multiple-slice abdominal MRI is the favoured option in large population studies such as 
biobanks compared to whole body or single-slice MRI. (Shuster, Patlas et al. 2012, Thomas, 
Fitzpatrick et al. 2013) 
 
Numerous studies have used MRI to measure adipose tissue, demonstrating differences in both 
content and distribution in addition to regional differences within the depots as an effect of age, 
BMI, gender, and ethnicity.(Misra, Garg et al. 1997, Thomas, Saeed et al. 1998, Toth, Tchernof 
et al. 2000, Smith, Lovejoy et al. 2001, Miyazaki, Mahankali et al. 2002, Ross, Aru et al. 2002, 
Shen, Punyanitya et al. 2004, Staiano and Katzmarzyk 2012, Thomas, Frost et al. 2012) As 
well as being used extensively to map unusual distributions of adipose tissue in various 
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syndromes such as Prader Willis syndrome, (Goldstone, Brynes et al. 2002, Ostberg, Thomas 
et al. 2005, Mussig, Staiger et al. 2009, McLaughlin, Ryan et al. 2012, Staiano and Katzmarzyk 
2012) MRI is becoming an essential tool in population studies. 
 
MRI has also been employed in interventional studies, quantifying the impact of diet and 
exercise (Ross and Janssen 1999, Christiansen, Paulsen et al. 2009, Viljanen, Lautamaki et al. 
2009, Ismail, Keating et al. 2012) as well the effect of various drugs (Marks, Moore et al. 1996, 
Miyazaki, Mahankali et al. 2002, Virtanen, Hallsten et al. 2003) and obesity surgery on adipose 
tissue content and distribution.(Johansson, Roos et al. 2008) 
 
1.8.2.iv Proton Magnetic Resonance Spectroscopy (1H MRS)  
 
Proton magnetic resonance spectroscopy (1H MRS) allows direct measurement of lipid content 
in different tissues. (Siegelman and Rosen 2001, Mehta, Thomas et al. 2008) It is a fast, safe, 
non-invasive method that has become an essential tool to accurately and reproducibly quantify 
metabolic data and is routinely used to detect fatty infiltration in skeletal muscle and liver. 
(Schick, Eismann et al. 1993, Boesch, Slotboom et al. 1997, Szczepaniak, Babcock et al. 1999, 
Szczepaniak, Nurenberg et al. 2005, Thomas, Hamilton et al. 2005, Thomas, Brynes et al. 
2006, Mehta, Thomas et al. 2008, Thomas, Fitzpatrick et al. 2013)  
 
It is also used to measure both cardiac (Szczepaniak, Dobbins et al. 2003) and 
pancreatic (Lingvay, Esser et al. 2009) fatty infiltrations. However, measurement of ectopic fat 
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in these organs is more technically arduous, due to motion when it comes to the heart, and size 
and location when it comes to the pancreas, leading to a predisposed contamination from 
surrounding adipose tissue signals.  (Cohen, Syme et al. 2013, Thomas, Fitzpatrick et al. 2013) 
 
In most studies, the frequently utilised localised technique is the point-resolved-
spectroscopy  sequence (PRESS ) developed in the early 1980s, (Bottomley 1987) stimulating 
protons within the volume of interest with minimal stimulation outside of this volume. 
 
An alternative sequence used, mainly in the liver, is Chemical Shift Imaging (CSI), which is a 
multi voxel technique that allows metabolite information to be measured in larger volumes of 
tissue that can be divided into smaller voxels of spectra asquisition covering the whole sample 
during the processing period. (Pykett and Rosen 1983, Brateman 1986) This allows spectra 
from across a 2D or 3D plane to be obtained in a single acquisition.(Thomas, Fitzpatrick et al. 
2013) 
 
1.8.2.v MRI-based methods for IHCL & IPCL 
 
Recently, there have been an increasing number of publications, describing new MRI-based 
techniques that have emerged as useful modalities and allow for very high resolution 
assessment of regional variations of fat content. (Fishbein, Castro et al. 2005, O'Regan, 
Callaghan et al. 2008, Cassidy, Yokoo et al. 2009, Lee, Park et al. 2010, Hu, Nayak et al. 2011, 
Patel, Abeysekera et al. 2011, Reeder, Cruite et al. 2011, Thomas, Fitzpatrick et al. 2013) 
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These MRI-based techniques, mainly for evaluating ectopic fat, fall into two categories: those 
that are based on differences in the signal phase of fat and water, and those that utilize the 
chemical shift differences between fat and water resonances and isolate these two components. 
Thus, giving a quantitative measure of the signal fraction of both resonances per se. (Thomas, 
Fitzpatrick et al. 2013) 
 
Those that are based on differences in the signal phase of fat and water are founded on the“
DIXON” sequence. (Dixon 1984) The technique acquires two separate images with a 
modified spin echo pulse sequence. One is a conventional spin echo image with water and fat 
signals in-phase and the other is acquired with the readout gradient slightly shifted so that the 
water and fat signals are 180° out-of-phase.  
 
The availability of both the water-only and fat-only images allows direct image-based water 
and fat quantitation which is now commonly used to incorporate all chemical-shift based 
sequences to attain separate water and fat images. (Thomas, Fitzpatrick et al. 2013) 
 
A fine-tuning of the DIXON technique is the Iterative Decomposition with Echo Asymmetry 
and Least squares estimation (3D IDEAL) imaging and reconstruction method.(Reeder, Pineda 
et al. 2005) This technique combines asymmetrically acquired echoes with an iterative least-
squares decomposition algorithm to maximize noise performance and be independent of the 
proportion of water and fat. (Reeder, Pineda et al. 2005) The advantage of this technique is that 
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the data is acquired as a volume, and is therefore a consistent and reproducible quantitative 
indicator of fat content in tissues. (Bydder, Yokoo et al. 2008) It has also been reported to have 
an improved outcome of fat-to-water ratios, by correcting the limiting factors for transverse 
relaxation (T1 bias and T (2)* decay) and overcoming field inhomogeneity difficulties. 
(Reeder, Cruite et al. 2011, N. S. Patel 2013, Thomas, Fitzpatrick et al. 2013) 
 
More recently, the development and application of multi-echo (ME) MRI sequence has proven 
to be the most accurate in measuring ectopic fat. (O'Regan, Callaghan et al. 2008) ME MRI 
uses a series of echoes acquired as a train following after a single excitation pulse. Multiple 
symmetrical or asymmetrical echoes can be acquired, typically T2 weighted.  
 
From the various images obtained with the ME sequence, decay curves are generated which 
present the change in signal intensity at each of the acquired echo times. This gives rise to 
oscillations in the decay curve depending on how high or low fat infiltration is enclosed in an 
organ .(Thomas, Fitzpatrick et al. 2013) From these data, ‘heat-maps’ can be made to visualise 
regional differences in fat deposition. 
 
The ME-MRI has been regularly used in the liver and pancreas. (Figure 1.5) It has the 
advantage that regional differences in ectopic fat distribution can be measured. Furthermore, it 
is often possible to obtain a single slice containing the liver and pancreas, thus reducing 
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scanning time and allowing coinciding measurement of fat within these two separate 
organs .(Thomas, Fitzpatrick et al. 2013)  
 
1.9  Factors that modulate fat distribution 
 
Regulation of energy homeostasis is a complex process, and that fact conveys a significant 
challenge in trying to explain the pathogenesis of obesity. (Shea, Diamandis et al. 2012) 
 
The intra-uterine environment and early post-natal life, genetic predisposition, environmental 
and behavioural factors certainly play a large role and are key determinants to the response of 
adipose tissue to excess energy intake over energy expenditure (Barker, Gluckman et al. 1993, 
Shea, Diamandis et al. 2012, Snel, Jonker et al. 2012) 
 
1.9.1 Diet 
 
Diets containing a great quantity of low-energy-dense foods and minimal amounts of high-
energy-dense foods should hypothetically prevent obesity. (Baranowski, Cerin et al. 2009) 
 
It has been known that the quality of a diet affects the specific location of the fat that is 
deposited. (Goss, Goree et al. 2013) Some studies have indicated that a relatively greater 
consumption of low glycaemic load (GL) diet is associated with a smaller waist 
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circumference.(Halkjaer, Sorensen et al. 2004) and induces reduction in intra-abdominal 
adipose tissue independent of weight change. (Goss, Goree et al. 2013) 
 
Moreover, a number of cross-sectional studies have shown associations between dietary fatty 
acid composition and fat distribution patterns and accumulation. (Garaulet, Hernandez-
Morante et al. 2006, Kishino, Watanabe et al. 2008, Tchernof and Despres 2013) However, 
research has not consistently supported this relationship. (Rampersaud, Pereira et al. 2005, 
Ledoux, Hingle et al. 2011) This may be due to failure in controlling for potential confounding 
variables such as physical activity.(Ledoux, Watson et al. 2011) 
 
Short-term low energy dense diets can also mobilize ectopic fat stores in all organs.(Snel, 
Jonker et al. 2012), concluding that ectopic and intra-abdominal fat are very responsive to 
weight loss. A loss of 10% of the initial body weight in an obese person for example, can reduce 
visceral fat by ~30% (Borel AL 2012) and ~50% of ectopic fat in the liver.(Vitola, 
Deivanayagam et al. 2009) 
 
Conversely, with high fat feeding, ectopic fat content in humans, especially IHCL, is easily 
modified, followed by visceral fat. (Bachmann, Dahl et al. 2001, Snel, Jonker et al. 2012)  
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1.9.2 Exercise 
 
The health benefits of engaging in regular physical activity have been well established. (Morris, 
Everitt et al. 1980, Blair, Kohl et al. 1989)  It has been regularly recommended as a method of 
improving weight management for its renowned ability to positively impact metabolic (Ryan 
2005) and psychological health. (King, Hopkins et al. 2009, Messier, Rabasa-Lhoret et al. 
2010) 
 
Current physical activity recommendations suggest that ∼250 min of weekly aerobic-type 
exercise is required for body weight management.(Donnelly, Hill et al. 2003, Haskell, Lee et 
al. 2007) Although, weight loss is often much less than anticipated, when exercise is used  as 
the sole mean of intervention.(Miller, Koceja et al. 1997) The actual reduction of weight and 
body fat with the recommended amount of physical activity in overweight and obese 
individuals is often small but increases with exercise levels. (Franz, Vanwormer et al. 2007, 
Donnelly, Blair et al. 2009) However, there is an acknowledgement that even with intensive 
programmes, weight loss in excess of 3–4 kg is challenging to maintain.(Franz, Vanwormer et 
al. 2007)  
 
In fact, diet-induced weight loss seemed to be more beneficial particularly in terms of ectopic 
fat depots and is associated with an improvement of the function of that organ.(Drenick, 
Simmons et al. 1970, Bugianesi, Marzocchi et al. 2004, Snel, Jonker et al. 2012, Schuppan and 
Schattenberg 2013) 
 
82 
 
Some studies reported that, in the short term, IHCL content is similarly reduced after diet only 
or exercise plus diet interventions. (Tamura, Tanaka et al. 2005, Albu, Heilbronn et al. 2010, 
Lazo, Solga et al. 2010) 
 
The type of exercise also plays an important role; Johnson et al.(Johnson, Sachinwalla et al. 
2009) has shown that aerobic exercise training programmes of lower energy expenditure than 
the recommended guidelines can induce a significant reduction in visceral and hepatic fat, even 
in the absence of weight loss. Conversely, resistance exercise training is known to positively 
affect insulin sensitivity and other developments associated with visceral fat accumulation. 
(Albright, Franz et al. 2000, Ismail, Keating et al. 2012) 
 
 
1.9.3 Early Life programing 
 
The intrauterine environment and early postnatal life are now recognized as key determinants 
of disease risk later in life. (Barker, Gluckman et al. 1993) The exposure to an unfavourable 
environment such as a sedentary lifestyle during post-natal life is hypothesized to results in 
compensatory developmental changes that become permanent. 
 
Preterm infants have an altered body composition, demonstrating decreased lean body mass 
and significantly larger fat deposition in deep subcutaneous and internal abdominal 
compartments as well as a significantly greater ectopic fat deposition when compared to their 
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full-term born counterparts. (Uthaya, Thomas et al. 2005) Interestingly these differences 
appear to persist into adulthood with premature adults having increased visceral fat, liver fat, 
and muscle fat compared with control adults born at term. (Thomas, Al Saud et al. 2012) 
 
In addition, low birth weight (LBW) arising from foetal growth restriction or preterm birth, is 
associated to an elevated risk of the metabolic syndrome. (Hales, Barker et al. 1991, Barker 
1997) with an association with insulin resistance and Type 2 diabetes later in life.(Hales, Barker 
et al. 1991, Newsome, Shiell et al. 2003). 
 
Over the last few years an increasing number of extremely preterm babies survived to 
adulthood, abnormalities related to insulin sensitivity, lipid metabolism, blood pressure and fat 
distribution appear to be recurring in these individuals. (Thomas, Al Saud et al. 2012) 
Moreover, unfavourable outcomes associated with preterm birth may extend to the next 
generation, a study by Mathai et al.(Mathai, Derraik et al. 2013) observed a similar increase in 
abdominal adiposity in children born at term of parents born preterm. 
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1.5 Hypothesis 
 
Ectopic fat distribution in the liver and pancreas is heterogeneous and may be determined by 
physiological factors that predicts progressive liver disease and diabetes. 
 
 
1.6 Aims of the thesis 
 
Aims of the thesis are 
 
 To evaluate Multi-echo (ME) imaging based techniques in measuring  fat content and 
distribution in the liver and pancreas 
 
 To determine variation in fat content and distribution in the liver and pancreas in 
lifestyle interventional studies using Multi-echo (ME) imaging based techniques 
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Chapter II: General Research Methods and Procedures 
 
This chapter describes the experimental details of all the techniques and measurements used 
for each investigation in this Thesis. 
 
Personal contribution to research presented in thesis 
 
Owing to the fact that there have been collaborative projects published from aspects of  
the data included in this thesis, it is necessary to outline my personal involvement and   
contribution to the work presented. 
 
During my time as a Phd student I was directly involved in writing the complete ethics of 
the overfeeding study (11/LO/1097) (Appendix 1), as well as being present in the scanning  
procedures of all its participants and performing some of their anthropometric 
measurements. 
 
I was not permitted to do the MRI analysis as data analysis was outsourced for reliability 
(see details in this chapter), but I was mentored by Dr Louise Thomas and radiographer  
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Julie A. Fitzpatrick to inform my work and understanding.  
 
While MR spectroscopy required one trained analyst (for reliability) I performed all the  
Multi-echo analysis in this thesis. 
 
During the course of the research, I personally recruited all the participants included in  
The overfeeding study (11/LO/1097) using emails, newspaper articles, flyers and  
posters. The remaining subjects from the cohort were from other studies in the group, to  
which I was granted access due to my contribution to performing all the ME data analysis. 
 
 
2.1 Ethics 
 
Ethical approval for this study was obtained from NRES Committee London - Queen Square 
(07/Q0411/19, 11/LO/1097, 12/LO/0139 and 10/H0711/91) (Appendix 1). The study was 
submitted for Site Specific Assessment (SSA) at each participating NHS Trust and was 
conducted in accordance with the recommendations for physicians involved in research on 
human subjects adopted by the 18th World Medical Assembly, Helsinki 1964 and later 
revisions. 
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All volunteers gave informed written consent for the study. Informed consent was obtained 
as follows: The study was discussed with each volunteer during a telephone screening 
checklist explaining the study procedures in detail, the potential benefits of participation, 
any potential risks and the rationale of the study itself. 
 
After the call, the individual was sent a participant information sheet (Appendix 1) and was 
given the opportunity to ask questions about the study. If the volunteer wants to take part in 
the study, they are given a participant consent form during a formal screening visit. 
(Appendix 1) Any objection to participating was accepted, and the volunteers did not need 
to provide a reason for a refusal to take part. The volunteers were assured that they were not 
obliged to enrol in the study and it was also made clear that they could withdraw from the 
study at any time without giving a reason and without penalty. 
 
2.2 Participants 
 
Inclusion criteria required that participants be ambulatory with no medical conditions that 
could potentially affect any of the variables under investigation.  
 
Participants were imaged at the Robert Steiner Magnetic Resonance Imaging (MRI) Unit, 
Hammersmith Hospital (London) according to a well-defined and well established protocol. 
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(Thomas, Saeed et al. 1998) This MRI protocol has been used for over a decade to scan and 
determine body fat content and distribution. It also included a clinical health questionnaire 
and anthropometric measurements prior to the MR scan. (Appendix 1) All participants 
completed detailed screening to ensure suitability for inclusion. (Appendix 1) 
 
2.2.1. Recruitment 
 
All participants were recruited via public advertisements, email mailing lists and Imperial 
College Healthcare NHS Trust websites as well as hospital clinics for the bariatric surgery 
intervention and advertisement in newspapers and any existing research volunteer databases. 
 
2.3. Assessment protocol 
 
All participants were asked to attend the MRI Unit on the morning of their booked assessment 
and were asked to be fasted from 11pm the night before. 
 
A complete check of medical history and general information documents were sent to all 
volunteers in advance before their first visit as well as witnessing the signed consent and metal 
check documents (Appendix 1).  Participants were then asked to change into hospital issue 
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theatre garments (scrubs) which was provided for them, retaining only their underwear. All 
jewellery/metal objects were to be removed.  
 
Baseline anthropometric measures were then performed. The MRI scan pre-check was 
completed to ensure that no metal was being taken into the magnet area. This included a verbal 
confirmation from the participant that their signed metal check was accurate.  
 
2.4. Anthropometric measurements 
 
Body mass (kg), height (cm), waist circumference (WC) (cm) and hip circumference (cm) were 
measured in each participant. Body mass was measured by means of a Seca scale (Vogel & 
Halke Hamburg, Germany), while height was recorded using a stadiometer (Invicta Plastics 
Ltd., Leicester, UK). 
 
From these values, BMI (kg/m2), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) 
were calculated. To ensure accuracy and reliability of anthropometric assessment, all 
measurements used established, standardised protocols. 
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2.5 Whole Body Magnetic Resonance Imaging (MRI) Fat scan 
 
On a single visit, participants underwent total body MRI scanning, in vivo proton (¹H) 
magnetic resonance spectroscopy (MRS) and multi-echo MRI of their liver and pancreas. 
 
2.5.1 Calibration 
 
The MR equipment was calibrated each day according to manufacture guideline using a 
standardized phantom to detect drifts in measurements. Additionally, equipment servicing 
and upgrading was performed regularly. 
 
2.5.2 Participant positioning and safety 
 
Participants were instructed to lay still in a prone position with arms straight above the head 
(to minimise respiratory motion and to ensure that large subjects would fit in the bore of the 
magnet).  
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Sandbags and foam pads were used to support / brace limbs and ease muscle tension or 
unnecessary discomfort and ear defenders were worn at all times during scanning. 
 
Participants were then scanned to up to 1 hour from their fingertips to their toes. Participants 
had constantly access to a buzzer to sound an alarm, and were able to hear and respond to 
instructions from the scanning console. The MR scanning environment is shown in (Figure 
2.0). 
 
 
Figure 2.0 Phillips Achieva 1.5T MRI Scanner at the Hammersmith Hospital, London used 
for all MRI/MRS/ME measurements. 
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2.6 MRI assessment of adiposity 
 
2.6.1. MRI of Total Body and Regional Adipose tissue 
 
Whole-body MRI was performed to determine a detailed quantitative map of adipose tissue 
content and distribution using a 1.5T multinuclear scanner (Phillips Achieva-TM, Philips 
Medical Systems, Best, Netherlands).  
 
The images were acquired with a whole body axial T1-weighted fast-spin-echo (FSE) sequence 
using the Q-body coil, without respiratory gating. Imaging parameters: repetition time (TR) 
560ms; echo time (TE) 18ms; slice thickness 10mm; inter-slice gap 10mm; flip angle 90 
degrees; number of excitations 1.  Transverse images were then acquired as nine equal stacks 
of 12 or 13 slices at the iso-centre of the magnet to avoid image distortion. Acquisition of 
images took between 5 and 10 min, depending on the length of the volunteer (Figure 2.1). 
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Figure 2.1 Typical Whole-body Dataset obtained from a Healthy Volunteer, containing 113 
Transverse T1 Weighted Images at 1.5 Tesla (Adipose Tissue appears as High Intensity 
Signal (white)) 
 
2.6.2 MRI Adipose Tissue Quantification (Data Analysis Methods) 
 
MR whole-body images were analysed using the commercially available software slice-O-
matic™ (Tomovision, Montreal, Canada) that employs a threshold based system that relies 
on the image intensity differences between adipose and lean tissues. (Figure 2.2) From the 
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acquired images (120-140 images/subject) the area of adipose tissue depots in (cm²) was 
calculated as the product of pixel number and pixel area. The adipose tissue volumes (cm³) 
of each compartment were calculated by multiplying the adipose tissue depot area by the 
sum of the slice thickness (10 mm) and slice gap (10mm). 
 
 
Figure 2.2 a) T1-weighted Whole Body Coronal Image, for visual purposes this image has 
been segmented into (b) single slice black and white scale image initially processed to 
segment the subcutaneous and internal fat (c) these were labelled with specific colour codes 
for each depot : subcutaneous (green) and internal (red) fat. 
 
Total and regional adipose tissue volumes were recorded in litres (l); comprising total 
adipose tissue (TAT), total subcutaneous adipose tissue (TSAT) and internal adipose tissue 
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(TIAT). These depots were then further refined to enable measurement of abdominal adipose 
tissue depots. (see Table 2.0) 
 
 
Table 2.0 Classification of adipose tissue depots. 
 
Thus, in summary: 
Total Adipose tissue (TAT) = Subcutaneous AT + internal AT 
Total Subcutaneous AT (TSAT) = Abdominal subcutaneous AT (ASAT) + non-abdominal 
(peripheral) subcutaneous AT (NASAT): TSAT = ASAT + NASAT 
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Total internal AT (TIAT) = intra-abdominal AT (IAAT) + non-abdominal (peripheral) 
internal AT (NAIAT): TIAT= IAAT + NAIAT. 
 
Abdominal region: this was defined from the images covering the region from the top of the 
liver down to the top of the head of the femoral bone. For most subjects this corresponds to 
between 15–17 images (Thomas, Saeed et al. 1998), giving intra-abdominal adipose tissue 
(IAAT) and abdominal subcutaneous adipose tissue (ASAT). 
 
Regular quality control duplicate datasets were also used to verify the accuracy of the image 
analysis. In these datasets adipose tissue areas were estimated by a single trained observer. 
The coefficient of Variation (CoV) of the analysis was very low, ranging from <1% for total 
fat to <5% for visceral fat. Adiposity data in this thesis is mainly expressed in absolute 
volume (adipose compartment volume in litres), though wherever necessary   the total 
volume of an adipose compartment as a percentage of body weight (% body-fat) is also 
given. 
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2.6.3 ¹H MR spectroscopy (MRS) of the Liver 
 
During the same scanning session, a ¹H MR spectrum was acquired using a flexible body coil. 
The golden standard ¹H MR was used in this thesis as a correlation to the novel ME based 
technique of image analysis explained below.  
 
Participants were positioned supine, arms resting by their side, and legs supported with the hips 
slightly flexed using a foam wedge (to prevent lumbar discomfort from flat surface of scanning 
table). Transverse images of the liver were used to ensure accurate positioning of a (2 × 2 × 2 
cm³) voxel in the liver, avoiding blood vessels, fatty tissue and the gall bladder. 
 
¹H MR spectra was obtained from the right lobe of the liver using a MRS localisation 
technique known as the PRESS sequence (point-resolved-spectroscopy) (TR 1500ms,TE 
135ms, 128 signal averages) without water suppression (Bottomley 1987, Thomas, Hamilton 
et al. 2005). The right lobe was chosen owing to its larger size.  
 
The coefficient variation of this method is <7% for IHCL.(Thomas, Hamilton et al. 2005). 
Acquisition of images took approx. 2 minutes. (Figure 2.3) 
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2.6.3.i ¹H MR spectroscopy analysis of Liver Fat  
 
¹H MR spectra were analysed to determine the levels of intra-hepatocellular lipid (IHCL) 
using the spectral fitting application jMRUI AMARES.(Naressi, Couturier et al. 2001) 
Quantification of the resonances was performed in the time-domain to fit water and fat, using 
established prior knowledge.(Vanhamme 1997, Thomas, Hamilton et al. 2005) 
 
The resulting spectrum includes resonances arising from water at 4.7 ppm, and the -CH2 and 
-CH3 parts of the fatty acid chain at 1.3 and 0.9 ppm respectively. The raw spectra were 
manually phased and the highest point of the water peak set at 4.7 parts per million.(Thomas, 
Hamilton et al. 2005) (Figure 2.3) 
 
IHCL was quantified in the spectrum as a percentage ratio of the -CH2 lipid resonances with 
reference to water resonance, after correcting for T1 and T2. (Thomas, Hamilton et al. 2005) 
(Figure 2.3) 
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Figure 2.3 Transverse Image showing Location of a 2 × 2 × 2 cm³ PRESS voxel positioned 
within the liver and corresponding ¹H MR Spectra from Volunteers with (a) low and (b) high 
levels of fat infiltration. Resonances can be seen arising from water, and the CH2 and CH3 
parts of the triglyceride for hepatic fat. IHCL content is calculated as the ratio of CH2 to 
water. 
 
2.6.4 Multi-Echo (ME) Imaging of the Liver and Pancreas 
 
During the same scanning session, multi-echo MRI sequence (ME-MRI) was also acquired 
(O'Regan, Callaghan et al. 2008). This method has the potential advantage over single voxel 
MRS in that regional difference in ectopic fat distribution can be assessed for IHCL and 
IPCL. (Thomas, Fitzpatrick et al. 2013) Imaging was performed by using a breath-hold 
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gradient-echo (GE) sequence with seven-echo readout,resulting in a total acquisition time of 
4 seconds for a single section of the liver and/or pancreas. 
 
A six-channel receiver coil was used, and images were acquired in held expiration. A single-
section multi-echo sequence was performed in a transverse plane passing through the liver 
and spleen, superior to the main portal vein. Another single-section multi-echo sequence was 
performed in a transverse plane passing through the pancreas. 
 
The multi-echo sequence parameters were as follows: flip angle, 20°; field of view, 530 mm; 
section thickness, 10 mm; acquired voxel size, 2.5 × 2.5 × 10 mm; repetition time, 17 msec; 
and number of signal average of 2.(O'Regan, Callaghan et al. 2008) 
 
2.6.4.i ME-MRI analysis of IHCL and IPCL 
 
In images acquired with the ME sequence, decay curves are formed which show the change 
in signal intensity at each of the acquired echo times. Signals are usually in-phase (higher 
signal) and out-of-phase (lower signal), at multiple echo times. This enables both 
simultaneous measurement of fat content and T2*. 
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Data obtained at each of the echo times corrects T2* effects, models the fat signal, and 
estimates fat and water proton densities from which the fat content can be calculated. Thus, 
an organ with little or no fat infiltration will generate a very smooth decay curve (without 
obvious oscillations in the decay), whereas one containing a higher level of fat will show 
significant oscillations throughout the decay. (Thomas, Fitzpatrick et al. 2013) From the 
single-section multi-echo sequence, the raw image data was exported from the scanner for 
off-line analysis using Matlab software with an in-house script (Matlab, version 7.0; 
Mathworks, Natick, Mass). 
 
The program performed an automated pixel-by-pixel analysis, after the liver and pancreas 
were isolated manually, to obtain color-coded parametric maps (heat-maps) of the whole 
liver/pancreas fat. This helps visualise regional differences in fat deposition. For instance, 
(Figure 2.4) shows the heat maps from three individuals with varying levels of fat in their 
liver and pancreas. 
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Figure 2.4 A Series of Multi-echo Heat-map Images taken from our ‘Comparing Multi Echo 
MRI and MRS to Measure Pancreatic Fat’ poster at the MRC imaging group showing three 
volunteers with varying levels of ectopic fat in both the liver and pancreas. A scale reflecting 
fat content from blue (low) to red (high) is also shown. Image (a) shows low fatty infiltration 
in liver and pancreas. Image (b) shows high fatty infiltration in liver and pancreas. Image (c) 
shows high fatty infiltration in liver and low fatty infiltration in pancreas. 
 
2.7 Exercise Level Assessment 
 
All participants filled a clinical health questionnaire prior to having the MR scan within the 
questionnaire aimed at determining relative weekly exercise activity (Appendix 1). 
 
This was based on an abridged International Physical Activity Questionnaires (IPAQ) 
method that was previously used and validated by our group. The purpose of the 
questionnaires was to provide data on health–related physical activity from each volunteer. 
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The results were subdivided into: ‘Low’ (1-3 times per week) ‘Moderate’ (3-5 times per 
week) and ‘High’ (>5 times per week). 
 
2.8 Interventional Studies 
 
Subjects originally scanned for the basal phenotyping were recruited specifically to continue 
into interventional studies focused on either reducing or increasing calorie intake in a 
controlled manner. The aim of these two studies was to determine the effects of 
reduced/increased calorie intake on ectopic fat content and distribution. 
 
Similar anthropometric measurements, MR imaging and analysis were obtained from all 
subjects at baseline and at follow ups. 
 
2.8.1 Overfeeding intervention 
 
Subjects were asked to take 600 kcal / day in the form of 2 x 125ml Fortisip Compact drinks 
(NutriDrinks, Perivale, UB6 7LQ, UK) after breakfast on top of their own standard diet for 
a period of 6 days. 
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All subjects were advised not to change their diet or physical activity during the duration of 
the intervention. The control group, which consisted of a gender/BMI matched individuals, 
were asked to drink a 0 kCal drink in the form of a 7UP soda (Dr Pepper Snapple Group 
Inc.; P.O. Box 86077; UK) for a period of 6 days (Appendix 1).  Both groups were scanned 
immediately before and the morning after they finish their intervention. 
 
2.8.2 Calorie Restriction intervention 
 
Subjects were instructed to fill in a 7-day diet diary which was subsequently used as the basis 
for individualised dietary counselling as part of a weight-loss strategy. This required for each 
volunteer to record all food items and drinks that they consumed over a period of 7 
consecutive days (including a weekend).  
 
As part of the dietary assessment, volunteers were also asked to provide details regarding 
the method of food preparation and whether food was prepared at home or 
delivered/prepared, together with all available details of each brand, including packaging. 
Food diaries were analysed using DietPlan6 (Forestfield Software Ltd, West Sussex, UK) 
by a trained independent researcher competent in nutritional analysis. 
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The results from these analyses were subsequently used to advice each subject to reduce 
~500 calorie intake to achieve a desired weight loss. On average it was aimed for subjects to 
achieve a 3.0 kg reduction in weight at the end of a 12 weeks intervention period. 
 
2.8.3 Bariatric Surgery  
 
Morbidly obese subjects were scanned before and after undergoing bariatric surgery to 
monitor the effect of the latter on ectopic fat content and distribution. Besides the normal 
exclusion criteria (Appendix 1), subjects were pre-selected based on their relative size due 
to magnet-bore size.  
 
2.9 Statistical Analysis 
 
Statistical calculations were performed using SPSS software (version 21.0, SPSS Inc,Chicago, 
IL, U.S.A) Microsoft Office Excel 2007 for Windows (Microsoft) and Unistat version 5.6.03, 
London, UK - throughout this thesis. Statistics appropriate to each study can be found in the 
relevant chapter. 
 
 
106 
 
Chapter III:  Determination of Liver and Pancreatic Fat Content and Distribution  
 
3.1 Introduction 
 
Quantification of body and organ fat distribution is essential in physiology research since they 
are indispensably needed in our perception of the causes and effects of steatosis, obesity, the 
metabolic syndrome and their associated co-morbidities. (Hu and Kan 2013) Consequently, 
this has led to a significant increase in our understanding of the relationship between adipose 
tissue and various ectopic fat depots, along with the development of conditions such as type II 
diabetes, cardiovascular disorders and particular types of cancer. (Cassidy, Yokoo et al. 2009, 
Thomas, Fitzpatrick et al. 2013). 
 
Up to the advent of imaging techniques, research into ectopic fat was, to a great degree, limited 
by the need to obtain tissue biopsies. Although muscle and occasionally liver biopsies could be 
attained for research purposes, study of ectopic fat in the heart and pancreas is clearly 
impractical and cannot be performed on living subjects. (N. S. Patel 2013, Thomas, Fitzpatrick 
et al. 2013) As a result, the use of non-invasive techniques for abdominal imaging and assessing 
ectopic fat content in vivo is experiencing exceptional growth in the last few decades. 
(Bartolozzi, Lencioni et al. 1999) 
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Ultrasound, computerized tomography (CT), magnetic resonance imaging (MRI) and proton 
magnetic resonance spectroscopy (¹H MRS) have all played a prominent  role in this process,  
(Mehta, Thomas et al. 2008)  with each technique having important advantages and limitations. 
(Lettner and Roden 2008, Cassidy, Yokoo et al. 2009, Thomas, Fitzpatrick et al. 2013) 
Reported sensitivities and specificities for the detection of ectopic fat deposition, in particular 
fatty liver deposition, have been widely documented, principally by the use of MRS. (Angulo 
2007, Thomas, Parkinson et al. 2012, Angulo, Bugianesi et al. 2013). 
 
In most cases, it has been stated that there is little or no variation in fat content across the liver. 
(Choji 1993, Angulo 2002, Saadeh, Younossi et al. 2002, Rinella, McCarthy et al. 2003) The 
most common and most frequently encountered MR imaging pattern in fatty liver is a diffuse 
and relatively homogeneous fat deposition across the organ. (Hamer, Aguirre et al. 2006) 
However, in a number of cases, fatty infiltration in the liver has been described as being patchy 
in distribution, its heterogeneous appearance is so pronounced that the fat is deposited in a 
constrained region (focal fatty infiltration). Alternatively, detached areas of the liver 
parenchyma remain uninvolved when the remainder of the liver is diffusely infiltrated with fat 
(focal fatty sparing). (Matsui, Kadoya et al. 1995, Hamer, Aguirre et al. 2006) The mechanism 
underlying these differences are yet unknown, nonetheless, these patterns may mimic 
inflammatory or vascular conditions, leading to confusion and to in some cases to unnecessary 
invasive diagnostic tests. (Hamer, Aguirre et al. 2006). 
 
Conversely, fatty pancreas deposition, differs from the relatively general uniform steatosis of 
the liver in Non-Alcoholic Fatty Liver Disease (NAFLD). Furthermore, there are fewer 
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publications regarding the non-invasive measurements of ectopic fat in this organ, due to its 
size and location. (N. S. Patel 2013, Thomas, Fitzpatrick et al. 2013) Insufficient depiction of 
the whole organ and contamination by surrounding adipose tissue contribute to high variability 
and overestimation of lipid contents. (Szendroedi and Roden 2009) Some studies have 
described a focal accumulation of fat in the pancreas, particularly in the anterior aspect of the 
head. (Marchal, Verbeken et al. 1989, Matsumoto, Mori et al. 1995, Isserow, Siegelman et al. 
1999, Kim, Byun et al. 2007) However, no consistent assessment of fat content and distribution 
within the pancreas has been undertaken so far. 
 
This has in part occurred because established MRI techniques assessing steatosis are limited 
by T1 bias, T(2)* decay and multi-frequency signal-interference effects of protons in fat. 
(O'Regan, Callaghan et al. 2008) Furthermore, the gold standard technique, ¹H MRS, only 
measures ectopic fat content in a small single region of interest, requiring repeated 
measurement for any assessment of distribution to be made. (Thomas, Fitzpatrick et al. 2013).  
 
In this chapter, I have used a Multi-echo (ME) imaging based technique to measure fat content 
and distribution in the liver and pancreas. The ability to accurately and noninvasively quantify 
fatty infiltration in organs such as the liver and the pancreas remains a critical component in 
understanding the link between obesity and its comorbidities such as type 2 diabetes and fatty 
liver disease. This technique overcomes some of the above limiting factors mentioned, and has 
therefore the potential to enable more accurate and effective measurement of tissue fat content 
and distribution in a single examination. (O'Regan, Callaghan et al. 2008, N. S. Patel 2013)  
109 
 
I will also be presenting a novel approach to assess ectopic fat distribution in the liver and 
pancreas, to further define potential changes across these organs.  Initially, the technique will 
be tested and validated in a cohort of subjects to ascertain how age, gender, BMI, gestational 
age and life-style affect distribution of fat across the liver and pancreas and their relationship 
to total and abdominal adipose tissue. 
 
3.2 Statistical Analysis 
 
All Data are presented as mean ± standard deviation. Differences related to gender were 
examined using the Student’s t test and overall mean difference for BMI and Age groups using 
ANOVA and a post hoc Tukey test. The distributions of the obtained fat contents were not 
normal, thus non-parametric correlations were analysed using the Spearman rank test. 
Univariate and multivariable linear regression were used to assess the effect of age, gender and 
interaction between age x gender on all the variables. The estimate reported was coefficient ± 
standard error and p-values. Multi-echo imaging and spectroscopy methods were evaluated 
using Bland &Altman plot. Statistical significance was accepted at p<0.05 
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3.3 Results 
 
3.3.1 Whole Cohort Anthropometry, Adiposity and Ectopic Fat measurements 
 
A summary of the anthropometric and body fat measurements for the whole cohort are shown 
in Table 3.0. In total, 61 volunteers (37 male and 24 female) were studied. The mean age of all 
subjects was 45.25 ± 14.34 years (range 18-65 years). 
 
The average BMI for this cohort was 31.4 ± 8.80 kg/m², with wide range of BMIs included in 
the group ranging from 18.7 to 50.9 kg/m². The average weight was 91.3 ± 22.8 kg (range 55.7-
151.1 kg). The mean waist circumference was 101.8 ± 20.8 cm (range 65.0-145.5cm) and 
waist-to-height ratio 0.64 ± 0.12 (range 0.32-0.93). Therefore the average measurements taken 
would make this cohort obese with a mean BMI>30 kg/m2, and at increased risk of metabolic 
disease with mean waist circumference >100cm. 
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Table 3.0 Whole Cohort Anthropometry, Adiposity and Ectopic Fat measurements 
 ALL COHORT (n=61) 
 Mean ± SD Range 
Anthropometric Variables 
Age (years) 45.3 ± 14.3 18-65 
Weight (kg) 91.3 ± 22.8 55.7-151.1 
 
BMI (kg/m²) 31.4 ± 6.1 
 
18.7-50.9 
 
WC (cm) 101.8 ± 20.8 
 
65-145 
 
Hip (cm) 109.3  ± 17.2 
 
55-147 
 
Height (cm) 171.4 ± 10.3 
 
141-192 
 
WHR 0.93 ± 0.10 
 
0.67-1.18 
 
WHtR 0.64 ± 0.12 
 
0.32-0.93 
 
Ectopic Liver Fat 
MRS IHCL 8.45 ± 13.47 
 
0.00-60.54 
ME IHCL 6.79 ± 7.53 
 
0.69-32.27 
 
Ectopic Pancreas Fat 
ME IPCL 5.62 ± 6.03 
 
0.40-24.18 
 
Adiposity Stores 
TAT (L) 37.20 ± 21.66 
 
9.79-87.67 
SAT (L) 30.20 ± 19.3 
 
7.61-76.64 
 
ASAT (L) 9.36 ± 7.08 
 
1.50-28.24 
 
NASAT (L) 20.84 ± 12.45 
 
5.95-51.30 
 
Internal (L) 6.96 ± 3.35 
 
1.45-13.53 
 
IAAT (L) 3.86 ± 2.21 
 
0.28-8.73 
 
NAIAT (L) 3.11 ± 1.29 
 
1.17-6.47 
 
IAAT/ASAT 0.52 ± 0.32 
 
0.10-1.57 
 
All data are presented as mean ± SD and range. WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-
to height ratio; IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid, adipose tissue deposits are 
in litres (l); TAT: total adipose tissue; SAT: subcutaneous adipose tissue; ASAT: abdominal subcutaneous adipose 
tissue; NASAT: non-abdominal subcutaneous adipose tissue; Internal: total internal adipose tissue; IAAT: intra-
abdominal adipose tissue; NAIAT: non-abdominal internal adipose tissue.  
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3.3.1.i Adipose Tissue Content and Distribution of Whole Cohort 
 
Participants had mean TAT content of 37.2 ± 21.7 litres (range: 9.8 - 87.7 litres) with a mean 
SAT of 30.2 ± 19.3 litres (range 7.6 - 76.6 litres). Total internal adipose tissue was subdivided 
into abdominal (IAAT: mean 3.9 ± 2.2 litres, range 0.3 - 8.7 litres) and non-abdominal internal 
adipose tissue (NAIAT: 3.1 ± 1.3 litres (range 1.2 - 6.5 litres). The mean IAAT/ASAT ratio 
(0.52 ± 0.32) (range 0.10 - 1.57), see Table 3.0. 
 
3.3.1.ii Liver Fat Content for the Whole Cohort 
 
IHCL was assessed by two different methods; MRS and ME (see Table 3.0). The mean IHCL 
value using 1H MRS was 8.45 ± 13.47 (range 0.0-60.54) as for ME was 6.79 ± 7.53 (range 
0.69-32.27). The measurements of IHCL obtained using MRS were stratified as being in the 
healthy, normal or elevated range, see Table 3.1. 
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Table 3.1 Classification of IHCL measured by 1H MRS in the Study Population 
IHCL class Number proportion of cohort 
‘Healthy’ range <2% IHCL 29 47.5% 
Normal range <5%  37 60.7% 
Elevated IHCL >5% 24 39.3% 
High IHCL >16%  11 18.03% 
Values of healthy, normal and elevated  levels of IHCL as established by our group. NB Normal values also 
include values from ‘healthy’ group, similarly subjects with liver fat >16% are also included in the group >5%. 
Clinical governance within the MRI unit at Hammersmith Hospital states that volunteers with a measured IHCL 
by 1H MRS of >16% should have this reported to their GP, with the recommendation that they have follow-up 
clinical investigation.  
 
3.3.1.iii Pancreatic Fat Content for the Whole Cohort 
 
Pancreatic fat content was obtained only using ME imaging, since the small size of the pancreas 
makes measurement by MRS unreliable due to contamination from surrounding adipose tissue 
signals. The mean pancreatic fat content was 5.62 ± 6.03, range 0.40-24.18 (see Table 3.0).  
The measurements of pancreatic fat obtained were also stratified as to being in the healthy, 
normal or elevated range, using the normative values for ectopic fat content previously derived 
in the liver see Table 3.2. 
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Table 3.2 Classification of Pancreatic Fat measured by ME Imaging in the Study Population 
class Number proportion of cohort 
‘Healthy’ range <2%  18 29.5% 
Normal range <5%  41 67.2% 
Elevated >5% 20 32.8% 
High >16%  6 9.8% 
There is limited published data of normal ranges of pancreatic fat content available; therefore values of healthy, 
normal and elevated levels of ectopic fat found in the liver were used as a general guide. NB Normal values also 
include values from ‘healthy’ group, similarly subjects with pancreas fat >16% are also included in the group 
>5%.  
 
3.3.2 Correlation Analysis for Whole Cohort Variable 
 
Whole cohort correlation analysis for all anthropometric variables, adipose tissue (in litres) and 
ectopic fat stores (arbitrary units) are shown in Table 3.3. 
 
3.3.2.i  Relationship between Anthropometric Measurements and Adipose tissue Depots 
 
Most of the adiposity store variables correlated with anthropometric variables to a significant 
degree (p<0.01).  BMI was the variable, which correlated to the greatest degree with all 
adiposity stores (TAT: r=0.91, SAT: r= 0.89, Internal : r= 0.80, ASAT : r= 0.90, IAAT : r= 
0.75, p<0.01, Table 3.1) followed by WHtR (TAT: r=0.92, SAT: r= 0.93, Internal: r= 0.66, 
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ASAT : r= 0.92, IAAT: r= 0.60, p<0.01, Table 3.1) and Hip circumference (TAT: r=0.91, SAT: 
r= 0.91, Internal : r= 0.73, ASAT : r= 0.91, and IAAT : r= 0.66,  p<0.01, Table 3.3).  
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Table 3.3 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores and Body Fat Stores in Whole Cohort. 
ALLCOHORT
n=61 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI
MRS 
IHCL
ME 
total 
IHCL
ME total 
IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.025
HEIGHT -.440** .078
WAIST .221 .855** -.156
HIP .207 .813** -.298* .847**
WHR .228 .550** .120 .684** .309*
WHtR .348** .612** -.617** .745** .919** 0.200
BMI 0.247 .854** -.386** .858** .890** .486** .861**
MRS Liver .224 .660** -.021 .716** .601** .653** .487** .623**
ME total IHCL .225 .662** .001 .705** .571** .657** .446** .613** .958**
ME total IPCL .513** .358** -.176 .456** .385** .419** .357** .422** .457** .404**
TAT .274* .764** -.434** .800** .913** .381** .916** .911** .577** .556** .436**
SAT .222 .724** -.471** .760** .912** .295* .931** .890** .518** .491** .365** .989**
Internal .395** .767** -0.146 .809** .726** .672** .655** .801** .748** .742** .586** .820** .740**
SAAT .254* .747** -.451** .772** .908** .350** .916** .902** .558** .526** .406** .980** .983** .761**
NASAT .226 .701** -.488** .748** .900** .277* .931** .877** .492** .463** .343** .983** .995** .725** .969**
IAAT .432** .721** -0.113 .773** .662** .679** .596** .753** .750** .741** .614** .748** .660** .980** .694** .643**
NAIAAT .302* .769** -0.210 .792** .781** .562** .715** .806** .654** .648** .487** .878** .822** .931** .816** .814** .849**
IAAT/ASAT .232 -.164 .441** -.099 -.376** .322* -.459** -.302* .187 .213 .196 -.377** -.481** .151 -.462** -.481** .260* -.066
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
 
All data are presented as Spearman rank test correlation. *p<0.05, **p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-
hepatocellular lipid; IPCL: intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous adipose tissue; ASAT: abdominal subcutaneous adipose tissue; NASAT: non abdominal 
subcutaneous adipose tissue; Internal: total internal adipose tissue; IAAT: intra-abdominal adipose tissue; NAIAT: non-abdominal internal adipose tissue. 
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3.3.2.ii  Relationship between Liver Fat, Adipose Tissue and Anthropometry 
 
There were significant correlations between IHCL and measures of anthropometry and 
adiposity, regardless of which method, (MRS or ME imaging), was used to measure IHCL 
content (see Table 3.3). For simplicity from here on, correlations from both methods will be 
presented in the tables, whilst only data obtain by ME will be given in the text. 
 
There was a significant correlation between IHCL and body weight (r=0.66, p<0.01) and waist 
circumference (r=0.71, p<0.01). Internal adipose tissue, particularly IAAT was the variable 
which correlated most strongly with IHCL content (r=0.74, p<0.01), see figure 3.1 followed 
by the Internal adiposity store (r=0.74, p<0.01).  
 
There were significant, but weaker correlations between IHCL and subcutaneous adipose tissue 
depots (r=0.49, p<0.01). 
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Figure 3.1 Relationship between IAAT and IHCL measured by ME Imaging. 
 
3.3.2.iii  Relationship between Pancreatic Fat, Adipose Tissue and Anthropometry 
 
There were significant correlations between IPCL, anthropometry and adiposity; However, 
these were in general weaker than those observed in the liver (Table 3.3). 
 
There was a strong correlation between age and IPCL (r= 0.51, p<0.01), indeed the correlation 
between IPCL and age, was stronger than the correlation with age and any of the other variables 
measured. 
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As with IHCL, the most significant correlations were between IPCL and internal adipose tissue 
(internal: r=0.59, p<0.01, IAAT: r=0.61, p<0.01). Interesting the relationship between IPCL 
and IHCL was weaker (see Figure 3.2), although still significant (r=0.40, p<0.01). 
 
Figure 3.2 Relationship between IHCL and IPCL both measured by ME Imaging. 
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3.3.3 Comparison between MRS and ME to measure IHCL 
 
There was a very strong correlation (r=0.96, p<0.01) between the MRS and ME imaging 
technique in assessing IHCL in the whole cohort. To further assess the validity of the 
techniques, Bland-Altman plot (Bland and Altman 1986) was utilised.  MRS was analysed 
against ME to determine the 95% limits of individual agreement, see Figure 3.3.  
 
Agreement between MRS and ME in measuring IHCL showed a mean difference of 1.66±6.75. 
In general there was good agreement between the two methods. However, substantial 
differences were observed between the two techniques at very high levels of IHCL. This arises 
from the differences in the formula used to calculate IHCL content in the two methods (MRS: 
fat/water ratio and ME: (fat/water + fat) ratio) rather than a differentiation in absolute levels of 
IHCL detected by the two techniques. 
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Figure 3.3 Bland Altman Plot showing agreement between MRS and ME in measuring IHCL. 
Central Line is group mean difference and the outer lines represent ± 2 standard deviations. 
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3.3.4 Gender Differences in Anthropometry, Adiposity and Ectopic Fat Measurements 
 
There were significant gender differences within this cohort, see Table 3.4. Females were 
significantly older (50.2 ± 11.1 vs. 42.1 ± 15.4 years, p=0.02) with a much greater BMI than 
their male counterparts (36.5 ± 10.0 vs. 28.1 ± 6.1 kg/m2, p<0.01). Similarly female subjects 
had significantly higher hip circumference (120.5 ± 17.4 vs. 102.1 ± 12.7 cm, p<0.01) 
compared with the male subjects. Waist circumference was also greater in the female group, 
though this did not reach significant (107.8 ± 23.6 vs. 97.8 ± 17.9 cm, p=0.08). 
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Table 3.4 Gender Differences in Anthropometry, Adiposity and Ectopic Fat Measurements 
 Male Subjects (n=37) Female Subjects (n=24)  
 Mean ± SD Range Mean ± SD Range p 
Anthropometric Variables  
Age (years) 42.1 ± 15.4 19-65 50.2 ± 11.1 18-64 0.02 
Weight (kg) 88.7 ± 20.2 63.2-151.1 
 
95.4 ± 26.3 55.7-135 
 
0.30 
BMI (kg/m²) 28.1 ± 6.1 
 
18.7-48.1 
 
36.5 ± 10.0 
 
21.6-50.9 
 
0.001 
WC (cm) 97.8 ± 17.9 
 
65-139 
 
107.8 ± 23.6 
 
74-145.5 
 
0.09 
Hip (cm) 102.1  ± 12.7 
 
55-133.5 
 
120.5  ± 17.4 
 
90.3-147 
 
<0.001 
Height (cm) 177.7 ± 6.7 
 
165-192 
 
161.6 ± 6.60 
 
141-171.8 
 
<0.001 
WHR 0.96 ± 0.09 
 
0.80-1.18 
 
0.89 ± 0.10 
 
0.67-1.02 
 
0.01 
WHtR 0.57 ± 0.10 
 
0.32-0.75 
 
0.75 ± 0.11 
 
0.55-0.93 
 
<0.001 
Liver Fat  
MRS IHCL 8.16 ± 13.78 
 
0.00-59.57 8.91 ± 13.25 
 
0.15-60.54 0.83 
ME IHCL 6.80 ± 7.95 
 
0.70-32.27 
 
6.78 ± 7.00 
 
0.69-30.00 
 
0.99 
Pancreas Fat  
ME IPCL 5.18 ± 6.12 
 
0.40-24.18 
 
6.29± 5.96 
 
0.55-21.62 
 
0.48 
Adiposity Stores  
TAT (L) 27.18 ± 15.08 
 
9.79-70.33 52.54 ± 21.48 
 
22.03-87.67 <0.001 
SAT (L) 20.68 ± 12.2 
 
7.61-59.11 
 
44.87 ± 19.19 
 
18.47-76.64 
 
<0.001 
ASAT (L) 6.18 ± 4.08 
 
1.50-22.64 
 
14.26 ± 7.35 
 
4.78-28.24 
 
<0.001 
NASAT (L) 14.50 ± 7.55 
 
5.95-36.47 
 
30.62 ± 12.28 
 
13.24-51.30 
 
<0.001 
Internal (L) 6.51 ± 3.5 
 
1.45-13.53 
 
7.67 ± 3.08 
 
2.01-13.33 
 
0.18 
IAAT (L) 3.72 ± 2.40 
 
0.28-8.73 
 
4.06 ± 1.91 
 
0.68-7.56 
 
0.55 
NAIAT (L) 2.78 ± 1.20 
 
1.17-6.47 
 
3.61 ± 1.28 
 
1.34-5.95 
 
0.02 
IAAT/ASAT 0.66 ± 0.32 
 
0.12-1.57 
 
0.31 ± 0.15 
 
0.10-0.77 
 
<0.001 
All data presented as mean ± SD and range. Where: WC: waist circumference; WHR: waist-to-hip ratio; 
WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid, 
Adipose tissue deposits are in litres; TAT: total adipose tissue; SAT: subcutaneous; ASAT: abdominal 
subcutaneous; NASAT: non-abdominal subcutaneous; Internal: total internal; IAAT: intra-abdominal; 
NAIAT: non-abdominal internal. Male versus female data were analysed by unpaired Student’s t-test 
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3.3.4.i Gender Differences in Adipose Tissue Content 
 
As might be expected due to their greater sizes and perhaps age, female subjects had higher 
levels of adipose tissue in all depot measured when compared to male subjects, see Table 3.4. 
Interestingly, while these gender differences were significant for subcutaneous depots (SAT 
p<0.001, ASAT p<0.001, NASAT p<0.001), they did not reach significance in internal depots 
(internal p=0.18, IAAT p=0.55).  
 
To account for the differences in size, adipose tissue depots were assessed as a proportion of 
total adipose tissue content, to determine whether there were differences in adipose tissue 
distribution independent of body size, see Table 3.5. 
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Table 3.5 Gender Differences in Adipose Tissue Depots as a Proportion of Total Adipose 
Tissue Content 
 Male Subjects (n=37) Female Subjects (n=24) significance 
% SAT  75.73 ± 6.22 
 
84.94 ± 4.06 
 
<0.001 
% ASAT  21.16 ± 4.13 
 
26.10 ± 4.37 
 
<0.001 
% NASAT  54.57 ± 5.58 
 
58.84 ± 4.08 
 
0.001 
% Internal  24.27 ± 6.22 
 
15.06 ± 4.06 
 
<0.001 
% IAAT  13.25 ± 5.48 
 
7.81 ± 2.75 
 
<0.001 
% NAIAT  11.02 ± 2.48 
 
7.25 ± 1.82 
 
<0.001 
All data presented as mean ± SD. Adipose tissue depots are expressed as a percentage of total adipose tissue 
content. SAT: subcutaneous; ASAT: abdominal subcutaneous; NASAT: non-abdominal subcutaneous; Internal: 
total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal. Male versus female data were analysed 
by unpaired Student’s t-test 
 
From Table 3.5, it can be clearly seen that despite the differences in size, there are clear gender 
differences in adipose tissue distribution between the groups.  
 
Male subjects carrying a significantly greater proportion of their adipose tissue internally 
(Male: 24.27 ± 6.22 vs. Female: 15.06 ± 4.06%, p<0.001) whereas female subjects carry a far 
higher proportion of their adipose tissue externally as subcutaneous adipose tissue (Female: 
84.94 ± 4.06 vs. Male: 75.73 ± 6.22%, p<0.001). 
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3.3.4.ii Gender Differences in Liver Fat Content 
 
There were no significant gender differences in IHCL measured by either MRS (Male: 8.16 ± 
13.78 vs. Female: 8.91 ± 13.25 p=0.83) or ME imaging (Male: 6.80 ± 7.95 vs Female: 6.78 ± 
7.00, p=0.99). 
 
3.3.4.iii Gender Differences in Pancreatic Fat Content 
 
There were no significant gender differences in IPCL between male and female subjects (Male: 
5.18 ± 6.12 vs. 6.29± 5.96 p=0.48). 
 
3.3.5 Interaction between Age, Gender and Adipose Tissue 
 
The specific interaction between gender and age was further investigated using Multivariate 
linear regression analysis (AGE x GENDER). The following variables had a significant impact 
on the interaction between the two: BMI, Weight, WC, WHR, TAT, SAT, ASAT, NASAT 
(Table 3.6 and Table 3.7) (p<0.05 for all). However, the mean values of Internal and IAAT 
were not significantly different between the two groups in the regression analysis. 
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3.3.6 Interaction between Age and Gender and IHCL 
 
Gender differences in IHCL content were detected in the multivariate analysis when age was 
adjusted for (Table 3.6 and Table 3.7), with male subjects having on average lower IHCL 
relative to female subjects , but this difference did not reach statistical significance (p=0.125). 
 
3.3.7 Interaction between Age and Gender and IPCL 
 
As previously observed in Table 3.3, there was a significant correlation between IPCL and age, 
however when the effect of Gender was adjusted for, the significance disappeared. 
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Table 3.6 Gender Specific Anthropometric Variable, Adiposity and Ectopic fat in Univariate 
Analysis 
GENDER β ᵃ GENDER p AGE β AGE p
Age (yrs) - - -
Weight (kg) -6.63±5.96 0.271 -0.14±0.21 0.52
BMI (kg/m²) -8.44±2.05 <0.001 0.07±0.08 0.38
WC (cm) -9.96±5.33 0.067 0.237±0.19 0.23
Hip (cm) -18.43±3.85 <0.001 0.16±0.15 0.31
Height (cm) 16.02±1.74 <0.001 -0.35±0.08 <0.001
WHR 0.07±0.025 0.009 0.001±0.001 0.259
WHtR -0.17±0.023 <0.001 0.002±0.001 0.044
MRS IHCL -0.76±3.56 0.83 0.10±0.12 0.42
ME IHCL 0.02±1.99 0.99 0.08±0.07 0.23
ME IPCL -1.11±1.59 0.486 0.19±0.05 <0.001
TAT (L) -25.36±4.68 <0.001 0.24±0.19 0.231
SAT (L) -24.20±4.01 <0.001 0.15±0.17 0.40
ASAT (L) -8.08±1.55 <0.001 0.05±0.06 0.417
NASAT (L) -16.12±2.54 <0.001 0.10±0.11 0.399
Internal (L) -1.16±0.87 0.187 0.09±0.028 0.003
IAAT (L) -0.34±0.58 0.567 0.07±0.02 <0.001
NAIAT (L) -0.83±0.32 0.013 0.02±0.01 0.076
IAAT/ASAT 0.35±0.07 <0.001 0.006±0.003 0.049
Adiposity Stores
Anthropometeric Variables
Ectopic Liver Fat
Ectopic Pancreas Fat
The effect of age and gender on anthropometric variables, individual adiposity and ectopic fat stores was 
determined using univariate regression analysis. Anthropometric variables, ectopic fat and adiposity depots were 
the dependent variables with age (year) and gender (male = 1, female = 0) as the independent variables. β 
represents the regression coefficient for each independent variable included in the model ± standard error. a Gender 
β represents difference for male minus female. WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-
to-height ratio; IHCL:  intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid. Adipose tissue deposits are 
in liters (l); TAT: total adipose tissue; SAT: subcutaneous AT; ASAT: abdominal subcutaneous AT; NASAT: 
non-abdominal subcutaneous AT; Internal: total internal AT; IAAT: intra-abdominal AT; NAIAT: non-abdominal 
internal AT. 
 
 
 
 
129 
 
Table 3.7 Gender Specific Anthropometric Variable, Adiposity and Ectopic Fat in Multivariate 
Analysis 
GENDER X 
AGE  P-value
Anthropometric Variables β ± SE P-value β ± SE P-value
Weight (kg)ᵇ 0.020 -63.25±23.65 0.010 -1.07±0.41 0.012
BMI (kg/m²)ᵇ 0.024 -27.03±8.22 0.002 -0.30±0.14 0.041
WC (cm)ᵇ 0.026 -55.71±21.28 0.011 -0.58±0.37 0.123
Hip (cm) 0.116 -43.01±15.79 0.009 -0.40±0.28 0.149
Height (m) 0.940 14.81±6.57 0.028 -0.20±0.11 0.082
WHRᵇ 0.019 -0.14±0.10 0.147 -0.002±0.002 0.320
WHtR 0.150 -0.30±0.09 0.002 -0.001±0.002 0.370
Ectopic Liver Fat
MRS IHCL 0.280 -15.49±14.70 0.300 -0.14±0.56 0.580
ME IHCL 0.094 -12.50±8.03 0.125 -0.12±0.14 0.405
Ectopic Pancreas Fat
ME IPCL 0.167 -7.39±5.83 0.210 0.08±0.10 0.464
TAT (L)ᵇ 0.010 -73.10±18.51 <0.001 -0.75±0.32 0.023
SAT (L)ᵇ 0.008 -67.01±15.76 <0.001 -0.75±0.28 0.009
ASAT (L)ᵇ 0.042 -20.85±6.25 0.001 -0.22±0.11 0.045
NASAT (L)ᵇ 0.003 -46.16±9.79 <0.001 -0.53±0.17 0.003
Internal (L) 0.089 -6.09±3.34 0.074 -0.01±0.06 0.934
IAAT (L) 0.104 -3.21±2.15 0.141 0.02±0.04 0.687
NAIAT (L) 0.093 -2.88±1.31 0.032 -0.02±0.02 0.382
IAAT/ASAT 0.417 0.22±0.26 0.390 0.006±0.004 0.151
AGE
Adiposity Stores
GENDER
The effect of age and gender on anthropometric variables, individual adiposity and ectopic fat stores was 
determined using a multivariate regression analysis. Anthropometric variables, ectopic fat and adiposity depots 
were the dependent variables with age (year), gender (male = 1, female = 0) and GENDER X AGE interaction as 
independent variables. β represents the regression coefficient for each independent variable included in the final 
model ± standard error. Gender β represents difference for male minus female.  b represents all the gender x age 
interaction  that was significant. WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio; 
IHCL:  intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid. Adipose tissue deposits are in liters (l); 
TAT: total adipose tissue; SAT: subcutaneous AT; ASAT: abdominal subcutaneous AT; NASAT: non-abdominal 
subcutaneous AT; Internal: total internal AT; IAAT: intra-abdominal AT; NAIAT: non-abdominal internal AT. 
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3.3.8 Impact of Age and Gender on the Relationship between Anthropometric 
Measurements and Adipose Tissue Depots   
 
Gender-specific correlation analysis for all anthropometric variables, adipose tissue (in litres) 
and ectopic fat stores (arbitrary units) are shown in Table 3.8 (Male) and Table 3.9 (Female).  
 
Apart from a few exceptions (Height and the majority of IAAT/ASAT ratio), all variables 
correlated with each other to a significant degree (p<0.01).  
 
3.3.8.i Relationship between Anthropometric Measurements and Adipose Tissue Depots  
in Male Subjects 
 
Most of the adiposity store variables correlated with the anthropometric parameters to a 
significant degree (p<0.01).  BMI was the variable, which correlated to the greatest degree with 
all adiposity stores in male subjects (TAT: r=0.88, SAT: r=0.88, Internal: r=0.79, SAAT: 
r=0.90, IAAT: r=0.78, p<0.01, Table 3.8) followed by WC (TAT: r=0.87, SAT: r=0.84, 
Internal: r=0.83, SAAT: r=0.84, IAAT: r=0.81, all p<0.01) 
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 Interestingly, Age was strongly associated with, Internal (r=0.55, p<0.01), IAAT (r=0.58, 
p<0.01), and IAAT/ASAT ratio (r=0.52, p<0.01). 
 
3.3.8.ii Relationship between Anthropometric Measurements and Adipose Tissue Depots  
in Female Subjects 
 
In female subjects, BMI once again was the variable, which correlated to the greatest degree 
with all adiposity stores (TAT: r=0.94, SAT: r=0.94, Internal: r=0.78, SAAT : r=0.91, IAAT: 
r=0.69, p<0.01, Table 3.9) followed by Hip (TAT: r=0.93, SAT: r= 0.93, Internal: r=0.80, 
SAAT : r=0.85, and IAAT: r= 0.76, all p<0.01).  
 
Age however lost its correlation in female subjects and only strongly associated with 
IAAT/ASAT ratio (r=0.55, p<0.01).  
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Table 3.8 Linear Correlation Analysis between Anthropometric Measurements, lipid Stores and Body Fat stores in Male Participants. 
MALES
n=37 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI
MRS 
IHCL
ME 
total 
IHCL
ME total 
IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT .126
HEIGHT -.496** .345*
WAIST .465** .772** .016
HIP .223 .824** 0.233 .893**
WHR .570** .584** -.213 .780** .569**
WHtR .409* .702** -0.162 .917** .906** .664**
BMI .375* .837** -0.175 .834** .766** .747** .862**
MRS Liver .363* .588** .112 .679** .646** .710** .588** .607**
ME total IHCL .452** .526** -.008 .654** .605** .698** .588** .591** .944**
ME total IPCL .602** .412* -.148 .560** .408* .671** .420** .485** .474** .445**
TAT .374* .821** -0.006 .870** .817** .809** .846** .881** .624** .612** .519**
SAT .282 .815** -0.004 .842** .830** .739** .854** .876** .569** .570** .441** .981**
Internal .550** .719** -0.026 .826** .684** .906** .722** .789** .735** .736** .603** .900** .823**
SAAT 0.317 .827** -0.030 .835** .810** .782** .837** .897** .616** .600** .519** .974** .977** .847**
NASAT .274 .779** -0.009 .831** .810** .718** .845** .844** .524** .524** .400* .973** .991** .803** .952**
IAAT .581** .686** -0.087 .809** .655** .886** .719** .784** .729** .732** .610** .861** .775** .985** .812** .752**
NAIAAT .456** .733** 0.138 .768** .675** .827** .641** .710** .674** .669** .516** .889** .830** .938** .826** .824** .880**
IAAT/ASAT .520** -.129 -0.183 .034 -0.165 0.273 -.085 -.031 .277 .319 .277 0.009 -0.12 .368* -0.091 -0.129 .445** .220
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
 
All data are presented as Spearman rank test correlation.*= p<0.05, **= p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-
hepatocellular lipid; IPCL: intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non abdominal subcutaneous; Internal: total 
internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal 
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Table 3.9 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores and Body Fat Stores in Female Participants. 
FEMALES
n=24 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI
MRS 
IHCL
ME 
total 
IHCL
ME total 
IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.392
HEIGHT -0.316 .196
WAIST -.222 .878** -.131
HIP -.213 .947** 0.058 .899**
WHR -.144 .566** -.254 .818** .539**
WHtR -0.145 .893** -0.126 .914** .967** .582**
BMI -0.300 .943** -0.074 .932** .916** .684** .924**
MRS Liver -.068 .683** -.057 .740** .670** .712** .694** .691**
ME total IHCL -.094 .751** .012 .776** .722** .690** .711** .737** .970**
ME total IPCL 0.237 0.300 -.173 0.293 0.349 0.137 0.378 0.293 .460* .429*
TAT -0.380 .981** 0.126 .865** .932** .543** .884** .938** .639** .704** 0.381
SAT -.420* .988** 0.167 .849** .927** .520** .870** .940** .616** .692** 0.318 .991**
Internal -0.043 .782** -0.043 .774** .799** .533** .816** .783** .768** .774** .588** .816** .774**
SAAT -0.250 .931** 0.057 .853** .953** .527** .906** .908** .620** .679** 0.294 .926** .930** .731**
NASAT -.444* .965** 0.152 .817** .890** .491* .849** .911** .576** .638** 0.299 .974** .981** .751** .894**
IAAT 0.059 .710** -0.047 .704** .756** .457* .781** .690** .799** .794** .637** .730** .685** .965** .681** .662**
NAIAAT -0.160 .791** -0.084 .788** .806** .530** .813** .823** .652** .673** .500* .849** .814** .937** .754** .787** .831**
IAAT/ASAT .549** -.316 -0.124 -.217 -0.271 -0.142 -.190 -.307 .165 .116 .454* -0.295 -0.35 .189 -0.403 -0.333 0.317 -.005
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
 
All data are presented as Spearman rank test correlation. *= p<0.05, **= p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-
hepatocellular lipid; IPCL: intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non abdominal subcutaneous; Internal: total 
internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal 
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3.3.8.iii Relationship between Body Composition Measurements and IHCL in Male 
Subjects 
 
In male subjects, internal adiposity correlated to the greatest degree with IHCL (IAAT: r=0.73, 
p<0.01; Internal r=0.74, p<0.01, Table 3.8).  
 
There was also a strong correlation between IHCL and WHR (r=0.70, p<0.01). Furthermore, 
all anthropometric parameters were greatly associated with all individual ectopic fat depots, 
except for height.  
 
3.3.8.iv Relationship between Body Composition Measurements and IHCL in Female 
Subjects 
 
Female subjects had similar adiposity stores correlating to IHCL (IAAT: r=0.79 followed by 
Internal: r=0.77, p<0.01, Table 3.9).  IHCL in females was also considerably associated with 
all anthropometric variables except for Age and Height, in particular, WC (r=0.78 p<0.01,) and 
Weight (r=0.75, p<0.01).  
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3.3.8.v Relationship between Body Composition Measurements and IPCL in Male 
Subjects 
 
In male subjects, internal adiposity was also correlated to the greatest degree with IPCL 
(Internal AT: r=0.60, p<0.01, IAAT r=0.61, p<0.01, Table 3.8).  
 
WHR and age were also strongly associated with IPCL (WHR: r=0.67, p<0.01, age r=0.60, 
p<0.01). There was a significant but weaker correlation between IPCL and IHCL (r=0.44, 
p<0.01). 
 
3.3.8.vi Relationship between Body Composition Measurements and IPCL in Female 
Subjects 
 
Female subjects also had the strongest correlations between IPCL and internal stores of adipose 
tissue, (IAAT: r=0.64, p<0.01, Internal: r=0.59, p<0.01, Table 3.9).  
 
There was lack of association with IPCL and any of the anthropometric variables.  
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3.3.8.vii Impact of Correcting for Waist Circumference on the Relationship between  
Adiposity and Ectopic Fat 
 
After adjusting for Waist circumference, the correlation between IAAT and IHCL was reduced 
in both male subjects (r= 0.43, p=0.009) and female subjects (r= 0.33, p=0.13).  
 
This had no impact on the relationship between IAAT and IPCL in female subjects but the 
correlation between IAAT and IPCL was reduced in male subjects (r=0.36, p=0.033). 
 
3.3.8.viii Impact of Correcting for Weight on the Relationship between  Adiposity and 
Ectopic Fat 
 
When Weight was adjusted for in female subjects, the relationship between IPCL and Internal 
adiposity stores was unchanged.   
 
For males the association with IAAT with IHCL (r=0.46, p=0.006) and IPCL (r=0.48, p=0.004) 
was similar. Adjustment is for Waist or Weight, made little difference in either genders. 
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3.3.9 The Impact of Age on Body Composition 
 
The age of subjects ranged from 18-65 years, with a mean age of 42 ± 15.4 years in men and 
50.2 ± 11.1 years in women.  
 
Age grouping was split for every 10 years (Thomas, Parkinson et al. 2012) which corresponded 
to the following ranges; 1: 16-25 years, 2: 26-35 years, 3: 36-45 years, 4: 46+ years. 15% of 
all subjects classified as group 1 (16-25 years old), 13% qualifying as group 2 (26-35 years 
old), 20% group 3 (36-45 years old) and 53% as group 4 (46+ years old), see Table 3.10 
 
3.3.9.i The Impact of Age on Anthropometry 
 
There was a tendency for BMI to increase with age, but this did not reach significance (p=0.59), 
see Table 3.10  
 
Similarly there were no age related changes in any of the other anthropometric parameters 
measured: weight (p=0.72), WC (p=0.32), Hip (p=0.66), WHR (p=0.23) or WHtr (p= 0.13).  
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Table 3.10 Age Group Specific Summary Measures in Whole Cohort 
 Data for whole cohort  
Age Group  16-25 26-35 36-45 >46  
number 9 8 12 32 p 
Anthropometric Variables  
Age (years) 22.3 ± 2.7 30.9 ± 2.9 40.8 ± 2.3 56.9 ± 6.2 <0.001 
Weight (kg) 88.2 ± 20.6 99.3 ± 27.8 93.0 ± 27.6 89.6 ± 20.7 0.72 
BMI (kg/m²) 28.0 ± 8.5 30.3 ± 9.9 31.9 ± 10.6 32.5 ± 8.0 0.59 
WC (cm) 92.2 ± 21.9 105.1 ± 20.9 97.4 ± 24.2 105.2 ± 18.8 0.32 
Hip (cm) 104.2 ± 14.8 107.9 ± 12.2 107.5 ± 25.9 111.8 ± 15.0 0.66 
Height (cm) 178.9 ± 7.4 182.0 ± 7.4 171.4 ± 8.8  166.6 ± 9.0 <0.001 
WHR 0.88 ± 0.08 0.97 ± 0.10 0.91 ± 0.12 0.94 ± 0.10 0.23 
WHtR 0.58 ± 0.10 0.59 ± 0.09 0.63 ± 0.17 0.67 ± 0.11 0.13 
Ectopic Liver Fat  
MRS IHCL 2.51 ± 4.41 7.05 ± 7.47 14.47 ± 21.95 8.22 ± 11.74 0.24 
ME IHCL 2.64 ± 3.64 7.03 ± 5.55 9.03 ± 10.88 7.06 ± 7.09 0.28 
Ectopic Pancreas Fat  
ME IPCL 1.72 ± 1.30 2.61 ± 1.37 5.54 ± 6.41 7.49 ± 6.67 0.03 
Adiposity Stores  
TAT (L) 26.22 ± 21.46 35.13 ± 24.76 39.48 ± 26.78 39.87 ± 18.73 0.40 
SAT (L) 21.87 ± 19.06 28.61 ± 21.87 32.80 ± 24.40 31.95 ± 16.78 0.54 
ASAT (L) 6.25 ± 6.40 8.75 ± 7.13 10.14 ± 8.28 10.09 ± 6.85 0.53 
NASAT (L) 15.62 ± 12.67 19.86 ± 14.85 22.66 ± 16.27 21.87 ± 10.22 0.56 
Internal (L) 4.35 ± 2.58 6.52 ± 3.40 6.67 ± 3.54 7.92 ± 3.14 0.04 
IAAT (L) 2.02 ± 1.55 3.28 ± 1.81  3.65 ± 2.23 4.59 ± 2.16 0.01 
NAIAT (L) 2.32 ± 1.14 3.24 ± 1.65 3.03 ± 1.40 3.33 ± 1.16 0.22 
IAAT/ASAT 0.41 ± 0.23 0.49 ± 0.24 0.50 ± 0.36 0.57 ± 0.34 0.57 
WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; 
IPCL: intra-pancreatic cellular lipid, Adipose tissue deposits are in litres (l); TAT: total adipose tissue; SAT: 
subcutaneous; ASAT: abdominal subcutaneous; NASAT: non abdominal subcutaneous; Internal: total internal; 
IAAT: intra-abdominal; NAIAT: non-abdominal internal. All data are presented as mean ± SD.  
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3.3.9.ii The Impact of Age on Adiposity 
 
There was a trend of total and subcutaneous adipose stores to increase with age, but this did 
not reach significance: TAT (p=0.40), ASAT (p=0.53) and SAT (p=0.54). There was a 
significant increase in both Internal (p=0.04) and IAAT (p=0.01) with age. 
 
3.3.9.iii The Impact of Age on Liver Fat Content 
 
There was a trend for an increase in IHCL from the 16-25 age group to the 36-45 age group, 
after which there was no further increase, although none of these changes were statistically 
significant (p=0.28) (Table 3.10, Figure 3.4)   
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Figure 3.4 Change in IHCL with Age 
 
3.3.9.iv The Impact of Age on Pancreatic Fat Content 
 
The mean value of IPCL, on the other hand, rose significantly (p=0.03) throughout the different 
age groups, (Table 3.10, Figure 3.5). 
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Figure 3.5 Increasing IPCL with Age 
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3.3.10 Impact of Body Mass Index (BMI) on Body Composition 
 
BMI grouping corresponded to the following ranges; 1: 18-25 kg/m², 2: 25-30 kg/m², 3: 30-40 
kg/m², 4: >40 kg/m². BMI ranged from 18.7 – 50.9 kg/m², with a mean of 28.1 ± 6.1 kg/m² in 
men and 36.5 ± 10.0 kg/m² in women. 32.8% of all subjects were classified as overweight 
(BMI: 25<30), 18.0% were classed as obese (BMI: 30<40) while 23% were morbidly obese 
(BMI: 40+), see Table 3.11. 
 
 
3.3.10.i Impact of Body Mass Index (BMI) on Anthropometry 
 
All anthropometric parameters increased significantly throughout the BMI groups Weight, 
WC, Hip, WHR and WHtr, (p<0.001 for all), see Table 3.11.  
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Table 3.11 BMI Group Specific Summary Measures in Whole Cohort 
 Data for whole cohort  
BMI Group  1 2 3 4  
number 16 20 11 14 p 
Anthropometric Variables  
Age (years) 36.1 ± 12.1 48.5 ± 14.60 54.3 ± 13.8 43.9 ± 11.6 0.01 
Weight (kg) 71.9 ± 8.9 80.3 ± 8.1 97.4 ± 9.2 124.5 ± 16.6 <0.001 
BMI (kg/m²) 23.3 ± 1.7 27.1 ± 1.4 32.6 ± 2.3 46.0 ± 2.9 <0.001 
WC (cm) 82.2 ± 4.5 92.1 ± 11.9 110.1 ± 8.7 131.4 ± 8.8 <0.001 
Hip (cm) 96.0 ± 4.7 100.6 ± 12.1 113.8 ± 7.2 133.6 ± 9.7 <0.001 
Height (cm) 175.6 ± 10.7 172.1 ± 8.9 172.8 ± 7.2 164.4 ± 11.0 0.02 
WHR 0.86 ± 0.06 0.92 ± 0.11 0.97 ± 0.10 0.99 ± 0.08 0.001 
WHtR 0.55 ± 0.04 0.59 ± 0.08 0.66 ± 0.06 0.82 ± 0.08 <0.001 
Ectopic Liver Fat  
MRS IHCL 0.54 ± 0.55 6.39 ± 10.94 14.47 ± 16.73 15.72 ± 16.60 0.004 
ME IHCL 1.43 ± 0.62 5.81 ± 6.65 11.14 ± 9.34 10.90 ± 7.63 <0.001 
Ectopic Pancreas Fat  
ME IPCL 1.75 ± 0.92 5.70 ± 6.04 8.48 ± 7.18 7.66 ± 6.64 0.011 
Adiposity Stores  
TAT (L) 17.01 ± 5.00 26.66 ± 7.46 42.77 ± 7.94 70.78 ± 9.72 <0.001 
SAT (L) 13.52 ± 4.56  20.73 ± 7.12 33.32 ± 7.36 60.31 ± 10.72 <0.001 
ASAT (L) 3.41 ± 1.43 5.78 ± 2.08 10.29 ± 2.68 20.53 ± 4.32 <0.001 
NASAT (L) 10.11 ± 3.20 14.96 ± 5.17 23.04 ± 5.07 39.78 ± 7.73 <0.001 
Internal (L) 3.48 ± 1.22 5.93 ± 2.10 9.45 ± 2.12 10.47 ± 2.24 <0.001 
IAAT (L) 1.58 ± 0.86 3.29 ± 1.63 5.90 ± 1.44 5.66 ± 1.50 <0.001 
NAIAT (L) 1.90 ± 0.43 2.64 ± 0.66 3.55 ± 0.86 4.81 ± 0.93 <0.001 
IAAT/ASAT 0.52 ± 0.30 0.64 ± 0.38 0.61 ± 0.22 0.30 ± 0.16 0.013 
WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; 
IPCL: intra-pancreatic cellular lipid, Adipose tissue deposits are in litres (l); TAT: total adipose tissue; SAT: 
subcutaneous; ASAT: abdominal subcutaneous; NASAT: non abdominal subcutaneous; Internal: total internal; 
IAAT: intra-abdominal; NAIAT: non-abdominal internal. All data are presented as mean ± SD. BMI grouping 
corresponds to the following BMI ranges; 1: 18.5<25, 2: 25<30, 3: 30<40, 4: 40+. 
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3.3.10.ii Impact of Body Mass Index (BMI) on Adiposity 
 
As might be expected all depots increased with increasing BMI, TAT, SAT, ASAT, Internal, 
IAAT (p<0.001 for all), see Table 3.11. 
 
Interestingly although internal adipose tissue increased in a stepwise fashion between BMI 
groups, this was not true for IAAT.  
 
There were significant increases from BMI groups 1-2, and 2-3 but not between BMI groups 3 
and 4. This may reflect the high proportion of female subjects in BMI Group 4 (11 Females, 3 
Males ), compared with BMI group 3 (4 Females, 7 Males), as previously shown in Table 3.5 
Female subjects carry most of their adipose tissue as subcutaneous adipose tissue. 
 
3.3.10.iii Impact of Body Mass Index (BMI) on Liver Fat Content 
 
Overall the mean value of IHCL increased significantly with BMI (p<0.001), Table 3.11 and 
Figure 3.6. 
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Interestingly IHCL increased significantly between groups 1-3, and 1-4, but not groups 1-2, 2-
3 or 3-4. 
 
 
 
 
 
 
 
Figure 3.6 Change in IHCL with BMI Group  
 
3.3.10.iv Impact of Body Mass Index (BMI) on Pancreatic Fat Content 
 
Overall the mean value of IPCL increased significantly with BMI (p<0.05), Table 3.11. 
Reflecting the changes observed in IHCL, IPCL increased significantly between groups 1-3, 
and 1-4, but not group 1-2, 2-3 or 3-4 (Table 3.11 and Figure 3.7). 
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Figure 3.7 Change in IPCL with BMI Group 
 
3.3.11 Impact of BMI Group on the Relationship between Anthropometric Measurements 
and Adipose Tissue Depots 
 
BMI group correlation analysis for all anthropometric variables, adipose tissue (in litres) and 
ectopic fat stores (arbitrary units) are shown in Tables 3.12 (Group 1= 18<25 kg/m²), Table 
3.13 (Group 2 = 25<30 kg/m²), Table 3.14 (Group 3 = 30<40 kg/m²) and Table 3.15 (Group 4 
= 40+ kg/m²).  
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3.3.11.i BMI Group 1 - Relationship Between Anthropometric Measurements and 
Adiposity 
 
In Group 1, apart from a few exceptions mentioned below, most variables did not correlate 
with each other. 
 
Height was the variable, which correlated predominantly and negatively with a few adiposity 
stores (TAT: r= -0.52 (p<0.05), SAT: r= -0.53 (p<0.05), SAAT: r=-0.62 (p<0.05), Table 3.12.  
 
Internal adiposity store was mainly associated with Waist (r=0.69 (p<0.01), as well as IAAT 
(r=0.67, p<0.01). 
 
3.3.11.ii BMI Group 1 - Relationship Between Body Composition and Liver Fat 
 
Internal adiposity store was the variable, which correlated to the greatest degree with IHCL (r 
= 0.68, P<0.01, Table 3.12). Waist circumference also correlated significantly with IHCL (r = 
0.63, p<0.01)  
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3.3.11.iii BMI Group 1 - Relationship Between Body Composition and Pancreatic Fat 
 
IPCL only correlated with age (r = 0.55, p<0.05, Table 3.12).  
 
 
 
149 
 
Table 3.12 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores and Body Fat Stores in BMI Group 1. 
BMI Group 1
n=16 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI
MRS 
IHCL
ME 
total 
IHCL
ME total 
IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.624**
HEIGHT -.801** .784**
WAIST .127 .499* .268
HIP -.249 0.496 0.244 0.235
WHR .372 0.079 .009 .643** -.507*
WHtR .527* -0.315 -.658** 0.050 0.457 -0.2941
BMI 0.233 0.276 -0.246 0.279 .639** -0.0412 .600*
MRS Liver .061 0.197 .237 0.304 -0.015 0.188 -0.103 -0.100
ME total IHCL -.083 0.441 .362 .629** 0.115 0.315 -0.044 0.012 .729**
ME total IPCL .545* -0.309 -.422 0.053 -0.187 0.365 0.097 0.247 0.162 -0.185
TAT 0.466 -0.229 -.517* 0.040 0.474 -0.309 .912** .585* 0.150 0.062 0.171
SAT .438 -0.238 -.525* -0.009 0.458 -0.321 .921** .559* 0.056 -0.018 0.147 .976**
Internal 0.258 0.135 0.040 .690** 0.211 0.353 0.309 0.285 .512* .679** 0.138 0.432 0.324
SAAT .549* -0.318 -.623* -0.084 0.302 -0.221 .885** .585* 0.053 -0.074 0.226 .929** .953** 0.282
NASAT .421 -0.268 -.517* -0.038 0.446 -0.362 .909** .500* 0.059 -0.012 0.115 .979** .991** 0.324 .924**
IAAT 0.263 0.1 0.019 .666** 0.122 0.385 0.268 0.241 0.444 .600* 0.085 0.359 0.229 .959** 0.212 0.238
NAIAAT 0.158 0.209 0.104 .508* 0.402 0.032 0.347 0.276 .538* .644** 0.100 .518* 0.412 .882** 0.344 0.424 .788**
IAAT/ASAT -.094 .300 0.406 .663** -0.031 0.488 -.271 -.079 .312 .506* -.100 -0.209 -0.34 .659** -0.4 -0.315 .774** .412
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
 
All data are presented as Spearman rank test correlation. MRS IHCL (M:12 , F:4), ME total IHCL (M:12 , F:4 ) and ME total IPCL (M:12 , F:4); *= 
p<0.05,**= p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; IPCL: 
intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non abdominal subcutaneous; 
Internal:total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal
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3.3.11.iv BMI Group 2 - Relationship between Anthropometric Measurements and 
Adiposity 
 
In Group 2, WHtR was the variable, which correlated predominantly with adiposity stores; 
TAT (r=0.67, p<0.01), SAT (r=0.71, p<0.01), and SAAT (r= 0.61, p<0.01), Table 3.13. 
 
Followed by Hip circumference, TAT (r=0.65, p<0.01), SAT (r=0.67, p<0.01), and SAAT (r= 
0.62, p<0.01), Table 3.13. WHR also correlated with Internal adipose tissue (r= 0.68, p<0.01), 
IAAT (r=0.70, p<0.01) and IAAT/ASAT (r= 0.80, p<0.01). 
 
3.3.11.v BMI Group 2 - Relationship between Body Composition and Liver Fat 
 
There was a significant correlation between WHR and IHCL (r =0.65, p<0.01), see Table 3.13.  
There was also a significant correlation between IAAT/ASAT and IHCL (r = 0.63, p<0.01) and 
IAAT (r = 0.55, p<0.05, Table 3.12)  
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3.3.11.vi BMI Group 2 - Relationship between Body Composition and Pancreatic Fat 
 
There was a significant correlation between height and IPCL (r = 0.48, p<0.05), see Table 3.13. 
IPCL was also strongly correlated with IAAT (r= 0.54, p<0.05), and Internal adiposity store 
(r= 0.46, p<0.05). 
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Table 3.13 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores and Body Fat Stores in BMI Group 2. 
BMI Group 2
n=20 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI
MRS 
IHCL
ME 
total 
IHCL
ME total 
IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.171
HEIGHT -0.185 .816**
WAIST .233 0.387 .496*
HIP .250 0.063 -0.008 0.307
WHR .144 0.366 .502* .633** -0.279
WHtR 0.361 -0.351 -.458* 0.048 .840** -.478*
BMI 0.129 0.203 -0.325 -0.003 0.317 -0.170 0.377
MRS Liver .062 0.318 .577** .502* 0.062 .624** -0.242 -0.356
ME total IHCL .077 0.293 .524* .539* 0.053 .650** -0.250 -0.262 .970**
ME total IPCL 0.377 0.284 .479* 0.300 0.037 0.392 -0.155 -0.355 0.383 0.325
TAT 0.285 -0.299 -0.322 0.005 .651** -0.205 .696** 0.173 -0.272 -0.271 0.059
SAT .171 -0.318 -0.336 -0.030 .666** -0.325 .705** 0.198 -0.337 -0.322 -0.062 .958**
Internal 0.381 0.263 0.339 0.411 0.077 .678** -0.093 -0.012 0.4 0.418 .459* 0.376 0.22
SAAT 0.147 -0.238 -0.255 -0.059 .618** -0.245 .611** 0.132 -0.254 -0.251 0.081 .926** .941** 0.281
NASAT .158 -0.361 -0.381 -0.044 .621** -0.340 .701** 0.194 -0.386 -0.379 -0.122 .943** .988** 0.186 .892**
IAAT 0.320 0.270 0.349 0.381 -0.044 .699** -0.203 -0.060 .526* .550* .537* 0.126 -0.05 .907** 0.045 -0.087
NAIAAT 0.361 0.215 0.330 0.229 0.152 .456* -0.009 -0.137 0.254 0.242 0.347 .496* 0.374 .797** 0.412 0.358 .570**
IAAT/ASAT .230 .267 0.438 .414 -0.436 .797** -.516* -.263 .627** .632** .402 -.459* -.623** .528* -.558* -.626** .714** .269
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
 
All data are presented as Spearman rank test correlation. MRS IHCL (M:15 , F:5), ME total IHCL (M:15 , F:5 ), and ME total IPCL (M:15 , F:5); *= 
p<0.05,**= p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; IPCL: 
intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non abdominal subcutaneous; 
Internal: total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal 
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3.3.11.vii BMI Group 3 - Relationship Between Anthropometric Measurements and 
Adiposity 
 
In Group 3, there was also a strong correlation between WHtR and adiposity; TAT (r=0.74, 
p<0.01), SAT (r=0.82, p<0.01), and SAAT (r=0.77, p<0.01) (Table 3.14) followed by Hip 
circumference SAT (r=0.74, p<0.01), and SAAT (r=0.77, p<0.01) (Table 3.14).  
 
3.3.11.viii BMI Group 3 - Relationship Between Body Composition and Liver Fat 
 
There were no significant correlations between IHCL and any of the anthropometric variables 
or adiposity stores in group 3. (Table 3.14)  
 
 
3.3.11.ix BMI Group 3 - Relationship Between Body Composition and Pancreatic Fat 
 
There was no association between IPCL and any of the anthropometric variables or adiposity 
stores in group 3. (Table 3.14)  
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Table 3.14 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores and Body Fat Stores in BMI Group 3. 
BMI Group 3
n=11 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI
MRS 
IHCL
ME 
total 
IHCL
ME total 
IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.456
HEIGHT -0.387 .700*
WAIST .182 0.582 .427
HIP -.473 0.059 -0.178 -0.169
WHR .310 0.527 .373 .873** -0.524
WHtR -0.082 -0.245 -.645* -0.264 .834** -0.518
BMI -0.050 0.355 -0.264 0.273 0.241 0.282 0.391
MRS Liver .296 0.227 .055 0.209 -0.251 0.209 -0.082 0.236
ME total IHCL .328 0.236 .145 0.05455 -0.556 0.236 -0.373 0.091 .864**
ME total IPCL 0.538 -0.491 -.409 0.109 -0.296 0.300 -0.091 0.064 -0.291 -0.282
TAT -0.100 0.036 -0.409 -0.036 0.569 -0.209 .736** .664* -0.036 -0.164 -0.091
SAT -.210 0.036 -0.327 -0.118 .743** -0.373 .818** 0.555 -0.064 -0.255 -0.291 .936**
Internal 0.433 0.209 0.045 0.445 -0.091 0.391 0.009 0.309 0.100 0.200 0.200 0.455 0.264
SAAT -0.337 0.073 -0.282 -0.218 .770** -0.464 .773** 0.573 -0.036 -0.245 -0.418 .764** .909** 0.018
NASAT -.137 -0.018 -0.382 -0.027 .661* -0.300 .782** .609* 0.009 -0.218 -0.182 .955** .964** 0.336 .855**
IAAT 0.333 0.382 0.191 0.527 -0.073 0.491 -0.082 0.227 0.055 0.164 0.200 0.255 0.073 .927** -0.136 0.109
NAIAAT 0.251 0.064 -0.009 0.291 0.023 0.218 0.073 0.236 -0.236 -0.109 0.282 0.545 0.355 .918** 0.082 0.427 .809**
IAAT/ASAT .506 .236 0.345 .500 -0.574 0.564 -.555 -.209 .409 .555 .173 -0.345 -0.52 .609* -.655* -0.427 .709* .382
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
 
All data are presented as Spearman rank test correlation. MRS IHCL (M:7 , F:4), ME total IHCL (M:7 , F:4) and  ME total IPCL (M:7 , F:4); *= p<0.05,**= 
p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; IPCL: intra-
pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non abdominal subcutaneous; Internal: 
total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal
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3.3.11.x  BMI Group 4 - Relationship Between Anthropometric Measurements and 
Adiposity 
 
Hip was once again the variable, which correlated most strongly with adiposity; TAT (r=0.67, 
p<0.01), SAT (r= 0.64, p<0.05) and SAAT (r=0.72, p<0.01) followed by BMI; TAT (r=0.67, 
p<0.01), SAT (r= 0.65, p<0.05) and SAAT (r=0.71, p<0.01) (Table 3.15).  
 
3.3.11.xi BMI Group 4 - Relationship Between Body Composition and Liver Fat 
 
In group 4, IHCL was significantly correlated to NAIAT (r=0.81, p<0.01) and Internal 
adiposity (r = 0.59, p<0.05), see Table 3.15. 
 
3.3.11.xii BMI Group 4 - Relationship Between Body Composition and Pancreatic  Fat 
 
In group 4, IPCL was negatively associated WHR (r= -0.54 p<0.05). There were no other 
significant correlations between IPCL and any other parameter, see Table 3.15. 
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Table 3.15  Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores and Body Fat Stores in BMI Group 4. 
BMI Group 4
n=14 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI
MRS 
IHCL
ME 
total 
IHCL
ME total 
IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.628*
HEIGHT -.666** .802**
WAIST .083 0.506 .169
HIP .224 0.154 -0.146 0.392
WHR -.144 0.314 .407 .561* -0.463
WHtR 0.513 -0.284 -.622* 0.145 .818** -.613*
BMI -0.013 0.376 -0.187 .587* 0.505 -0.046 0.429
MRS Liver -.058 -0.042 -.046 0.117 -0.115 0.218 0.024 -0.226
ME total IHCL -.238 0.154 .141 0.226 0.009 0.231 -0.002 -0.134 .933**
ME total IPCL 0.299 -0.081 -.336 -0.097 0.265 -.543* 0.420 0.248 0.240 0.224
TAT -0.308 0.477 0.130 0.253 .666** -0.429 0.429 .670** -0.218 0.018 0.345
SAT -.374 0.354 0.029 0.132 .642* -0.495 0.446 .653* -0.248 -0.022 0.248 .960**
Internal -0.024 0.305 0.433 0.139 -0.229 0.367 -0.301 -0.336 .604* .587* 0.165 -0.213 -0.4
SAAT 0.150 0.279 -0.134 0.488 .721** -0.257 0.530 .710** -0.385 -0.255 0.231 .578* .565* -0.332
NASAT -.378 0.191 -0.064 -0.108 0.509 -.626* 0.415 0.481 -0.310 -0.165 0.196 .833** .912** -.574* 0.3846
IAAT 0.164 0.187 0.319 0.022 -0.174 0.169 -0.196 -0.358 0.499 0.429 0.380 -0.226 -0.43 .921** -0.297 -.543*
NAIAAT -0.188 0.213 0.257 0.169 -0.223 0.389 -0.222 -0.218 .793** .805** 0.059 -0.134 -0.24 .855** -0.363 -0.420 .631*
IAAT/ASAT .080 .125 0.248 -.163 -0.348 0.099 -.253 -.389 .521 .411 .437 -0.284 -0.46 .833** -0.495 -0.486 .930** .587*
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
 
All data are presented as Spearman rank test correlation. MRS IHCL (M:3, F:11), ME total IHCL (M:3 , F:11) and ME total IPCL (M:3 , F:11); *= 
p<0.05,**= p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; IPCL: 
intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT:  subcutaneous abdominal; NASAT: non abdominal subcutaneous; 
Internal: total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal
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3.3.12 Impact of Habitual Exercise on Body Composition 
 
All participants filled a clinical health questionnaire prior to having the MR study, see 
Appendix 1. Within the questionnaire enquiries were made regarding habitual weekly 
exercise activity.  
 
They were categorized as: 
‘Low’: measured as 1-3 times per week  
‘Moderate’: 3-5 times per week  
‘High’: >5 times per week. 
 
25% of all subjects were classified as having a high exercise level (93% of men, 7% women), 
23% had a moderate exercise level (50% men, 50% women) while 52% reported a low exercise 
level (52% of men, 48% of women).   
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3.3.12.i Impact of Habitual Exercise on Adiposity 
 
There were significant difference in adipose tissue volume between subjects who reported 
low/sedentary levels of physical activity, and those who reported both moderate (p<0.001) and 
high levels of activity (p<0.001). Interesting there were no significant differences between the 
high and moderate groups, see Table 3.16 and Figure 3.8. 
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Table 3.16 Impact of Exercise Level on Body Composition 
 Data for whole cohort  
Exercise Level  Sedentary/Low Moderate High 
4 
 
number 31 14 15 
14 
p 
Anthropometric Variables  
Age (yrs) 49.2 ± 13.7 45.8 ± 14.7 35.9 ± 11.8 
43.9 ± 11.6 
0.011 
Weight (kg) 103.9 ± 23.8 79.2 ± 16.8 77.9 ± 6.9 
124.5 ± 16.6 
<0.001 
BMI (kg/m²) 36.6 ± 9.3 27.1 ± 4.4 25.0 ± 2.3 
46.0 ± 2.9 
<0.001 
WC (cm) 113.6 ± 20.9 94.0 ± 14.5 85.8 ± 6.4 
131.4 ± 8.8 
<0.001 
Hip (cm) 117.6 ± 19.5 104.6 ± 9.8 97.0 ± 5.1 
133.6 ± 9.7 
<0.001 
Height (cm) 169.5 ± 10.2 170.4 ± 9.7 176.9 ± 9.6 
164.4 ± 11.0 
0.060 
WHR 0.97 ± 0.11 0.90 ± 0.09 0.89 ± 0.05 
0.99 ± 0.08 
0.006 
WHtR 0.70 ± 0.14 0.61 ± 0.06 0.55 ± 0.04 
0.82 ± 0.08 
<0.001 
Ectopic Liver Fat  
MRS IHCL 12.84 ± 15.67 7.24 ± 12.34 1.06 ± 1.63 
15.72 ± 16.60 
0.02 
ME IHCL 9.91 ± 8.36 5.45 ± 6.57 1.95 ± 1.57 
7.66 ± 6.64 
0.002 
Ectopic Pancreas Fat  
ME IPCL 7.10 ± 6.36 5.46 ± 7.00 2.95 ± 3.23 
7.66 ± 6.64 
0.09 
Adiposity Stores  
TAT (L) 50.63 ± 21.40 28.75 ± 10.41 17.23 ± 5.60 
70.78 ± 9.72 
<0.001 
SAT (L) 41.51 ± 20.00  23.10 ± 9.23 13.35 ± 4.77 
60.31 ± 10.72 
<0.001 
ASAT (L) 13.27 ± 7.64 7.01 ± 3.46 3.49 ± 1.50 
20.53 ± 4.32 
<0.001 
NASAT (L) 28.23 ± 12.75 16.09 ± 5.86 9.85 ± 3.33 
39.78 ± 7.73 
<0.001 
Internal (L) 9.12 ± 2.88 5.65 ± 2.42 3.89 ± 1.49 
10.47 ± 2.24 
<0.001 
IAAT (L) 5.12 ± 1.95 3.22 ± 1.87 1.96 ± 1.16 
5.66 ± 1.50 
<0.001 
NAIAT (L) 4.00 ± 1.15 2.43 ± 0.60 1.93 ± 0.50 
4.81 ± 0.93 
<0.001 
IAAT/ASAT 0.51 ± 0.30 0.53 ± 0.37 0.57 ± 0.31 
0.30 ± 0.16 
0.82 
WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; 
IPCL: intra-pancreatic cellular lipid, Adipose tissue deposits are in litres (l); TAT: total adipose tissue; SAT: 
subcutaneous; ASAT: abdominal subcutaneous; NASAT: non abdominal subcutaneous; Internal: total internal; 
IAAT: intra-abdominal; NAIAT: non-abdominal internal. All data are presented as mean ± SD.. 
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Figure 3.8 Relationship between Exercise Group and IAAT Content 
 
3.3.12.ii Impact of Habitual Exercise on Liver Fat Content  
 
IHCL in different exercise level groups are shown in (Figure 3.9). As expected, the higher the 
exercise level the lower the IHCL content, although there was no significant difference between 
the moderate and high intensity groups (p=0.36) or the moderate and low groups (p=0.12).  
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There was a significant difference between the high and low intensity groups (p=0.001). 
 
 
Figure 3.9 HCL distributions in the High, Moderate and Low Exercise Level Groups  
 
3.3.12.iii Impact of Habitual Exercise on Pancreatic Fat Content 
 
IPCL levels between the low and moderate, and between the moderate and high intensity 
exercise groups were not significantly different (p=0.67 and p=0.49 respectively), see Figure 
3.10.  
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However, the difference in IPCL between the high and low intensity exercise groups 
approached significance (P=0.074).  
 
 
Figure 3.10 Pancreas Fat (IPCL) Distribution in the High, Moderate and Low Exercise Level 
Groups  
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3.3.13 Fat Distribution in the Liver 
 
Currently, IHCL content is reported as part of a localized measurement (MRS) or by measuring 
the total IHCL content using different non-invasive methods. (Choji 1993, Vanhamme 1997, 
Szczepaniak, Nurenberg et al. 2005, Thomas, Hamilton et al. 2005, Cassidy, Yokoo et al. 2009, 
Lee, Park et al. 2010, Reeder, Cruite et al. 2011, Thomas, Parkinson et al. 2012, Angulo, 
Bugianesi et al. 2013, Thomas, Fitzpatrick et al. 2013) However, these approaches do not give 
any indication of the possible heterogeneity in the distribution of IHCL across this particular 
organ.  
 
Therefore, in order to resolve this matter, I have taken a more in depth look at IHCL content 
by using standard clinical and surgical procedures to segment the liver in the Multi-echo 
images. Couinaud used the ramifications of the portal vein as the basis of division (Strasberg 
2005, Couinaud 1957) whereby the liver is divided into eight functionally independent 
segments (Figure 3.11). Each segment has its individual vascular inflow, outflow and biliary 
drainage. In the midpoint of each segment there is a branch of the portal vein, hepatic artery 
and bile duct. In the periphery of each segment derives vascular outflow through the hepatic 
veins. (Fischer, Thorn et al. 2005, Fasel, Majno et al. 2010, Couinaud 1957) 
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Figure 3.11 Image taken from http://www.imaios.com/. There are 8 liver segments, which are 
numbered in a clockwise manner. Segment 1 (caudate lobe) is located posteriorly, and is not 
visible on a frontal view. 
 
The same automated pixel-by-pixel analysis performed in the ME of the whole liver described 
in Chapter 2 was performed to obtain heat maps of segment (I, II & III, IV, V & VIII and VI 
& VII) respectively according to Couinaud classification (Soler, Delingette et al. 2001, 
Couinaud 1957, Varupula 2012 ) and mimicking the CT images of Surgery textbooks and 
reported studies. (Lafortune, Madore et al. 1991, Smith, Downey et al. 1998, Rieker, Klos et 
al. 2003, Townsend 2004, Kodama, Ng et al. 2007) Care was taken to avoid blood vessels, bile 
ducts, and artefacts (Figure 3.12 and Figure 3.13). Segments II & III, V & VIII and VI & VII 
refer to the superior (II, IV, VII and VIII) and inferior (III, IV, V and VI) plane of the liver 
(Couinaud 1957) (Figure 3.11). 
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Figure 3.12 Image taken from http://www.radgray.com showing Sequential CT scan through 
the liver with Couinaud’s segments divided and numbered  
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Figure 3.13 Heat maps generated from multi-echo images acquired at various segments 
throughout the liver showing variations in IHCL 
 
3.3.14 Fat distribution in the pancreas 
 
IPCL content normally assessed by localized 1H MRS or by measuring the total IPCL content 
using different non-invasive methods. (Jacobs, Coleman et al. 1994, Matsumoto, Mori et al. 
1995, Bartolozzi, Lencioni et al. 1999, Isserow, Siegelman et al. 1999, Lingvay, Esser et al. 
2009, Sijens, Edens et al. 2010, Borghei, Sokhandon et al. 2013, Thomas, Fitzpatrick et al. 
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2013) However, these approaches once again do not give any indication of the possible 
heterogeneity in the distribution of IPCL across this particular organ. Therefore, applying the 
same principle as for IHCL distribution to resolve this matter, I have taken a more in depth 
look at IPCL content by using standard clinical and surgical procedures to divide the pancreas 
into regions in the Multi-echo images. Surgeons typically describe the location of pathology 
within the pancreas in relation to four regions: the head, neck, body, and tail. (F. Brunicardi 
2009) 
 
The head of the pancreas was defined as the area of the pancreas nestled in the C-loop of the 
duodenum to the anatomic right of the superior mesenteric vein (F. Brunicardi 2009). The body 
was defined as the anatomic right half of the remaining pancreatic tissue and the tail was 
defined as the anatomic left half of the remaining pancreatic tissue. The body and tail of the 
pancreas lie anterior to the splenic artery and vein (F. Brunicardi 2009, N. S. Patel 2013), see 
Figure 3.14. 
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Figure 3.14 Anatomy of the pancreas. Image taking from the Dana-Fraber Cancer institute 
http://www.dana-farber.org  The Pancreas has three areas: head, body, and tail. 
 
Data obtained and analysis of the multi-echo imaging sequences applied the same procedures 
as the analysis of IHCL (see Chapter 2). Following the automated pixel-by-pixel analysis, heat-
maps of total pancreas, as well as the head, body and tail of the pancreas were obtained to 
provide fat and water percentages (Figure 3.15).  
 
Mean inter-examination coefficient of variation (CoV) CH2+CH3/water+fat examination, was 
assessed by analysing each segment or region three times, and was found to be <1%  for total 
and regional IHCL and IPCL. 
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Figure 3.15 Heat maps generated from multi-echo images acquired at various regions 
throughout the pancreas showing variations in IPCL 
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3.3.15 Regional Ectopic Fat Content in the Liver and Pancreas – Whole Cohort Analysis 
 
A summary of the ectopic fat content and distribution for the whole cohort with the novel 
method in ME is shown in (Table 3.17).  
 
Table 3.17 Whole Cohort Variable Data with Segmentation 
 All Cohort (n=61) 
 Mean ± SD Range 
Liver Fat 
IHCL (MRS) 8.45 ± 13.47 0.00 - 60.54 
Total IHCL (ME) 6.79 ± 7.53 0.69 - 32.27 
Segment 1  5.98 ± 6.94 0.16 – 29.42 
Segment 2&3  6.22 ± 6.96 0.60 – 29.96 
Segment 4  6.77 ± 7.28 0.63 – 32.11 
Segment 5&8  7.01 ± 8.31 0.44 – 33.69 
Segment 6&7  7.01 ± 8.43 0.57 – 36.01 
Pancreatic Fat 
Total IPCL 5.62 ± 6.03 0.40 – 24.18 
Head  4.75 ± 5.22 0.13 – 23.63 
Body 5.31 ± 6.56 0.13 – 31.74 
Tail  4.86 ± 4.77 0.14 – 25.29 
All data are presented as mean ± SD and range. IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular 
lipid.  
 
171 
 
3.3.15.i Distribution of Fat Content across the Liver in the Whole Cohort 
 
Segment 5&8 (7.01 ± 8.31) and Segment 6&7 (7.01 ± 8.43) had the highest mean values of 
IHCL compared to other segments in the liver, although none of these differences reach 
statistical significance (Table 3.17, Figure 3.16). 
 
 
Figure 3.16 Liver Fat (IHCL) Distributions in Whole Cohort  
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3.3.15.ii Distribution of Fat Content across the Pancreas in the Whole Cohort 
 
The Body has a higher level of IPCL (5.31 ± 6.56) compared with the Head (4.75 ± 5.22) and 
Tail (4.86 ± 4.77) regions, though this did not reach statistical significance (Table 3.17, Figure 
3.17). 
 
 
Figure 3.17 Pancreas Fat (IPCL) Distributions in Whole Cohort 
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3.3.16 Correlation Analysis for Whole Cohort Variable with Segmentation 
 
Whole cohort correlation analysis for all anthropometric variables, adipose tissue (in litres) and 
ectopic fat stores (arbitrary units) with the novel method in ME are shown in Table 3.18.  
 
All Adiposity store variables except for IAAT/ASAT ratio correlate with ectopic fat stores to 
a significant degree (p<0.01).   
 
3.3.16.i Liver Fat Content – Relationship between Different Segments and their 
Association with Adiposity 
 
Total Internal adiposity store was the variable, which correlated to the greatest degree with 
IHCL in all segments (segment 1: r= 0.69, segment 2&3: r= 0.68, segment 4: r= 0.76, segment 
5&8: r= 0.73 and segment 6&7: r= 0.75 p<0.01).  
 
Similar results were found with IAAT adiposity store (segment 1: r= 0.67, segment 2&3: r= 
0.67, segment 4: r= 0.75, segment 5&8: r=0.72 and segment 6&7: r= 0.74 p<0.01), see Table 
3.18. Moreover, IHCL in all segments remained highly correlated with all anthropometric 
parameters except for age and height.  
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3.3.16.ii Pancreatic Fat Content – Relationship between Different Segments and their 
Association with Adiposity 
 
IAAT adiposity store was correlated most strongly with regional IPCL content (Head: r=0.41, 
Body: r=0.47 and Tail: r=0.40, p<0.01, Table 3.18) but less strongly than the correlation 
between IHCL and IAAT.  
 
There was also a strong correlation between Internal adiposity and IPCL (Head: r=0.37, Body: 
r=0.45 and Tail: r=0.36, p<0.01).  
 
Age was strongly associated with IPCL (Head: r=0.39, Body: r=0.42 and Tail: r=0.38, p<0.01).  
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Table 3.18 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores with Segmentation and Body Fat Stores in Whole 
Cohort. 
ALLCOHORT
n=61 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI MRS IHCL
ME total 
IHCL
ME segment 
1  IHCL
ME 
segment 
2&3 IHCL
ME 
segment 4 
IHCL
ME 
segment 
5&8 IHCL
ME 
segment 
6&7 IHCL
ME total 
IPCL
ME Head 
IPCL
ME Body 
IPCL ME Tail IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.025
HEIGHT -.440** .078
WAIST .221 .855** -.156
HIP .207 .813** -.298* .847**
WHR .228 .550** .120 .684** .309*
WHtR .348** .612** -.617** .745** .919** 0.200
BMI .247 .854** -.386** .858** .890** .486** .861**
MRS Liver .224 .660** -.021 .716** .601** .653** .487** .623**
ME total IHCL .225 .662** .001 .705** .571** .657** .446** .613** .958**
ME segment 1 IHCL .247 .630** -.009 .669** .571** .603** .450** .598** .939** .954**
ME segment 2&3 IHCL .165 .659** .016 .680** .525** .607** .399** .578** .892** .942** .912**
ME segment 4 IHCL .258* .664** .010 .704** .598** .648** .465** .615** .940** .979** .953** .926**
ME segment 5&8 IHCL .214 .650** .004 .680** .574** .616** .447** .595** .965** .983** .948** .918** .962**
ME segment 6&7 IHCL .242 .672** -.025 .712** .609** .627** .489** .643** .962** .975** .959** .910** .954** .985**
ME total IPCL .513** .358** -.176 .456** .385** .419** .357** .422** .457** .404** .363** .383** .442** .418** .394**
ME Head IPCL .391** .191 -.169 .277* .230 0.223 0.224 0.245 .257* .253* .199 .249 .278* .262* .220 .805**
ME Body IPCL .422** .258* -.222 .309* .308* 0.230 .303* .341** .358** .334** .309* .362** .387** .355** .297* .837** .737**
ME Tail IPCL .377** .197 -.149 .322* .216 .361** 0.197 .256* .332** .262* .229 .266* .311* .276* .255* .810** .607** .633**
TAT .274* .764** -.434** .800** .913** .381** .916** .911** .577** .556** .550** .517** .577** .561** .598** .436** .244 .366** .221
SAT .222 .724** -.471** .760** .912** .295* .931** .890** .518** .491** .494** .457** .513** .502** .541** .365** .183 .313* .163 .989**
Internal .395** .767** -.146 .809** .726** .672** .655** .801** .748** .742** .692** .676** .755** .729** .747** .586** .370** .450** .364** .820** .740**
SAAT .254* .747** -.451** .772** .908** .350** .916** .902** .558** .526** .524** .480** .546** .537** .573** .406** .214 .343** .192 .980** .983** .761**
NASAT .226 .701** -.488** .748** .900** .277* .931** .877** .492** .463** .468** .431** .484** .471** .513** .343** .164 .292* .148 .983** .995** .725** .969**
IAAT .432** .721** -.113 .773** .662** .679** .596** .753** .750** .741** .672** .666** .745** .724** .736** .614** .406** .470** .403** .748** .660** .980** .694** .643**
NAIAAT .302* .769** -.210 .792** .781** .562** .715** .806** .654** .648** .645** .613** .677** .640** .672** .487** .293* .385** .254* .878** .822** .931** .816** .814** .849**
IAAT/ASAT .232 -.164 .441** -.099 -.376** .322* -.459** -.302* .187 .213 .143 .152 .198 .188 .159 .196 .180 .094 .214 -.377** -.481** .151 -.462** -.481** .260* -.066
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
All data are presented as Spearman rank test correlation. MRS IHCL (M:37 , F:24 ), ME total IHCL (M:37 , F:24 ), segment 1 IHCL (M:37: , F:24 ), segment 2&3 (M:37 , F:24 ), segment 4 (M:37 , F:24 ), segment 5&8 
(M:37 , F:24 ), segment 6&7 (M:37 , F:24 ), ME total IPCL (M:37 , F: 24), head (M:37 , F:24 ) , body (M37: , F:24 ) and tail (M:37 , F:24 ); *= p<0.05,**= p< 0.01. Abbreviations: WC: waist circumference; WHR: 
waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non 
abdominal subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal. 
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3.3.17 Gender Differences in Regional Ectopic Fat Content 
 
Gender specific characteristics with the novel method in ME are shown in (Table 3.19). 
Subjects were found to have an overall non significance in all ectopic fat depots and their 
segments.  
 
Table 3.19 Gender Differences in Regional Ectopic Fat Content 
 Male (n=37) Female (n=24)  
 Mean ± SD Range Mean ± SD Range p 
Liver Fat    
IHCL(MRS) 8.16 ±13.78 0.00 – 59.57 8.91 ± 13.25 0.15 - 60.54 0.83 
Total IHCL 
(ME) 
6.80 ± 7.95 0.70 - 32.27 6.78 ± 7.00 0.69 – 30.00 0.99 
Segment 1 
IHCL 
5.98 ± 7.36 0.16 – 29.42 5.99 ± 6.37 0.71 – 26.77 0.99 
Segment 2&3 
IHCL 
6.02 ± 7.15 0.97 – 29.96 6.53± 6.79 0.60 – 28.08 0.78 
Segment 4 
IHCL 
6.97 ± 7.93 0.64 – 32.11 6.47 ± 6.30 0.63 – 27.01 0.79 
Segment 5&8 
IHCL 
7.00 ± 8.80 0.44 – 33.69 7.03 ± 7.67 0.62 – 33.53 0.99 
Segment 6&7 
IHCL 
6.85 ± 8.71 0.59 – 35.21 7.26 ± 8.16 0.57 – 36.01 0.86 
Pancreatic  Fat    
Total IPCL 5.18 ± 6.12 0.40 – 24.18 6.29 ± 5.96 0.55 – 21.62 0.49 
Head  4.34 ± 5.33 0.13 – 23.63 5.37 ± 5.08 0.24 – 17.56 0.46 
Body  4.49 ± 6.00 0.13 – 25.53 6.57 ± 7.29 0.32 – 31.74 0.23 
Tail  4.89 ± 5.23 0.14 – 25.29 4.80 ± 4.07 0.27 – 13.8 0.94 
All data are presented as mean ± SD and range. IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular 
lipid. Male versus female data was analysed by unpaired Student’s t-test 
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3.3.17.i Gender Differences in Regional Liver Fat Content 
 
Segment 5&8 had the highest mean value of IHCL in males compared to other segments (7.00 
± 8.80), whereas segment 6&7 had the highest level of IHCL in female subjects (7.26 ± 8.16) 
(Table 3.19).  
 
When investigating for gender and age specific interactions using Multivariate linear 
Regression analysis (AGE x GENDER), the segments of the liver were not significant between 
gender once the effect of age was adjusted for (Table 3.20, Table 3.21). 
 
3.3.17.ii Gender Differences in Regional Pancreatic Fat Content 
 
In male subjects, the highest mean value of IPCL was found in the Tail compared to other 
regions (4.89 ± 5.23). In female subjects highest mean value of IPCL was found in the Body 
compared to other regions (6.57 ± 7.29), (Table 3.19).  
 
A substantial association with age in univariate analysis was observed: Head (p=0.001), Body 
(p=0.007) and Tail (p=0.001) (Table 3.20). However, there were no difference between men 
and women in terms of IPCL content in different regions of the pancreas.  
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In the multivariate analysis, IPCL regions were no longer significant in age or gender (Table 
3.21 
 
Table 3.20 Gender specific Ectopic Fat with Segmentation in Univariate Analysis 
GENDER β ᵃ GENDER p AGE β AGE p
MRS IHCL -0.76±3.56 0.83 0.10±0.12 0.42
ME IHCL 0.02±1.99 0.99 0.08±0.07 0.23
ME segment 1 IHCL -0.01±1.83 0.10 0.07±0.06 0.29
ME segment 2&3 IHCL -0.51±1.84 0.78 0.07±0.06 0.24
ME segment 4 IHCL 0.50±0.19 0.80 0.09±0.07 0.18
ME segment 5&8 IHCL -0.03±2.20 0.99 0.08±0.08 0.28
ME segment 6&7 IHCL -0.40±2.22 0.86 0.08±0.08 0.30
ME IPCL -1.11±1.59 0.486 0.19±0.05 <0.001
ME Head IPCL -0.10 ± 1.37 0.455 0.15 ± 0.04 0.001
ME Body IPCL -2.08±1.71 0.230 0.16±0.06 0.007
ME Tail IPCL 0.09±1.26 0.944 0.14±0.04 0.001
Ectopic Liver Fat
Ectopic Pancreas Fat
The effect of age and gender on ectopic fat stores was determined using univariate regression analysis. Ectopic 
fat was the dependent variables with age (year) and gender (male = 1, female = 0) as the independent variables. β 
represents the regression coefficient for each independent variable included in the model ± standard error. a Gender 
β represents difference for male minus female. IHCL:  intra-hepatocellular lipid; IPCL: intra-pancreatic cellular 
lipid.  
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Table 3.21 Gender Specific Ectopic Fat with Segmentation in Multivariate Analysis 
GENDER X AGE  
P-value
β ± SE P-value β ± SE P-value
Ectopic Liver Fat
MRS IHCL 0.280 -15.49±14.70 0.300 -0.14±0.56 0.580
ME IHCL 0.094 -12.50±8.03 0.125 -0.12±0.14 0.405
ME segment 1 IHCL 0.106 -11.25±7.44 0.136 -0.11±0.13 0.388
ME segment 2&3 IHCL 0.128 -11.09±7.47 0.143 -0.10±0.13 0.446
ME segment 4 IHCL 0.089 -11.62±1.72 0.138 -0.10±0.13 0.455
ME segment 5&8 IHCL 0.106 -13.46±8.91 0.136 -0.13±0.16 0.395
ME segment 6&7 IHCL 0.083 -15.15±9.02 0.098 -0.16±0.16 0.317
Ectopic Pancreas Fat
ME IPCL 0.167 -7.39±5.83 0.210 0.08±0.10 0.464
ME Head IPCL 0.268 -5.46±5.22 0.300 0.06±0.9 0.500
ME Body IPCL 0.191 -9.49±6.72 0.163 0.01±0.12 0.908
ME Tail IPCL 0.265 -3.75±4.68 0.426 0.08±0.08 0.359
GENDER AGE
The effect of age and gender on ectopic fat stores was determined using a multivariate regression analysis. Ectopic 
fat was the dependent variables with age (year), gender (male = 1, female = 0) and GENDER X AGE interaction 
as independent variables. β represents the regression coefficient for each independent variable included in the 
final model ± standard error. Gender β represents difference for male minus female. . b represents all the gender x 
age interaction  that was significant.  Statistical analysis was performed on log10 transformed variables. IHCL:  
intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid.  
 
3.3.18 Correlation Analysis Gender Differences in Regional Ectopic Fat Content 
 
Gender-specific correlation analysis for all anthropometric variables, adipose tissue (in litres) 
and ectopic fat stores (arbitrary units) with the novel method in ME are shown in Table 3.22 
(men) and Table 3.23 (women). Apart from a few exceptions, all variables correlated with each 
other to a significant degree (p<0.01). 
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Table 3.22 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores with Segmentation and Body Fat Stores in Male 
Participants. 
MALES
n=37 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI MRS IHCL
ME total 
IHCL
ME segment 
1  IHCL
ME 
segment 
2&3 IHCL
ME 
segment 4 
IHCL
ME 
segment 
5&8 IHCL
ME 
segment 
6&7 IHCL
ME total 
IPCL
ME Head 
IPCL
ME Body 
IPCL ME Tail IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT .126
HEIGHT -.496** .345*
WAIST .465** .772** .016
HIP .223 .824** 0.233 .893**
WHR .570** .584** -.213 .780** .569**
WHtR .409* .702** -0.162 .917** .906** .664**
BMI .375* .837** -0.175 .834** .766** .747** .862**
MRS Liver .363* .588** .112 .679** .646** .710** .588** .607**
ME total IHCL .452** .526** -.008 .654** .605** .698** .588** .591** .944**
ME segment 1 IHCL .411* .522** .087 .601** .582** .617** .520** .548** .924** .939**
ME segment 2&3 IHCL .411* .461** .041 .552** .467** .601** .433** .484** .835** .905** .874**
ME segment 4 IHCL .456** .574** .052 .667** .647** .691** .600** .596** .919** .974** .934** .884**
ME segment 5&8 IHCL .408* .517** .078 .610** .579** .661** .525** .539** .955** .981** .936** .870** .948**
ME segment 6&7 IHCL .431** .538** .044 .641** .597** .664** .567** .583** .958** .965** .940** .863** .926** .979**
ME total IPCL .602** .412* -.148 .560** .408* .671** .420** .485** .474** .445** .408* .407* .479** .434** .426**
ME Head IPCL .467** .166 -.086 0.320 .166 .387* 0.149 0.210 .204 .258 .175 .246 0.278 .259 .196 .771**
ME Body IPCL .424** 0.285 -.045 .343* 0.255 .455** 0.224 .343* .372* .411* .385* .448** .459** .394* .331* .735** .731**
ME Tail IPCL .507** .109 -.283 0.289 .176 .406* 0.225 0.230 0.190 0.154 .129 0.145 0.206 0.146 .142 .793** .499** .485**
TAT .374* .821** -0.006 .870** .817** .809** .846** .881** .624** .612** .577** .488** .638** .564** .609** .519** .215 0.317 .239
SAT .282 .815** -0.004 .842** .830** .739** .854** .876** .569** .570** .534** .448** .598** .519** .567** .441** .142 0.262 .175 .981**
Internal .550** .719** -.026 .826** .684** .906** .722** .789** .735** .736** .677** .617** .748** .701** .711** .603** .341* .415* 0.293 .900** .823**
SAAT 0.317 .827** -0.030 .835** .810** .782** .837** .897** .616** .600** .566** .472** .629** .560** .604** .519** .211 .333* .236 .974** .977** .847**
NASAT .274 .779** -0.009 .831** .810** .718** .845** .844** .524** .524** .490** .401* .552** .468** .519** .400* .106 0.212 .150 .973** .991** .803** .952**
IAAT .581** .686** -.087 .809** .655** .886** .719** .784** .729** .732** .652** .607** .735** .696** .705** .610** .387* .426** 0.301 .861** .775** .985** .812** .752**
NAIAAT .456** .733** .138 .768** .675** .827** .641** .710** .674** .669** .663** .576** .708** .635** .651** .516** 0.232 .352* 0.214 .889** .830** .938** .826** .824** .880**
IAAT/ASAT .520** -.129 -0.183 .034 -0.165 0.273 -.085 -0.031 .277 .319 .237 .261 .277 .319 .286 .277 .313 .227 .161 0.009 -0.123 .368* -0.091 -0.129 .445** .220
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
All data are presented as Spearman rank test correlation. MRS IHCL (M:37  ), ME total IHCL (M: 37), segment 1 (M:37 ), segment 2&3 (M: 37  ), segment 4 (M:37 ), segment 5&8 (M:37 ), segment 6&7 (M:37 ), total 
IPCL(M:37 ), head (M:37 ) , body (M:37 ) and tail (M:37); *= p<0.05,**= p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; 
IPCL: intra-pancreatocellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non abdominal subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: non-
abdominal internal 
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Table 3.23 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores with Segmentation and Body Fat Stores in Female 
Participants. 
FEMALES
n=24 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI MRS IHCL
ME total 
IHCL
ME segment 
1  IHCL
ME 
segment 
2&3 IHCL
ME 
segment 4 
IHCL
ME 
segment 
5&8 IHCL
ME 
segment 
6&7 IHCL
ME total 
IPCL
ME Head 
IPCL
ME Body 
IPCL ME Tail IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.392
HEIGHT -0.316 .196
WAIST -.222 .878** -.131
HIP -.213 .947** 0.058 .899**
WHR -.144 .566** -.254 .818** .539**
WHtR -0.145 .893** -0.126 .914** .967** .582**
BMI -.300 .943** -0.074 .932** .916** .684** .924**
MRS Liver -.068 .683** -.057 .740** .670** .712** .694** .691**
ME total IHCL -.094 .751** .012 .776** .722** .690** .711** .737** .970**
ME segment 1 IHCL -.091 .726** -.023 .769** .696** .720** .697** .736** .945** .973**
ME segment 2&3 IHCL -.223 .778** .041 .787** .735** .679** .721** .743** .945** .975** .930**
ME segment 4 IHCL -0.077 .750** -.002 .781** .729** .684** .729** .743** .964** .987** .973** .964**
ME segment 5&8 IHCL -.122 .751** .091 .773** .709** .698** .695** .721** .969** .985** .955** .971** .978**
ME segment 6&7 IHCL -.112 .765** .065 .787** .725** .702** .710** .750** .958** .984** .972** .957** .976** .990**
ME total IPCL 0.237 0.3 -.173 0.293 0.349 0.137 0.378 0.293 .460* .429* 0.303 .434* .444* .448* 0.380
ME Head IPCL 0.214 .270 -.253 0.275 .344 0.116 0.378 0.288 .412* .383 .313 .378 0.385 .384 .340 .847**
ME Body IPCL 0.226 0.243 -.142 0.252 0.307 0.123 0.361 0.232 .462* .413* 0.293 .433* .439* .435* 0.351 .949** .776**
ME Tail IPCL 0.181 .256 -.201 0.334 .285 0.297 0.365 0.3 .550** .463* .396 .460* .517** .528** .463* .833** .739** .816**
TAT -0.380 .981** 0.126 .865** .932** .543** .884** .938** .639** .704** .664** .737** .703** .705** .718** 0.381 .347 0.306 .309
SAT -.420* .988** 0.167 .849** .927** .520** .870** .940** .616** .692** .657** .727** .690** .690** .706** 0.318 .290 0.244 .255 .991**
Internal -0.043 .782** -.043 .774** .799** .533** .816** .783** .768** .774** .697** .775** .772** .779** .783** .588** .488* .543** .522** .816** .774**
SAAT -0.250 .931** 0.057 .853** .953** .527** .906** .908** .620** .679** .657** .690** .678** .662** .691** 0.294 .283 0.234 .230 .926** .930** .731**
NASAT -.444* .965** 0.152 .817** .890** .491* .849** .911** .576** .638** .610** .685** .639** .650** .665** 0.299 .261 0.224 .261 .974** .981** .751** .894**
IAAT 0.059 .710** -.047 .704** .756** .457* .781** .690** .799** .794** .702** .791** .784** .795** .788** .637** .523** .606** .569** .730** .685** .965** .681** .662**
NAIAAT -0.160 .791** -.084 .788** .806** .530** .813** .823** .652** .673** .617** .681** .680** .671** .688** .500* .477* .448* .425* .849** .814** .937** .754** .787** .831**
IAAT/ASAT .549** -.316 -0.124 -.217 -0.271 -0.142 -.190 -0.307 .165 .116 .057 .056 .104 .138 .098 .454* .347 .452* .398 -0.295 -0.350 .189 -0.403 -0.333 0.3165 -.005
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
All data are presented as Spearman rank test correlation. . MRS IHCL (F:24 ), ME total IHCL (, F:24 ), segment 1 (F:24 ), segment 2&3 (F:24 ), segment 4 ( F:24 ), segment 5&8 ( F:24 ), segment 6&7 ( F:24 ), ME total 
IPCL (F: 24), ME head ( F:24 ) , body ( F:24 ) and tail ( F: 24); *= p<0.05,  **= p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; 
IPCL: intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non abdominal subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: non-
abdominal internal 
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3.3.18.i Correlation Analysis Gender Differences in Regional Liver Fat Content 
 
In male subjects, Internal adiposity store was the variable, which correlated to the greatest 
degree with IHCL in individual segments (segment 1: r=0.68, segment 2&3: r=0.62, segment 
4: r=0.75, segment 5&8: r=0.70 and segment 6&7: r=0.71, p<0.01), followed by IAAT 
(segment 1: r=0.65, segment 2&3: r=0.61, segment 4: r=0.74, segment 5&8: r=0.70 and 
segment 6&7: r=0.71, p<0.01). 
 
In addition, all anthropometric parameters correlated strongly with IHCL in different segments, 
except for height, see Table 3.22. 
 
While in female subjects, IAAT had the strongest correlation with IHCL in all segments 
(segment 1: r=0.70, segment 2&3: r=0.79, segment 4: r=0.78, segment 5&8: r=0.80 and 
segment 6&7: r=0.79, p<0.01, Table 3.23), followed by Internal (segment 1: r=0.70, segment 
2&3: r=0.78, segment 4: r=0.77, segment 5&8: r=0.78 and segment 6&7: r=0.78, p<0.01).  
 
Moreover, all anthropometric parameters correlated strongly with IHCL in different segments, 
except for Age and Height.  
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3.3.18.ii Correlation Analysis Gender Differences in Regional Pancreatic Fat Content 
 
In male subjects, IAAT was the variable, which correlated to the greatest degree with IPCL in 
individual regions (Body: r=0.43, p<0.01 and Head: r=0.39, p<0.05, Table 3.22) with the 
exception of (Tail: r=0.30). Internal adiposity store also correlated strongly with IPCL in 
individual regions (Body: 0.42 p<0.05 and Head, r=0.34, p<0.05) with the exception once again 
of (Tail: r=0.29). 
 
In addition, Age correlated strongly with IPCL in different pancreatic regions. (Head: r=0.47, 
Body: r= 0.42 and Tail: r= 0.51, p<0.01, Table 3.22) 
 
In female subjects, IAAT had the strongest correlation with IPCL in individual regions (Head: 
r=0.64, Body: r= 0.52 and Tail: r= 0.61, p<0.01, Table 3.23), followed by Internal (Head: 
r=0.59 p<0.01, Body: r= 0.49 p<0.05 and Tail: r= 0.54 p<0.01, Table 3.23). 
 
In female subjects, IPCL did not associate with any of the anthropometric parameters in 
different pancreatic regions. 
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3.3.18.iii Correlation Analysis Gender Differences in Regional Ectopic Fat Content – The 
Impact of Correcting for Weight and Waist 
 
When Weight or Waist was adjusted for separately in male and female subjects, none of the 
liver segments nor the pancreatic regions correlated to a significant level with adiposity or 
anthropometric parameters. The exception was a strong association between IPCL in all regions 
and Age when Weight was adjusted for in men (Head: r=0.52, Body: r=0.49 and Tail: r=0.53, 
all p=0.001). 
  
Similar correlations were found between Age and IPCL in the regions when Waist was adjusted 
for in men; the partial correlation was stronger when Weight was controlled for than when 
Waist was controlled for (Head: r=0.480, Body: r= 0.459, and Tail: r= 0.509, all p<0.05).  
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3.3.19 The Effect of Age on Regional Fat Content in the Liver 
 
As seen previously (Table 3.10) the highest levels of  total IHCL were seen in subjects between 
the ages of 36-45 years old (9.03 ± 10.88).  
 
The same was observed for the regional analysis, with subjects aged between 36-45 years old 
having the highest level of IHCL in each liver segment, although these differences did not reach 
the level of significance, see Figure 3.18, and Table 3.24. 
 
Figure 3.18 Variation in Regional IHCL Content in Different Age Groups 
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Table 3.24 Age Group Specific Summary measures in Whole Cohort with Segmentation 
 Data for whole cohort  
Age Group 
(years) 
16-25 26-35 36-45 >46  
number 9 8 12 32 p 
Liver Fat  
IHCL (MRS) 2.51 ± 4.41 7.05 ± 7.47 14.47 ± 21.95 
 
8.22 ± 11.74 0.24 
Total IHCL (ME) 2.64 ± 3.64 7.03 ± 5.55 9.03 ± 10.88 7.06 ± 7.09 0.28 
Segment 1 2.46 ± 4.07 6.46 ± 5.71 7.89 ± 10.16 6.14 ± 6.31 0.36 
Segment 2&3 
IHCL 
2.39 ± 2.91 6.02 ± 4.94 8.67 ± 9.75 6.43 ± 6.76 0.24 
Segment 4 2.58 ± 3.42 6.86 ± 5.65 8.95 ± 10.42 7.11 ± 6.83 0.25 
Segment 5&8 
IHCL 
2.43 ± 3.93 7.64 ± 5.96 9.66 ± 11.99 7.15 ± 7.85 0.26 
Segment 6&7 
IHCL 
2.67 ± 4.67 7.41 ± 6.03 9.43 ± 12.25 7.23 ± 7.95 0.34 
Pancreatic Fat  
Total IPCL 1.72 ± 1.30 2.61 ± 1.37 5.54 ± 6.41 7.49 ± 6.67 0.03 
Head 1.50 ± 0.84 2.61 ± 2.21 4.78 ± 5.41 6.18 ± 5.89 0.06 
Body 1.46 ± 1.39 2.03 ± 1.10 6.78 ± 8.97 6.67 ± 6.64 0.07 
Tail 2.28 ± 1.76 2.65 ± 1.47 4.35 ± 3.25 6.33 ± 5.79 0.05 
All data are presented as mean ± SD. IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid. 
Age ranges ; 1: 16-25 years , 2: 26-35 years, 3: 36-45 years, 4: 46+ years old. Differences between age ranges 
were tested for using ANOVA and Post-hoc Turkey analysis. 
 
3.3.20 The Effect of Age on Regional Fat Content in the Pancreas 
 
There was a significant increase in total IPCL content across the different age groups (p<0.05), 
however whilst IPCL levels increased by age group in all three pancreatic levels, these 
differences did not quite reach statistical significance, see Table 3.24 and Figure 3.19.  
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Figure 3.19 Variation in Regional IPCL Content across Different Age Groups 
 
188 
 
3.3.21 The Effect of BMI on Regional Fat Content in the Liver 
 
The mean value of liver ectopic fat (IHCL) increased significantly (p<0.001 for all) in the 
different BMI groups, see Table 3.25 and Figure 3.20. 
 
Post hoc analysis revealed significant differences in IHCL content between BMI groups 1 and 
3 (p<0.05) and also between BMI groups 1 and 4 (p<0.01) for all liver segments. Additionally 
for segment 2&3 there was an additional difference between BMI groups 2 and 4 (p=0.09). 
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Table 3.25 BMI Group Specific Summary measures with Segmentation in Whole Cohort 
 Data for whole cohort  
BMI Group  1 2 3 4  
number 16 20 11 14 p 
Liver Fat  
IHCL (MRS) 0.54 ± 0.55 6.39 ± 10.94 14.47 ± 16.73 15.72 ± 16.60 0.004 
Total IHCL (ME) 1.43 ± 0.62 5.81 ± 6.65 11.14 ± 9.34 10.90 ± 7.63 <0.001 
Segment 1  1.15 ± 0.64 5.28 ± 5.91 9.60 ± 8.65 9.66 ± 7.60 0.001 
Segment 2&3 
IHCL 
1.58 ± 0.70 5.30 ± 6.23 9.29 ± 9.16 10.41 ± 6.87 0.001 
Segment 4  1.39 ± 0.86 5.78 ± 6.63 11.30 ± 8.50 10.78 ± 7.21 <0.001 
Segment 5&8 
IHCL 
1.25 ± 0.62 5.94 ± 7.20 11.80 ± 10.43 11.37 ± 8.74 0.001 
Segment 6&7 
IHCL 
1.23 ± 0.65 5.84 ± 7.12 11.83 ± 10.59 11.50 ± 9.10 0.001 
Pancreatic Fat  
Total IPCL 1.75 ± 0.92 5.70 ± 6.04 8.48 ± 7.18 7.66 ± 6.64 0.01 
Head  2.42 ± 1.99 5.04 ± 5.08 5.56 ± 7.01 6.34 ± 5.96 0.19 
Body  1.83 ± 1.43 4.71 ± 5.72 7.38 ± 7.06 8.54 ± 8.93 0.02 
Tail  2.37 ± 1.51 5.13 ± 5.68 6.86 ± 5.65 5.74 ± 4.34 0.07 
IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid. All data are presented as mean ± SD. 
BMI grouping corresponds to the following BMI ranges ; 1: 18.5<25, 2: 25<30, 3: 30<40, 4: 40+. Differences 
between BMI groups were tested for using ANOVA and Post-hoc Turkey analysis. 
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Figure 3.20 Change in Regional IHCL Content across Different BMI Groups 
 
3.3.22 The Effect of BMI on Regional Fat Content in the Pancreas 
 
The effect of BMI on regional differences in IPCL were less clear cut. There was a trend for 
IPCL to increase with increasing BMI group, but this only reached significance in the body of 
the pancreas (between BMI groups 1 and 4, p<0.05), with no statistically significant differences 
in the head or tail regions, despite a strong trend, Table 3.25 and Figure 3.21).   
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Figure 3.21 Change in Regional IPCL Content across Different BMI Groups 
 
3.3.23 Impact of BMI Group on Correlation Analysis of Body Composition and Regional 
Ectopic Fat Content 
 
BMI group correlation analysis for all anthropometric variables, adipose tissue (in litres) and 
ectopic fat stores (arbitrary units) with the novel method ME segmentation analysis are 
shown in Table 3.26 (Group 1= 18<25 kg/m²), Table 3.27 (Group 2 = 25<30 kg/m²), Table 
3.28 (Group 3 =30<40 kg/m²) and Table 3.29 (Group 4 =40+ kg/m²).  
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In Group 1, apart from a few exceptions mentioned below, most variables did not correlate 
with each other. 
 
3.3.23.i  Correlation Analysis of Body Composition and Regional Liver Fat Content in 
BMI Group 1 
 
Internal adiposity store was the variable, which correlated to the greatest degree with some 
individual segments in the liver (segment 5&8: r=0.65, segment 6&7: r=0.71, all p<0.01, 
segment 4: r=0.61, p<0.05, Table 3.26). Similarly there was a strong correlation between 
IAAT and regional IHCL (segment 5&8: r=0.55 and segment 6&7: r=0.68, all p<0.01, 
segment 4: r=0.51, p<0.05).  
 
Waist was the only anthropometric variable that correlated to some degree to regional liver 
fat content (segment 4: r=0.52, segment 5&8: r =0.51 and segment 6&7: r = 0.60, p<0.05). 
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3.3.23.ii  Correlation Analysis of Body Composition and Regional Pancreatic Fat Content 
in BMI Group 1 
 
There were no significant correlations between regional IPCL and adiposity, although there 
was a significant negative association between Body IPCL and Weight (r= -0.58, p<0.05, 
Table 3.24) and between Body IPCL and Waist (r= -0.52, p<0.05, Table 3.26)
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Table 3.26 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores with Segmentation and Body Fat Stores in BMI    
Group 1. 
BMI Group 1
n=16 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI MRS IHCL
ME total 
IHCL
ME segment 
1  IHCL
ME 
segment 
2&3 IHCL
ME 
segment 4 
IHCL
ME 
segment 
5&8 IHCL
ME 
segment 
6&7 IHCL
ME total 
IPCL
ME Head 
IPCL
ME Body 
IPCL ME Tail IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.624**
HEIGHT -.801** .784**
WAIST .127 .499* .268
HIP -.249 0.496 0.244 0.235
WHR .372 0.079 .009 .643** -.507*
WHtR .527* -0.315 -.658** 0.050 0.457 -0.294
BMI .233 0.276 -0.246 0.279 .639** -0.041 .600*
MRS Liver .061 0.197 .237 0.304 -0.015 0.188 -0.103 -0.1
ME total IHCL -.083 0.441 .362 .629** 0.115 0.315 -0.044 0.012 .729**
ME segment 1 IHCL .004 0.247 .265 0.222 0.137 0.003 -0.068 -0.065 .841** .779**
ME segment 2&3 IHCL -.092 0.303 .166 .557* -0.202 0.474 -0.162 -0.132 0.268 .738** 0.341
ME segment 4 IHCL -0.099 0.378 .341 .523* 0.187 0.190 0 0.007 .668** .957** .808** .668**
ME segment 5&8 IHCL -.099 0.390 .387 .514* 0.186 0.178 -0.050 -0.034 .907** .839** .831** 0.400 .800**
ME segment 6&7 IHCL .041 0.365 .315 .601* 0.109 0.285 -0.015 -0.029 .844** .815** .747** 0.406 .723** .930**
ME total IPCL .545* -0.309 -.422 0.053 -0.187 0.365 0.097 0.247 0.162 -0.185 0.047 -0.271 -0.184 0.025 -0.065
ME Head IPCL 0.443 -.224 -.328 0.086 .096 0.179 0.197 0.391 -.068 -.147 .044 -.247 -0.077 -.068 -.147 .735**
ME Body IPCL 0.145 -.576* -.356 -.523* -0.180 -0.265 0.003 -0.212 -0.091 -0.356 0.041 -0.247 -0.216 -0.191 -0.406 0.459 0.332
ME Tail IPCL 0.211 .141 -.059 0.185 .056 0.312 -0.156 0.329 0.009 -0.171 -.100 -0.188 -0.121 -0.066 -.050 0.474 0.35 -0.018
TAT 0.466 -0.229 -.517* 0.040 0.474 -0.309 .912** .585* 0.15 0.062 0.118 -0.241 0.059 0.125 0.135 0.171 .126 0.009 -.226
SAT .438 -0.238 -.525* -0.009 0.458 -0.321 .921** .559* 0.056 -0.018 0.035 -0.253 -0.001 0.054 0.044 0.147 .074 0.053 -.256 .976**
Internal 0.258 0.135 .040 .690** 0.211 0.353 0.309 0.285 .512* .679** 0.456 0.315 .612* .645** .712** 0.138 0.147 -0.274 -0.103 0.432 0.324
SAAT .549* -0.318 -.623* -0.084 0.302 -0.221 .885** .585* 0.053 -0.074 0.015 -0.3 -0.069 0.004 0.029 0.226 .153 0.026 -.191 .929** .953** 0.282
NASAT .421 -0.268 -.517* -0.038 0.446 -0.362 .909** .500* 0.059 -0.012 0.041 -0.256 0.006 0.040 0.029 0.115 .038 0.062 -.297 .979** .991** 0.324 .924**
IAAT 0.263 0.1 .019 .666** 0.122 0.385 0.268 0.241 0.444 .600* 0.321 0.268 .512* .552* .679** 0.085 0.121 -0.409 -0.035 0.359 0.229 .959** 0.212 0.238
NAIAAT 0.158 0.209 .104 .508* 0.402 0.032 0.347 0.276 .538* .644** .635** 0.153 .615* .675** .712** 0.1 0.147 -0.194 -0.206 .518* 0.412 .882** 0.344 0.424 .788**
IAAT/ASAT -.094 .300 0.406 .663** -0.031 0.488 -.271 -0.079 .312 .506* .153 .353 .403 .409 .529* -.100 -.009 -.465 .118 -0.209 -0.344 .659** -0.400 -0.315 .774** .412
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
All data are presented as Spearman rank test correlation. *= p<0.05, **= p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; 
IPCL: intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non abdominal subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: 
non-abdominal internal. 
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3.3.23.iii Correlation Analysis of Body Composition and Regional Liver Fat Content in 
BMI Group 2 
 
In Group 2, from the anthropometric parameters, Height was greatly correlated with IHCL in 
different segments (segment 1: r=0.53, segment 5&8: r=0.54 and segment 6&7: r=0.50, all 
p<0.05, and segment 2&3: r=0.69, segment 4: r=0.58, both p<0.01, see Table 3.25). There were 
also significant correlations between WHR and regional IHCL content (segment 1: r=0.57, 
segment 2&3: r=0.59, segment 5&8: r=0.57 and segment 6&7: r=0.56, all p<0.01 segment 4: 
r=0.56, p<0.05). 
 
The adipose variable which correlated most strongly with regional IHCL content in BMI group 
2 was the IAAT/ASAT ratio, (segment 2&3: r = 0.60, p<0.01, segment 1: r=0.55, segment 4: 
r=0.53, segment 5&8: r =0.54 and segment 6&7: r=0.51, all p<0.05, Table 3.27). 
   
3.3.23.iv Correlation Analysis of Body Composition and Regional Pancreatic Fat Content 
in BMI Group 2 
 
IAAT, was the adipose depot, which correlated to the greatest degree with IPCL in the head 
and body of the pancreas, but not the tail (Head: r=0.63, p<0.01 and Body: r=0.47, p<0.05). 
There were no significant correlations between regional IPCL and anthropometric variables. 
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Table 3.27 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores with Segmentation and Body Fat Stores in BMI 
Group 2. 
BMI Group 2
n=20 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI MRS IHCL
ME total 
IHCL
ME segment 
1  IHCL
ME 
segment 
2&3 IHCL
ME 
segment 4 
IHCL
ME 
segment 
5&8 IHCL
ME 
segment 
6&7 IHCL
ME total 
IPCL
ME Head 
IPCL
ME Body 
IPCL ME Tail IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.171
HEIGHT -0.185 .816**
WAIST .233 0.387 .496*
HIP .250 0.063 -0.008 0.307
WHR .144 0.366 .502* .633** -0.279
WHtR 0.361 -0.351 -.458* 0.048 .840** -.478*
BMI .129 0.203 -0.325 -0.003 0.317 -0.170 0.377
MRS Liver .062 0.318 .577** .502* 0.062 .624** -0.242 -0.356
ME total IHCL .077 0.293 .524* .539* 0.053 .650** -0.250 -0.262 .970**
ME segment 1 IHCL .178 0.244 .526* .459* 0.079 .571** -0.250 -0.361 .895** .899**
ME segment 2&3 IHCL -.024 0.399 .685** 0.440 -0.100 .588** -.450* -0.433 .886** .881** .910**
ME segment 4 IHCL 0.114 0.275 .577** .492* 0.140 .558* -0.189 -0.376 .953** .956** .940** .916**
ME segment 5&8 IHCL .038 0.263 .541* .482* 0.071 .568** -0.236 -0.373 .965** .956** .877** .887** .964**
ME segment 6&7 IHCL .106 0.238 .497* .463* 0.097 .564** -0.228 -0.327 .929** .944** .919** .881** .965** .978**
ME total IPCL 0.377 0.284 .479* 0.300 0.037 0.392 -0.155 -0.355 0.383 0.325 0.328 0.411 0.412 0.364 0.343
ME Head IPCL 0.339 .296 .380 0.381 .268 0.269 0.048 -0.056 .368 .335 .257 .308 0.371 .385 .352 .817**
ME Body IPCL 0.158 0.220 .443 0.052 -0.115 0.288 -0.265 -0.396 0.341 0.242 0.233 0.400 0.323 0.305 0.246 .865** .749**
ME Tail IPCL 0.391 .032 .267 0.233 -.135 0.338 -0.156 -0.439 0.232 0.165 .203 0.293 0.245 0.189 .166 .859** .490* .733**
TAT 0.285 -0.299 -0.322 0.005 .651** -0.205 .696** 0.173 -0.272 -0.271 -0.191 -0.346 -0.167 -0.209 -0.169 0.059 .208 -0.013 -.062
SAT .171 -0.318 -0.336 -0.030 .666** -0.325 .705** 0.198 -0.337 -0.322 -0.268 -0.409 -0.223 -0.256 -0.226 -0.062 .125 -0.118 -.171 .958**
Internal 0.381 0.263 .339 0.411 0.077 .678** -0.093 -0.012 0.4 0.418 0.414 0.374 0.421 0.435 .466* .459* .535* 0.378 0.205 0.376 0.220
SAAT 0.147 -0.238 -0.255 -0.059 .618** -0.245 .611** 0.132 -0.254 -0.251 -0.217 -0.362 -0.134 -0.167 -0.138 0.081 .223 -0.023 -.102 .926** .941** 0.281
NASAT .158 -0.361 -0.381 -0.044 .621** -0.340 .701** 0.194 -0.386 -0.379 -0.322 -.453* -0.292 -0.314 -0.291 -0.122 .065 -0.147 -.185 .943** .988** 0.186 .892**
IAAT 0.320 0.270 .349 0.381 -0.044 .699** -0.203 -0.060 .526* .550* .451* 0.444 .489* .535* .544* .537* .632** .469* 0.263 0.126 -0.048 .907** 0.045 -0.087
NAIAAT 0.361 0.215 .330 0.229 0.152 .456* -0.009 -0.137 0.254 0.242 0.392 0.316 0.341 0.253 0.300 0.347 0.301 0.270 0.135 .496* 0.374 .797** 0.412 0.358 .570**
IAAT/ASAT .230 .267 0.438 .414 -0.436 .797** -.516* -0.263 .627** .632** .552* .600** .534* .541* .514* .402 .307 .402 .353 -.459* -.623** .528* -.558* -.626** .714** .269
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
All data are presented as Spearman rank test correlation.. *= p<0.05, **= p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; 
IPCL: intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non abdominal subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: 
non-abdominal internal 
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3.3.23.v  Correlation Analysis of Body Composition and Regional Liver Fat Content in 
BMI Group 3 
 
In Group 3, apart from IAAT/ASAT ratio which showed a strong correlation with IHCL in 
segment 4 of the liver (r=0.71 p<0.05, Table 3.28) and segment 5&8 of the liver (r= 0.63 
p<0.05, Table 3.28) variables did not correlate with each other. 
 
3.3.23.vi Correlation Analysis of Body Composition and Regional Pancreatic Fat Content 
in BMI Group 3 
 
There was no association between regional IPCL and any of the adiposity depots in BMI group 
3 (Table 3.28).  
 
Head was only associated with Age (r= 0.62, p<0.05) and Body negatively with Weight (r= -
0.62, p<0.05) 
 
198 
 
Table 3.28 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores with Segmentation and Body Fat Stores in BMI 
Group 3. 
BMI Group 3
n=11 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI MRS IHCL
ME total 
IHCL
ME segment 
1  IHCL
ME 
segment 
2&3 IHCL
ME 
segment 4 
IHCL
ME 
segment 
5&8 IHCL
ME 
segment 
6&7 IHCL
ME total 
IPCL
ME Head 
IPCL
ME Body 
IPCL ME Tail IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.456
HEIGHT -0.387 .700*
WAIST .182 0.582 .427
HIP -.473 0.059 -0.178 -0.169
WHR .310 0.527 .373 .873** -0.524
WHtR -0.082 -0.245 -.645* -0.264 .834** -0.518
BMI -.050 0.355 -0.264 0.273 0.241 0.282 0.391
MRS Liver .296 0.227 .055 0.209 -0.251 0.209 -0.082 0.236
ME total IHCL .328 0.236 .145 0.055 -0.556 0.236 -0.373 0.091 .864**
ME segment 1 IHCL .214 0.282 .182 0.155 -0.460 0.227 -0.345 0.118 .909** .936**
ME segment 2&3 IHCL .282 0.200 -.036 -0.045 -0.442 0.127 -0.200 0.200 .836** .964** .918**
ME segment 4 IHCL 0.419 0.236 .082 0.245 -0.446 0.336 -0.273 0.073 .891** .900** .918** .882**
ME segment 5&8 IHCL .424 0.100 .109 0.036 -.610* 0.200 -0.427 0.000 .827** .964** .945** .927** .900**
ME segment 6&7 IHCL .278 0.264 .173 0.1 -0.401 0.200 -0.255 0.155 .945** .964** .927** .909** .882** .909**
ME total IPCL 0.538 -0.491 -.409 0.109 -0.296 0.300 -0.091 0.064 -0.291 -0.282 -0.327 -0.309 -0.127 -0.182 -0.336
ME Head IPCL .624* -.400 -.473 0.127 -.533 0.427 -0.200 0.200 -.064 .027 -.036 .036 0.127 .109 -.082 .909**
ME Body IPCL 0.597 -.618* -.427 -0.127 -0.428 0.100 -0.182 -0.245 -0.291 -0.118 -0.209 -0.127 0.000 0.009 -0.255 .873** .827**
ME Tail IPCL 0.424 -.409 -.318 0.136 -.374 0.355 -0.200 -0.064 -0.118 -0.182 -.191 -0.227 0.009 -0.118 -.209 .873** .827** .709*
TAT -0.100 0.036 -0.409 -0.036 0.569 -0.209 .736** .664* -0.036 -0.164 -0.200 -0.045 -0.227 -0.264 -0.082 -0.091 -.118 -0.191 -.382
SAT -.210 0.036 -0.327 -0.118 .743** -0.373 .818** 0.555 -0.064 -0.255 -0.273 -0.145 -0.336 -0.355 -0.127 -0.291 -.373 -0.409 -.527 .936**
Internal 0.433 0.209 .045 0.445 -0.091 0.391 0.009 0.309 0.100 0.200 0.136 0.182 0.255 0.218 0.155 0.200 0.218 0.264 -0.182 0.455 0.264
SAAT -0.337 0.073 -0.282 -0.218 .770** -0.464 .773** 0.573 -0.036 -0.245 -0.200 -0.109 -0.345 -0.309 -0.118 -0.418 -.464 -0.573 -.582 .764** .909** 0.018
NASAT -.137 -0.018 -0.382 -0.027 .661* -0.300 .782** .609* 0.009 -0.218 -0.182 -0.109 -0.264 -0.282 -0.091 -0.182 -.245 -0.318 -.436 .955** .964** 0.336 .855**
IAAT 0.333 0.382 .191 0.527 -0.073 0.491 -0.082 0.227 0.055 0.164 0.118 0.145 0.309 0.173 0.1 0.200 0.200 0.264 -0.100 0.255 0.073 .927** -0.136 0.109
NAIAAT 0.251 0.064 -.009 0.291 0.023 0.218 0.073 0.236 -0.236 -0.109 -0.173 -0.118 -0.100 -0.082 -0.164 0.282 0.209 0.345 -0.164 0.545 0.355 .918** 0.082 0.427 .809**
IAAT/ASAT .506 .236 0.345 .500 -0.574 0.564 -.555 -0.209 .409 .555 .555 .455 .709* .627* .464 .173 .273 .355 .118 -0.345 -0.518 .609* -.655* -0.427 .709* .382
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
All data are presented as Spearman rank test correlation. *= p<0.05, **= p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; 
IPCL: intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non abdominal subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: 
non-abdominal internal 
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3.3.23.vii Correlation Analysis of Body Composition and Regional Liver Fat Content in 
BMI Group 4 
 
In BMI Group 4, IHCL in all segments correlated to the greatest degree with NAIAT (segment 
1: r=0.77, segment 2&3: r=0.69, segment 4: r=0.75, segment 5&8: r=0.79 and segment 6&7: 
r=0.79, all p<0.01, Table 3.29) followed by Internal adiposity store in certain segments 
(segment 2&3: r=0.54, segment 4: r=0.56 and segment 5&8: r=0.56, all p<0.05). 
 
3.3.23.viii Correlation Analysis of Body Composition and Regional Pancreatic Fat 
Content in BMI Group 4 
 
IPCL was negatively associated with WHR in the Head (r=-0.54 p<0.05) and Body (r=-0.59 
p<0.05) and Tail (r= -0.55, p<0.05, Table 3.29) of the pancreas.  
 
In addition, Head IPCL was significantly associated with WHtR (r= 0.56, p<0.05, Table 3.27) 
and Tail IPCL with IAAT/ASAT ratio (r= 0.60, p<0.05, Table 3.29). 
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Table 3.29 Linear Correlation Analysis between Anthropometric Measurements, Lipid Stores with Segmentation and Body Fat Stores in BMI 
Group 4. 
BMI Group 4
n=14 AGE WEIGHT HEIGHT WAIST HIP WHR WHtR BMI MRS IHCL
ME total 
IHCL
ME segment 
1  IHCL
ME 
segment 
2&3 IHCL
ME 
segment 4 
IHCL
ME 
segment 
5&8 IHCL
ME 
segment 
6&7 IHCL
ME total 
IPCL
ME Head 
IPCL
ME Body 
IPCL ME Tail IPCL TAT SAT Internal SAAT NASAT IAAT NAIAAT
AGE
WEIGHT -.628*
HEIGHT -.666** .802**
WAIST .083 0.506 .169
HIP .224 0.154 -0.146 0.392
WHR -.144 0.314 .407 .561* -0.463
WHtR 0.513 -0.284 -.622* 0.145 .818** -.613*
BMI -.013 0.376 -0.187 .587* 0.505 -0.046 0.429
MRS Liver -.058 -0.042 -.046 0.117 -0.115 0.218 0.024 -0.226
ME total IHCL -.238 0.154 .141 0.226 0.009 0.231 -0.002 -0.134 .933**
ME segment 1 IHCL -.270 0.130 .116 0.260 0.015 0.292 0.002 -0.130 .930** .972**
ME segment 2&3 IHCL -.212 0.235 .196 0.273 0.165 0.156 0.081 -0.068 .864** .959** .921**
ME segment 4 IHCL -0.166 0.108 .086 0.240 0.022 0.226 0.037 -0.152 .947** .986** .969** .965**
ME segment 5&8 IHCL -.312 0.152 .178 0.158 -0.018 0.204 -0.042 -0.196 .930** .986** .974** .934** .969**
ME segment 6&7 IHCL -.319 0.143 .160 0.227 -0.029 0.292 -0.064 -0.165 .916** .968** .987** .890** .947** .982**
ME total IPCL 0.299 -0.081 -.336 -0.097 0.265 -.543* 0.420 0.248 0.240 0.224 0.055 0.305 0.244 0.165 0.046
ME Head IPCL 0.341 -.147 -.481 -0.037 .404 -.587* .556* 0.398 .191 .152 .042 .240 0.187 .099 .015 .925**
ME Body IPCL 0.367 -0.064 -.376 -0.015 0.342 -.552* 0.508 0.310 0.187 0.174 0.007 0.248 0.191 0.103 -0.007 .978** .912**
ME Tail IPCL 0.314 -.354 -.433 -0.211 -.190 -0.235 0.138 -0.099 0.481 0.341 .240 0.314 0.407 0.323 .235 .736** .692** .670**
TAT -0.308 0.477 0.130 0.253 .666** -0.429 0.429 .670** -0.218 0.018 -0.051 0.095 -0.059 0.015 -0.020 0.345 .376 0.385 -.156
SAT -.374 0.354 0.029 0.132 .642* -0.495 0.446 .653* -0.248 -0.022 -0.051 0.046 -0.095 -0.011 -0.029 0.248 .327 0.270 -.213 .960**
Internal -0.024 0.305 .433 0.139 -0.229 0.367 -0.301 -0.336 .604* .587* 0.503 .538* .560* .560* 0.530 0.165 0.029 0.152 0.279 -0.213 -0.402
SAAT 0.150 0.279 -0.134 0.488 .721** -0.257 0.530 .710** -0.385 -0.255 -0.253 -0.143 -0.248 -0.332 -0.284 0.231 .367 0.319 -.244 .578* .565* -0.332
NASAT -.378 0.191 -0.064 -0.108 0.509 -.626* 0.415 0.481 -0.310 -0.165 -0.174 -0.121 -0.222 -0.108 -0.138 0.196 .244 0.209 -.182 .833** .912** -.574* 0.385
IAAT 0.164 0.187 .319 0.022 -0.174 0.169 -0.196 -0.358 0.499 0.429 0.314 0.429 0.437 0.407 0.336 0.380 0.226 0.345 0.481 -0.226 -0.433 .921** -0.297 -.543*
NAIAAT -0.188 0.213 .257 0.169 -0.223 0.389 -0.222 -0.218 .793** .805** .771** .692** .754** .785** .793** 0.059 0.002 0.055 0.226 -0.134 -0.235 .855** -0.363 -0.420 .631*
IAAT/ASAT .080 .125 0.248 -.163 -0.348 0.099 -.253 -0.389 .521 .411 .288 .407 .429 .402 .297 .437 .257 .385 .604* -0.284 -0.459 .833** -0.495 -0.486 .930** .587*
ANTHROPOMETRIC VARIABLES ECTOPIC FAT STORES ADIPOSITY STORES in LITRES
All data are presented as Spearman rank test correlation. *= p<0.05, **= p< 0.01. Abbreviations: WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; 
IPCL: intra-pancreatic cellular lipid, TAT: total adipose tissue; SAT: subcutaneous; SAAT: subcutaneous abdominal; NASAT: non abdominal subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: 
non-abdominal internal 
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3.3.24 Correlation Analysis and the Relationship between Regional and Total Liver Fat 
Content  
 
The higher the BMI the stronger the correlation between ME total IHCL and ME segments 
IHCL, see Table 3.30.  
 
Nevertheless, the IHCL content in segment 4 of the liver shows a near perfect correlation 
with total liver fat IHCL in all groups regardless of their BMI (r=0.96-0.99) ( Table 3.30).  
 
As for segment 2&3, it has the lowest association when compared to the other segments 
(r=0.74- 0.96) (Table 3.30). 
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Table 3.30 BMI Group Specific Correlation Coefficients (r) of MRS and ME for estimating   
Liver Fat 
                                                        
BMI Group 1 2 3 4
ME vs MRS IHCL 0.73   P=0.001 0.97  P <0.001 0.86   P=0.001 0.93  P <0.001
ME total IHCL vs ME  segment 1 IHCL 0.78  P<0.001 0.90  P <0.001 0.94   P <0.001 0.97   P <0.001
ME total IHCL vs ME segment 2&3 IHCL 0.74   P=0.001 0.88   P <0.001 0.96   P < 0.001 0.96   P <0.001
ME total IHCL vs ME segment 4 IHCL 0.96  P <0.001 0.96   P <0.001 0.90   P <0.001 0.99  P<0.001
ME total IHCL vs ME segment 5&8 IHCL 0.84  P <0.001 0.96   P <0.001 0.96   P <0.001 0.99   P<0.001
ME total IHCL vs ME segment 6&7 IHCL 0.82   P< 0.001 0.94   P <0.001 0.96   P <0.001 0.97   P<0.001
Correlation coefficients ( r )
Data was analysed by Spearman rank test correlation, Where MRS- Magnetic Resonance Spectroscopy, ME- 
Multi-echo 
 
3.3.25 Correlation Analysis and the Relationship between Regional and Total Pancreatic 
Fat Content  
 
In the pancreas there was a similar pattern as observed in the liver, the higher the BMI the 
greater the correlation between the regions (Table 3.31).  
 
In BMI group 1 there was no significant correlation between  total  IPCL and the Body IPCL 
and Tail  IPCL (r= 0.46, r=0.47) respectively (Table 3.31).  
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Table 3.31 BMI Group Specific Correlation Coefficients (r) of ME for estimating Pancreatic 
Fat 
                                                        
BMI Group 1 2 3 4
ME total IPCL vs ME Head IPCL 0.74   P= 0.001 0.82   P<0.001 0.91   P<0.001 0.93   P<0.001
ME total IPCL vs ME  Body IPCL 0.46   P= 0.074 0.87  P<0.001 0.87   P<0.001 0.98   P<0.001
ME total IPCL vs ME Tail IPCL 0.47  P= 0.064 0.86   P<0.001 0.87   P<0.001 0.74  P=0.003
Correlation coefficients ( r )
Data was analysed by Spearman rank test correlation, Where ME- Multi-echo 
 
3.3.26 Matrix Analysis and the Relationship between Regional and Total Ectopic Fat 
Content  
 
When the BMI range is normal (Group 1=18<25 kg/m²) there appears to be a variation 
between the total and regional ectopic fat content in both the liver and pancreas (Figure 3.22).  
 
As the BMI increases to an overweight range (Group 2: 25<30 kg/m², see Figure 3.23) there 
is less variation in regional and total fat content in both organs.  
 
The correlations between total and regional IHCL continue to strengthen in both the obese 
(Group 3: 30<40 kg/m²) (Figure 3.24) and morbidly obese groups (Group 4: 40+ kg/m²) 
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(Figure 3.25). A similar result is found in the pancreas, with the exception of the tail IPCL 
in the pancreas. (Figure D).  
 
Figure 3.22 Matrix Correlations of Total Pancreas Fat, Head Pancreas Fat, Body Pancreas 
Fat and Tail Pancreas Fat with Total Liver Fat and Liver Segments in BMI group 1  
Shaded boxes indicate BMI Group 1 specific variation in total Multi-echo imaging of liver fat (ME total 
IHCL), segment 1 liver fat Multi-echo (ME segment 1 IHCL), segment 2&3 liver fat Multi-echo (ME segment 
2&3 IHCL), segment 4 liver fat Multi-echo (ME segment 4 IHCL), segment 5&8 liver fat Multi-echo (ME 
segment 5&8 IHCL), segment 6&7 liver fat Multi-echo (ME segment 6&7 IHCL) (A) and total Multi-echo 
imaging of pancreas fat (ME total IPCL) (B) Head Multi-echo imaging of pancreas fat (ME head IPCL) (C) 
Body Multi-echo imaging of pancreas fat (ME Body IPCL) (D) Tail Multi-echo imaging of pancreas fat (ME 
tail IPCL) 
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Figure 3.23 Matrix Correlations of Total Pancreas Fat, Head Pancreas Fat, Body Pancreas 
Fat and Tail Pancreas Fat with Total Liver Fat and Liver Segments in BMI group 2 
Shaded boxes indicate BMI Group 2 specific variation in total Multi-echo imaging of liver fat (ME total 
IHCL), segment 1 liver fat Multi-echo (ME segment 1 IHCL), segment 2&3 liver fat Multi-echo (ME segment 
2&3 IHCL), segment 4 liver fat Multi-echo (ME segment 4 IHCL), segment 5&8 liver fat Multi-echo (ME 
segment 5&8 IHCL), segment 6&7 liver fat Multi-echo (ME segment 6&7 IHCL) (A) and total Multi-echo 
imaging of pancreas fat (ME total IPCL) (B) Head Multi-echo imaging of pancreas fat (ME head IPCL) (C) 
Body Multi-echo imaging of pancreas fat (ME Body IPCL) (D) Tail Multi-echo imaging of pancreas fat (ME 
tail IPCL) 
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Figure 3.24 Matrix Correlations of Total Pancreas Fat, Head Pancreas Fat, Body Pancreas 
Fat and Tail Pancreas Fat with Total Liver Fat and Liver Segments in BMI group 3 
Shaded boxes indicate BMI Group 3 specific variation in total Multi-echo imaging of liver fat (ME total 
IHCL), segment 1 liver fat Multi-echo (ME segment 1 IHCL), segment 2&3 liver fat Multi-echo (ME segment 
2&3 IHCL), segment 4 liver fat Multi-echo (ME segment 4 IHCL), segment 5&8 liver fat Multi-echo (ME 
segment 5&8 IHCL), segment 6&7 liver fat Multi-echo (ME segment 6&7 IHCL) (A) and total Multi-echo 
imaging of pancreas fat (ME total IPCL) (B) Head Multi-echo imaging of pancreas fat (ME head IPCL) (C) 
Body Multi-echo imaging of pancreas fat (ME Body IPCL) (D) Tail Multi-echo imaging of pancreas fat (ME 
tail IPCL) 
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Figure 3.25 Matrix Correlations of Total Pancreas Fat, Head Pancreas Fat, Body Pancreas 
Fat and Tail Pancreas Fat with Total Liver Fat and Liver Segments in BMI group 4 
Shaded boxes indicate BMI Group 4 specific variation in total Multi-echo imaging of liver fat (ME total 
IHCL), segment 1 liver fat Multi-echo (ME segment 1 IHCL), segment 2&3 liver fat Multi-echo (ME segment 
2&3 IHCL), segment 4 liver fat Multi-echo (ME segment 4 IHCL), segment 5&8 liver fat Multi-echo (ME 
segment 5&8 IHCL), segment 6&7 liver fat Multi-echo (ME segment 6&7 IHCL) (A) and total Multi-echo 
imaging of pancreas fat (ME total IPCL) (B) Head Multi-echo imaging of pancreas fat (ME head IPCL) (C) 
Body Multi-echo imaging of pancreas fat (ME Body IPCL) (D) Tail Multi-echo imaging of pancreas fat (ME 
tail IPCL) 
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3.3.27 Impact of Exercise Level Intensity on Regional Liver Fat Content 
 
IHCL content in different the segments of the liver according to exercise level groups are 
shown in (Table 3.32 and Figure 3.26).  
 
As expected, the higher the exercise level the lower the IHCL content in all regions of the liver. 
There were significant differences in IHCL content between the Sedentary/Low and High 
intensity groups in all regions (all p<0.01).  
 
However there were no significant differences between the moderate and high intensity groups 
or between the Moderate and Low intensity groups.  
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Figure 3.26 Liver Fat Distributions in the High, Moderate and Low Exercise Level Groups 
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Table 3.32 Impact of Exercise Level Intensity on Regional Ectopic Fat Content 
 Data for whole cohort  
Exercise Level  Sedentary/Low Moderate High 
4 
 
number 31 14 15 
14 
p 
Liver Fat  
IHCL (MRS) 12.84 ± 15.67 7.24 ± 12.34 1.06 ± 1.63 
15.72 ± 16.60 
0.017 
Total IHCL 
(ME) 
9.91 ± 8.36 5.45 ± 6.57 1.95 ± 1.57 
7.66 ± 6.64 
0.002 
Segment 1  8.86 ± 7.83 4.57 ± 5.82 1 6 .25 0.002 
Segment 2&3 
IHCL 
9.07 ± 7.75 4.73 ± 6.26 2.04 ± 1.30 0.003 
Segment 4 
IHCL 
9.96 ± 7.95 5.25 ± 6.32 1.93 ± 1.69 0.001 
Segment 5&8 
IHCL 
10.36 ± 9.41 5.61 ± 6.93 1.82 ± 1.82 0.003 
Segment 6&7 
IHCL 
10.38 ± 9.64 5.60 ± 6.90 1.74 ± 1.62 0.003 
Pancreas Fat  
Total IPCL 7.10 ± 6.36 5.46 ± 7.00 2.95 ± 3.23 
7.66 ± 6.64 
0.09 
Head  5.80 ± 5.88 4.53 ± 5.74 3.03 ± 2.27 0.24 
Body  7.05 ± 7.51 4.37 ± 6.29 2.85 ± 3.47 0.10 
Tail 5.49 ± 4.59 5.00 ± 6.48 3.72 ± 3.09 0.51 
IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid. All data are presented as mean ± SD. 
Differences between exercise levels were tested for using ANOVA and Post-hoc Turkey analysis. 
   
3.3.28 Impact of Exercise Level Intensity on Regional Pancreatic Fat Content 
 
There was a similar trend in the pancreas with the lowest IPCL content observed in the group 
which undertook the highest intensity exercise (Table 3.32 and Figure 3.27), however, none of 
these differences reach significance.  
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Figure 3.27 Pancreas Fat Distributions in the High, Moderate and Low Exercise Level Groups. 
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3.4 Discussion 
 
In this chapter I have described the relationship between ectopic fat content in both the liver 
and pancreas and how this related to body composition, in particular adipose tissue content. I 
have also applied novel analysis techniques which have allowed me to map regional 
accumulation of ectopic fat in both the liver and pancreas, compared this with conventional 
MR methods of measuring ectopic fat content and seen how regional fat distribution related to 
body composition. 
 
There was a wide range of variability in my cohort in liver ectopic fat content, with ~40% 
displaying elevated IHCL, coinciding with other population studies. (Donhoffer 1974, Seppala-
Lindroos, Vehkavaara et al. 2002, Tarasow, Siergiejczyk et al. 2002, Thomas, Hamilton et al. 
2005) This may be due to the relatively small number of subjects, and gender imbalance 
particularly in different BMI groups. By comparison, a slightly smaller proportion of the cohort 
had elevated pancreatic fat content (~33%); though a recent study by Wong et al. (Wong 
Vincent Wai-Sun 2014) claimed that the upper limit for normal IPCL content is 10.4% in 
healthy volunteers, generating yet a clinically unclear relevant cut-off point for IPCL. 
 
In this study, ME of total IHCL displayed a generally good correlation and concordance with 
regard to the gold standard MRS IHCL (r =0.96), but not at high levels of IHCL. This is most 
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likely due to the different methods’ formulas rather than differences between MR techniques 
per se. (MRS= (CH2/Water) vs. ME= CH2+CH3/water+fat)  
 
When utilising the novel ME derived technique,  that allows regional assessment of ectopic fat 
in liver, I found that overall, regardless of which segment of the liver I measured to determine 
the lipid content it correlated significantly (p<0.001) to total IHCL, with a reproducibility of 
<1%, although, there was quite an inter-individual variation. 
 
The lack of significant overall regional variation between segments might be the outcome of a 
‘diffuse fatty liver’ deposition in my cohort, which is the most prevalent form of NAFLD. 
(Cassidy, Yokoo et al. 2009, Decarie, Lepanto et al. 2011) The liver seems to be 
homogeneously involved by fat accumulation. (Thomas, Hamilton et al. 2005, Decarie, 
Lepanto et al. 2011, N. S. Patel 2013)  However, studies have reported focal fatty sparing or 
infiltration at liver imaging. (Halvorsen, Korobkin et al. 1982, Kammen, Pacharn et al. 2001, 
Yoshimitsu, Honda et al. 2001) 
 
A study from Capitan et al. (Capitan, Petit et al. 2012) demonstrated a heterogeneous effect at 
the segmental level, indicating a more geographical fat deposition. (Cassidy, Yokoo et al. 2009, 
Decarie, Lepanto et al. 2011, Capitan, Petit et al. 2012) This implies that ectopic fat in the liver 
have various atypical patterns of distribution that may be affected not only by fat infiltration 
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but also other metabolic conditions, (Mills, Doppman et al. 1977) hence, leading to 
misdiagnosis.(Capitan, Petit et al. 2012)  
 
IPCL, alternatively, had an uneven accumulation of fat throughout its regions, although 
significantly associated (p<0.001) with a reproducibility of <1%, the Head and Body regions 
had the highest correlation with the total IPCL, when compared to the disengaged Tail region.  
 
This uneven fatty infiltration may be caused by differences in the histological characteristics 
between the 2 embryological pancreatic buds. (Marchal, Verbeken et al. 1989, Donald, 
Shorvon et al. 1990, Jacobs, Coleman et al. 1994, Matsumoto, Mori et al. 1995) The pancreas 
forms from 2 separate buds: the dorsal and the ventral buds. Fusion of these 2 buds forms the 
resulting pancreas. The ventral bud forms the posterior parts of the head and the uncinate 
process while the larger dorsal bud forms the body, tail, and anterior part of the head.  (Suda, 
Mizuguchi et al. 1981, Uchida, Takada et al. 1999, Borghei, Sokhandon et al. 2013) 
 
There are reports that detected a markedly fat deposition in pancreas islet cells. (Noronha, 
Salgadinho et al. 1981, Tushuizen, Bunck et al. 2007) However, according to some studies 
with pathological and histological observations, pancreas lipid deposition occurred mainly in 
adipocytes within the exocrine tissue or in the adipose tissue in the interlobular space rather 
than in cells. (Tham, Heyerman et al. 1991, Ferrozzi, Bova et al. 1996, Nghiem, Olson et al. 
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2004) Ensuing that ectopic fat content in the pancreas is unlikely to serve as a biomarker of the 
endocrine function of the pancreas. (Szendroedi and Roden 2009) 
 
3.4.1 Anthropometry, IHCL and IPCL 
 
There were significant correlations between total and regional IHCL and most anthropometric 
measurements especially BMI, weight, WC (more significantly in females) and WHR (more 
significantly in males), in agreement with previous studies.(Flegal, Shepherd et al. 2009, 
Thomas, Parkinson et al. 2012)  
 
Furthermore, Sijens et al. (Sijens, Edens et al. 2010) observed a strong relationship between 
IPCL and BMI. Interestingly, in my cohort only men mirrored this connection, more 
pronouncedly when looking at the pancreas fat content as a whole (ME total IPCL) less so in 
individual regions.  
 
Whilst most variables, as expected, increased with increasing BMI group, the changes in IHCL 
and IPCL are less clear with an apparent rise from group 1-3 followed by a decrease in group 
4. Further examination of the data suggests this may be related to the gender balance within 
these groups, where BMI Group 1 and 2 contain 75% male subjects, whilst BMI group 4 is 
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78% females. Therefore it is likely that gender differences in body composition and ectopic fat 
are masking differences related to BMI. 
 
Men also showed a strong affiliation with WC and IPCL content. A few studies observed 
similar associations as well. (Lee, Kim et al. 2009, Heni, Machann et al. 2010, Wong Vincent 
Wai-Sun 2014) Nonetheless, more profoundly was the significant association of pancreatic fat 
content in men with WHR in all pancreatic regions (p<0.05). Though, intriguingly, female 
subjects in my study showed no association with WC and WHR in the pancreatic regions or 
with any of the anthropometric variables. 
 
Thus WHR in my study, a measurement known to be more closely related to the intra-
abdominal compartment (Borkan, Gerzof et al. 1982, Ashwell, Cole et al. 1985, Vanderkooy, 
Leenen et al. 1993), may be an appropriate anthropometric parameter for IHCL and IPCL 
content particularly in men. 
 
3.4.2 Adiposity, IHCL and IPCL 
 
Adiposity stores, in particular IAAT, had a profound effect on ectopic fat accumulation in the 
liver, independent of gender. Though, IHCL may be masked by gender differences in adiposity, 
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where despite a wide range of BMI, males had significantly higher proportion of total internal 
fat compared to females (p<0.001).  
 
Furthermore, previous studies have shown clear gender differences in IHCL with significantly 
higher levels in male when compared with female subjects.(Schwimmer, McGreal et al. 2005, 
Rossi, Fantin et al. 2011, Thomas, Parkinson et al. 2012) 
 
Nevertheless, my results are consistent with previous studies demonstrating that visceral 
abdominal adipose tissue is one of the determinants of liver fat content. (Nielsen, Guo et al. 
2004, Thomas, Hamilton et al. 2005, Eguchi, Eguchi et al. 2006, Jakobsen, Berentzen et al. 
2007, Rossi, Fantin et al. 2011) This may be due to the anatomical position of the liver, where 
the hepatic vascular network consists of a dual input: from the hepatic artery, which delivers 
~30%, and the portal vein, which delivers ~70% of the blood reaching the liver. (Sase, Monden 
et al. 2002)Visceral fat venous blood is drained directly to the liver through the portal vein. 
This contrasts with subcutaneous fat where venous drainage is through systemic veins. 
(Ibrahim 2010) However, although visceral fat provides direct hepatic access to FFA and 
adipokines secreted by visceral adipocytes, (Ibrahim 2010) studies from patients with 
lipodystrophy suggest that even with little or no adipose tissue, fatty liver, and insulin 
resistance can still develop quite strikingly, (Garg 2004) which undermines the portal 
hypothesis.  
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Moreover, Nielsen et al. (Nielsen, Guo et al. 2004) have observed that the relative influence of 
portal vein FFA derived from visceral fat is minor when compared with FFA derived from 
subcutaneous fat; only about 5% and 20% in lean and obese subjects, respectively during post-
absorptive conditions. 
 
Therefore, the amount of fat present in hepatocytes arises from an imbalance between lipid 
acquisition and removal  (Cohen, Horton et al. 2011) and represents a complex interaction of 
(1) adipose tissue lipolysis about 59% (2) de novo lipogenesis by 26% and (3) dietary 
chylomicrons (15%). (Donnelly 2005, Fabbrini, Sullivan et al. 2010, Cohen, Horton et al. 2011, 
Ghosh 2014) 
 
Comparable to liver fat content, lipid accumulation in the pancreas was also affected by IAAT 
in both genders and more so in overweight participants (BMI: 25<30 kg/m²) where the Head 
and Body regions of the pancreas had the greatest influence. The Tail did not follow that 
pattern. 
 
Though, once again similarly to IHCL, this may be masked by gender differences in adiposity, 
where males had significantly higher proportion of total internal fat compared to females. 
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Nevertheless, association between fatty pancreas and IAAT has been previously observed in 
some (Lee, Kim et al. 2009, Heni, Machann et al. 2010, Rossi, Fantin et al. 2011)  but not all 
studies. (Hannukainen, Borra et al. 2011, van der Zijl, Goossens et al. 2011) Parallel to my 
results, Heni et al. (Heni, Machann et al. 2010) observed a significant association between 
pancreatic fat content and visceral fat in overweight participants, whilst van der Zijl et al.(van 
der Zijl, Goossens et al. 2011) and Hannukainen et al. did. (Hannukainen, Borra et al. 2011) 
 
The use of different methods for measuring pancreatic lipid content as well as differences in 
the study population may partially explain inconsistency in the findings of these studies. (Heni, 
Machann et al. 2010, Hannukainen, Borra et al. 2011, van der Zijl, Goossens et al. 2011) 
Ordinarily, the peribiliary region (head and body), has been shown to be the most fat infiltrated, 
(Matsumoto, Mori et al. 1995, Saisho, Butler et al. 2007, Kawamoto, Siegelman et al. 2009) 
while other studies showed no significant difference in fat content across the regions. (Li, Xie 
et al. 2011, N. S. Patel 2013) 
 
Ultimately, although a correlation between total IHCL and IPCL is present, it was weaker than 
might be expected, and less clear cut than the relationship between IHCL and IAAT. 
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3.4.3 Age, IHCL and IPCL 
 
IHCL was shown to have an effect with age at (36-45 years old), explicitly in men in all age 
groups when it came to IPCL, when compared to other age groups (with no significance). These 
observations mirror the prevalence of NAFLD in the general population which increases 39% 
in those aged 40 to 50 years. (Kagansky, Levy et al. 2004, Adams, Angulo et al. 2005, Argo 
and Caldwell 2009, Okanoue, Umemura et al. 2011) As well as being more prevalent in men 
than women up to the age of 60 years. (Browning, Szczepaniak et al. 2004, Fan and Farrell 
2009, Hashimoto and Tokushige 2011) 
 
 But at older ages the disorder is more prevalent in women. (Browning, Szczepaniak et al. 
2004)  
 
The underlying mechanisms for this gender dimorphism is currently unknown, but may be 
related to a decline in hepatic blood flow (by 33%), hepatic volume (up to 25%), and liver 
function with age. (Frith, Day et al. 2009) which follows identifiable prevalence trends of those 
for the metabolic syndrome, peaking in middle age, and decreasing in octogenarians. (Frith, 
Day et al. 2009, Gan, Chitturi et al. 2011) 
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Moreover, when age was taken into account in IPCL significant gender differences were noted 
in all three pancreatic regions, Saisho et al. noted similar results in men with the progression 
of fat deposition in the pancreas until the 4th decade of life, whereas the pancreatic fat volume 
in women remained unchanged from the 2nd to the 9th decade. (Saisho, Butler et al. 2007) 
 
3.4.3 Exercise, IHCL and IPCL 
 
Impact of exercise showed that participants with higher physical activity and fitness had lower 
hepatic fat content in all segments than less active and less fit individuals. This observation is 
consistent with previous studies demonstrating that this may be mediated, in part, by a 
reduction in hepatic lipogenesis. (Di Mauro, Pagano et al. 2009, Marques, Motta et al. 2010, 
Aoi, Naito et al. 2011, Hannukainen, Borra et al. 2011, Johnson, Keating et al. 2012) 
 
Though, there is a lack of significance in IHCL levels between the moderate and high fitness 
groups. This may have been greatly affected by, once again, gender. Very few women reported 
high exercise levels (7% women), which accounts for the higher IAAT/ASAT ratio in this 
group, a similar analysis in a single sex cohort may produce different results. 
 
Alternatively, physical activity through different intensities, showed no significant effect on 
IPCL content, mirroring a study by Hannukainen et al.(Hannukainen, Borra et al. 2011). A 
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significant decrease was only observed between the two extremities of low and high fitness 
groups, except in the Tail region of the pancreas, where it appeared unaltered.  
 
It is challenging to arrive to clear conclusions with IPCL, due to the difficulty of tissue 
collection from the pancreas, which limits histological proof. Thus, using this non-invasive 
novel ME segmented technique may be an innovative approach in looking at challenging 
organs such as the latter and interpreting a more illustrative fatty infiltration. 
 
In conclusion, overweight participants (Group 2: BMI: 25<30 kg/m²) presented the most 
significant correlations. In addition to  having the strongest affiliation with different pancreatic 
regions and liver fat segments as well as having these two organs associated with each other in 
fat content solely in this group when compared to obese participants ( BMI: 30< 40 kg/m²) and 
morbidly obese participants (BMI: +40 kg/m²). Height was unexpectedly greatly correlated in 
this group with Liver and its segments but only with pancreas fat content as a whole and not 
with individual regions. 
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Chapter IV: The Impact of Lifestyle Interventions on Liver and Pancreatic Fat Content 
and Distribution  
 
4.1 Introduction 
 
It has been shown that genetic, environmental, and behavioural factors determine the response 
of adipose tissue to excess energy intake over energy expenditure. (Snel, Jonker et al. 2012) 
Diet and lifestyle interventions are powerful tools in improving both ectopic fat deposition and 
the function of the organ in which the ectopic fat is accumulated. A lifestyle characterized by 
inactivity and a high-calorie diet is a known risk factor for obesity and Type 2 Diabetes as well 
as for impaired insulin sensitivity. (Schrauwen 2007, Knudsen, Hansen et al. 2012, Snel, Jonker 
et al. 2012) 
 
Body composition, particularly the accumulation of visceral fat (Gastaldelli, Cusi et al. 2007, 
Goossens 2008, Usui, Asaka et al. 2010) and poor aerobic fitness (Eriksson and Lindgarde 
1996) are key determinants of the metabolic syndrome. (Kissebah, Vydelingum et al. 1982, 
Krotkiewski, Bjorntorp et al. 1983) In humans, hepatic lipid content is the most easily modified 
by high fat feeding, followed by visceral fat. (Bachmann, Dahl et al. 2001, Snel, Jonker et al. 
2012) Although, lifestyle modification such as calorie restriction and weight loss are the 
recommended therapy in NAFLD, (Westerbacka, Lammi et al. 2005, Zivkovic, German et al. 
2007, Bellentani, Dalle Grave et al. 2008, Kirk, Reeds et al. 2009, Nicklas, Wang et al. 2009, 
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Musso, Gambino et al. 2010, Peng, Wang et al. 2011) there are currently no systematic 
evaluations of its efficacy. (Thoma, Day et al. 2012) 
 
Moreover, accumulation of lipids in beta-cells has a negative effect on beta-cell function in 
rodents. Zucker (ZDF) rats on relatively high fat diets have shown excessive lipid inflow into 
the islets, the increased secretion pressure resulted in beta-cell deterioration and eventually 
apoptosis. (Pick, Clark et al. 1998) Conversely, restriction in food intake by pre-diabetic rats, 
counteracted the accumulation of fat and deterioration of beta-cells. (Ohneda, Inman et al. 
1995) 
 
In humans, recent studies have shown that lipid accumulation in the pancreas was increased in 
individuals with impaired glucose metabolism and T2DM. However, there were no clear 
association with beta-cell dysfunction in some studies. (van Raalte, van der Zijl et al. 2010, 
van der Zijl, Goossens et al. 2011) Whereas a study by Lim et al. (Lim, Hollingsworth et al. 
2011) shows a significant decrease in pancreatic fat and a normalisation of beta cell function 
by acute negative energy balance alone. 
 
The nature and rapidity of weight loss has also been shown to be important. (Andersen, Gluud 
et al. 1991) Previous studies have used surgical methods such as gastric banding (Raz, Eldor 
et al. 2005, Luyckx, Desaive et al. 1998, Dixon, Bhathal et al. 2004, Mattar, Velcu et al. 2005, 
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Shaffer 2006) and very low calorie diets (Andersen, Gluud et al. 1991, Petersen, Dufour et al. 
2005) to promote significant rapid weight loss, resulting in reduced hepatic lipid content.  
 
However, large and rapid reduction in weight may deteriorate underlying inflammation and 
fibrosis in patients with non-alcoholic steatohepatitis (NASH). (Andersen, Gluud et al. 1991, 
Luyckx, Desaive et al. 1998) Although weight loss induced by bariatric surgery decreases 
steatosis, inflammation, and fibrosis whilst having considerable beneficial metabolic effects in 
the liver by decreasing hepatic glucose production as well as hepatic VLDL-triglyceride 
secretion rate, and diminishing hepatic gene expression of factors that regulate hepatic 
inflammation and fibrogenesis. (Dixon, Bhathal et al. 2004, Clark, Alkhuraishi et al. 2005, 
Klein, Mittendorfer et al. 2006, Fabbrini, Sullivan et al. 2010) 
 
Non-invasive techniques such as Proton (¹H)-magnetic resonance spectroscopy (MRS) and 
magnetic resonance imaging (MRI) are the norm in assessing hepatic TG content in nutritional 
interventions in obese and T2DM subjects. (Petersen, Dufour et al. 2005, Tamura, Tanaka et 
al. 2005, Thomas, Brynes et al. 2006, Thamer, Machann et al. 2007) 
 
Consequently, I have used once again the Multi-echo (ME) Imaging based technique to look 
at fat content and distribution in the liver and pancreas in the overfeeding (Study 1), calorie 
restriction (Study 2) and bariatric surgery (Study 3) interventional studies (Chapter 2.6). I 
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will also be incorporating the novel approach to map regional fat distribution in the liver and 
pancreas (as described in Chapter 3), to further define potential changes across these organs 
before and after intervention.  
 
4.2 Statistical Analysis 
 
All Data are presented as mean ± standard deviation in the tables. Differences related to groups 
were examined by paired or unpaired Student’s t test, mean ± standard errors of the differences 
are reported, as well as ANOVA to compare mean differences. The distributions of the obtained 
fat contents were not normal, thus non-parametric correlations were analysed using the 
Spearman rank test. Statistical significance was accepted at p<0.05. 
 
4.3 Results 
 
4.3.1 Study 1 – The Impact of Overfeeding on Body Composition 
 
Subjects were asked to take 600 kcal / day in the form of 2 x 125ml Fortisip Compact drinks 
(250ml total) (nutritional content in Appendix 1) after breakfast on top of their own standard 
diet for a period of 6 days.  
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The control group, matched for gender and BMI were asked to drink a 0 kCal drink in the form 
of a 7UP soda (nutritional content in Appendix 1) for a period of 6 days. 
 
Both groups were scanned immediately before and the morning after they concluded their 
intervention.  
 
Participants were all male, with a mean age range of 19-47 years old. At baseline the 0kcal 
overfeeding group were older by 2 years and weighed 10kg less than the 600kcal overfeeding 
group (Table 4.0); these differences did not reach statistical significance. 
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Table 4.0 Baseline Characteristics of Study Participants 
 0 kCal Group (n=6) 600 kCal Group (n=6)  
 Mean ± SD Range Mean ± SD Range p 
Anthropometric Variables  
Age (years) 34.2 ± 12.4 22-47 32.3 ± 10.3  19-46 0.79 
Weight (kg) 73.9 ± 7.1 63.2-83.0 84.0 ± 10.4 66.8-95.4 0.08 
BMI (kg/m²) 24.7 ± 3.8 18.7-29.4 26.4 ± 2.4 24.0-30.5 0.38 
WC (cm) 78.7 ± 12.5 63.0-92.0 89.0 ± 13.3 66.8-104.0 0.20 
Hip (cm) 91.4 ± 4.1 84.0-95.0 112.7 ± 26.8   97.0-167.0 0.11 
Height (cm) 174 ± 7.3 165-184 178 ± 8.5 167-191 0.35 
WHR 0.86 ± 0.08 0.75-0.97 0.92 ± 0.05 0.83-0.98 0.20 
WHtR 0.46 ± 0.07 0.37-0.56 0.51 ± 0.06 0.45-0.59 0.16 
Ectopic Liver Fat  
MRS IHCL 0.41 ± 0.32 0.06-0.98 2.04 ± 2.73 0.08-6.43 0.21 
ME IHCL 1.25 ± 0.36 0.76-1.81 3.11 ± 3.67 0.70-9.92 0.27 
Segment 1 0.96 ± 0.44 0.26-1.57 2.64 ± 3.12 0.66-8.68 0.25 
Segment 2&3 1.49 ± 0.46 0.97-2.24 2.66 ± 2.21 1.18-6.84 0.26 
Segment 4 0.98 ± 0.40 0.64-1.75 2.97 ± 3.40 0.75-8.89 0.21 
Segment 5&8 1.11 ± 0.46 0.63-1.98 3.43 ± 4.48 0.44-11.55 0.26 
Segment 6&7 1.20 ± 0.40 0.69-1.92 3.04 ± 3.59 0.59-9.35 0.26 
Ectopic Pancreas Fat  
ME IPCL 1.61 ± 0.71 0.56-2.66 3.20 ± 2.23 0.73-6.69 0.13 
Head 2.18 ± 1.85 0.36-5.20 3.06 ± 1.82 1.35-5.60 0.43 
Body 1.35 ± 0.90 0.13-2.33 3.18 ± 2.44 0.81-7.86 0.13 
Tail 1.79 ± 1.35 0.25-3.96 3.77 ± 2.49 0.14-6.64 0.13 
Adiposity Stores  
TAT (L) 15.84 ± 4.26 10.62-21.26 21.37 ± 8.02 9.79-32.7 0.18 
SAT (L) 11.9 ± 3.33 7.61-15.05 17.26 ± 6.39 8.34-26.4 0.11 
ASAT (L) 2.95 ± 1.01 1.50-4.23 5.20 ± 2.42 2.39-8.81 0.08 
NASAT (L) 8.94 ± 2.41 6.11-11.25 12.06 ± 4.04 5.95-17.62 0.14 
Internal (L) 3.95 ± 1.80 1.97-6.45 4.11 ± 1.76 1.45-6.27 0.88 
IAAT (L) 2.14 ± 1.46 0.58-4.32 1.97 ± 1.22 0.28-3.66 0.83 
NAIAT (L) 1.82 ± 0.37 1.39-2.26 2.15 ± 0.63 1.17-2.87 0.31 
IAAT/ASAT 0.74 ± 0.37 0.15-1.14 0.35 ± 0.14 0.12-0.48 0.05 
All data are presented as mean ± SD .WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height 
ratio; IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatocellular lipid, Adipose tissue deposits are in litres (l); 
TAT: total adipose tissue; SAT: subcutaneous; ASAT: abdominal subcutaneous; NASAT: non-abdominal 
subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal. Baseline 
differences between 0 kcal 600 kcal groups were analysed by unpaired Student’s t-test. 
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4.3.1.i Changes in Body Composition following 0 Calorie Overfeeding  
 
During the 6 day overfeeding period with 0 kcal, there was a small, but significant decrease in 
BMI (pre: 24.7 ± 3.8 vs. 24.6 ± 3.8 kg/m², p<0.05). There was also a decrease of 0.30 ± 0.30 
kg in weight, though did not reach statistical significance (p=0.06), see Table 4.1. 
 
4.3.1.ii Changes in Adiposity following 0 Calorie Overfeeding 
 
There were small increases in most adipose tissue depots, but none of these changes reached 
statistical significance, see Table 4.1. There was no statistical difference between baseline and 
post overfeeding (0kcal) in all the adiposity stores (P>0.05 for all) (Table 4.1). 
 
4.3.1.iii Changes in Liver Fat following 0 Calorie Overfeeding 
 
There were small increases in both total and regional IHCL content between baseline and post 
overfeeding (0kcal), but none of these changes reached statistical significance, see Table 4.1. 
Interestingly, unlike other regions of the liver, there was a slight reduction in IHCL content in 
segment 2&3 0.25± 0.12, but this did not reach no statistical significance (p=0.09). 
 
4.3.1.iv Changes in Pancreatic Fat following 0 Calorie Overfeeding 
 
There was a trend for small increases in total, body and tail IPCL content following the 0 calorie 
intervention though none of these changes reached statistical significance, see Table 4.1. There 
was a non-significant decrease in head IPCL (p= 0.31).   
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Table 4.1 Impact of 0 kCal Supplementation on Body Composition 
 
 0 kCal Baseline (n=6) 0 kCal Follow-up (n=6)  
 Mean ± SD Range Mean ± SD Range p 
Anthropometric Variables  
Weight (kg) 73.9 ± 7.1 63.2-83.0 73.6 ± 6.9 63.4-82.4 0.06 
BMI (kg/m²) 24.7 ± 3.8 18.7-29.4 24.6 ± 3.8 18.7-29.2 0.05 
WC (cm) 78.7 ± 12.5 63.0-92.0 83.9 ± 5.6 74.5-91.0 0.20 
Hip (cm) 91.4 ± 4.1 84.0-95.0 93.5 ± 2.7 90.0-97.0 0.25 
WHR 0.86 ± 0.08 0.75-0.97 0.90 ± 0.05 0.83-0.96 0.25 
WHtR 0.46 ± 0.07 0.37-0.56 0.48 ± 0.05 0.41-0.55 0.23 
Ectopic Liver Fat  
MRS IHCL 0.41 ± 0.32 0.06-0.98 0.67 ± 0.58 0.12-1.71 0.06 
ME IHCL 1.25 ± 0.36 0.76-1.81 1.26 ± 0.43 0.87-2.11 0.94 
Segment 1 0.96 ± 0.44 0.26-1.57 1.18 ± 0.59 0.62-2.31 0.26 
Segment 2&3 1.49 ± 0.46 0.97-2.24 1.24 ± 0.46 0.74-1.89 0.09 
Segment 4 0.98 ± 0.40 0.64-1.75 1.16 ± 0.48 0.65-2.07 0.13 
Segment 5&8 1.11 ± 0.46 0.63-1.98 1.30 ± 0.56 0.80-2.38 0.11 
Segment 6&7 1.20 ± 0.40 0.69-1.92 1.44 ± 0.63 0.91-2.69 0.17 
Ectopic Pancreas Fat  
ME IPCL 1.61 ± 0.71 0.56-2.66 1.78 ± 0.58 1.13-2.46 0.81 
Head 2.18 ± 1.85 0.36-5.20 1.64 ± 1.03 0.35-2.83 0.31 
Body 1.35 ± 0.90 0.13-2.33 1.69 ± 0.95 0.76-3.32 0.31 
Tail 1.79 ± 1.35 0.25-3.96 2.07 ± 1.44 0.98-4.92 0.73 
Adiposity Stores  
TAT (L) 15.84 ± 4.26 10.62-21.26 16.05 ± 4.53 10.29-21.36 0.34 
SAT (L) 11.89 ± 3.32 7.61-15.05 12.08 ± 3.42 7.61-15.32 0.10 
ASAT (L) 2.95 ± 1.01 1.50-4.23 2.97 ± 1.00 1.58-4.30 0.58 
NASAT (L) 8.94 ± 2.41 6.11-11.25 9.11 ± 2.53 6.02-11.69 0.14 
Internal (L) 3.95 ± 1.80 1.97-6.45 3.97 ± 1.91 1.99-6.51 0.88 
IAAT (L) 2.14 ± 1.45 0.58-4.32 2.08 ± 1.53 0.45-4.31 0.31 
NAIAT (L) 1.82 ± 0.38 1.39-2.26 1.89 ± 0.46 1.43-2.44 0.40 
IAAT/ASAT 0.74 ± 0.37 0.15-1.14 0.69 ± 0.38 0.12-0.14 0.12 
All data are presented as mean ± SD .WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height 
ratio; IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid, Adipose tissue deposits are in litres 
(l); TAT: total adipose tissue; SAT: subcutaneous; ASAT: abdominal subcutaneous; NASAT: non-abdominal 
subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal. Differences 
before and after the 0 kcal supplement were analysed by paired Student’s t-test. 
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4.3.1.v Changes in Body Composition following 600 Calorie Overfeeding  
 
Following the overfeeding with 600kcal, there was a trend to increase in body weight by (1%), 
BMI (1%) and waist (3%); though none of these changes reached statistical significance, see 
Tables 4.2 and 4.3 
 
4.3.1.vi Changes in Adiposity following 600 Calorie Overfeeding 
 
Following the 600kcal overfeeding intervention, there were small increases in most adipose 
tissue depots, although this only reached statistical significance in the subcutaneous AT depot 
(17.26 ± 6.39 vs.17.82 ± 6.15 L, p=0.05), see Tables 4.2 and 4.3. 
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Table 4.2 Impact of 600 kCal Supplementation on Body Composition 
 
 600 kCal Baseline (n=6) 600 kCal Follow-up (n=6)  
 Mean ± SD Range Mean ± SD Range p 
Anthropometric Variables  
Weight (kg) 84.0 ± 10.4 66.8-95.4 84.6 ± 10.17 68.4-95.5 0.15 
BMI (kg/m²) 26.4 ± 2.4 24.0-30.5 26.56 ± 2.17 24.5-30.5 0.17 
WC (cm) 89.0 ± 13.3 66.8-104.0 92.0 ± 9.6 82.0-108.0 0.29 
Hip (cm) 112.7 ± 26.8   97.0-167.0 99.8 ± 7.2 86.4-107.0 0.39 
WHR 0.92 ± 0.05 0.83-0.98 0.92 ± 0.06 0.83-1.01 0.59 
WHtR 0.51 ± 0.06 0.45-0.59 0.52 ± 0.06 0.45-0.61 0.35 
Ectopic Liver Fat  
MRS IHCL 2.04 ± 2.73 0.08-6.43 1.77 ± 2.47 0.05-5.15 0.46 
ME IHCL 3.11 ± 3.67 0.70-9.92 2.95 ± 3.10 0.78-8.21 0.65 
Segment 1 2.64 ± 3.12 0.66-8.68 2.51 ± 2.28 0.66-6.40 0.80 
Segment 2&3 2.66 ± 2.21 1.18-6.84 2.72 ± 2.28 0.93-6.75 0.68 
Segment 4 2.97 ± 3.40 0.75-8.89 2.95 ± 3.43 0.65-8.86 0.69 
Segment 5&8 3.43 ± 4.48 0.44-11.55 -3.30 ± 3.79 0.72-9.55 0.74 
Segment 6&7 3.04 ± 3.59 0.59-9.35 3.07 ± 3.25 0.83-8.12 0.94 
Ectopic Pancreas Fat  
ME IPCL 3.20 ± 2.22 0.73-6.69 3.42 ± 2.77 0.44-7.12 0.48 
Head 3.06 ± 1.82 1.35-5.60 3.82 ± 2.19 0.33-5.70 0.30 
Body 3.18 ± 2.44 0.81-7.86 2.35 ± 2.53 0.17-6.96 0.07 
Tail 3.77 ± 2.49 0.14-6.64 3.57 ± 2.79 0.46-8.30 0.67 
Adiposity Stores  
TAT (L) 21.37 ± 8.02 9.79-32.7 22.04 ± 7.88 10.82-32.94 0.11 
SAT (L) 17.26 ± 6.39 8.34-26.4 17.82 ± 6.15 9.18-26.37 0.05 
ASAT (L) 5.20 ± 2.42 2.39-8.81 5.33 ± 2.48 2.55-8.85 0.16 
NASAT (L) 12.06 ± 4.04 5.95-17.62 12.48 ± 3.80 6.63-17.51 0.12 
Internal (L) 4.11 ± 1.76 1.45-6.27 4.23 ± 1.80 1.64-6.57 0.55 
IAAT (L) 1.97 ± 1.22 0.28-3.66 1.97 ± 1.35 0.36-3.90 0.97 
NAIAT (L) 2.15 ± 0.63 1.17-2.87 2.25 ± 0.59 1.29-2.89 0.08 
IAAT/ASAT 0.35 ± 0.14 0.12-0.48 0.34 ± 0.13 0.14-0.49 0.66 
All data are presented as mean ± SD .WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height 
ratio; IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid, Adipose tissue deposits are in litres 
(l); TAT: total adipose tissue; SAT: subcutaneous; ASAT: abdominal subcutaneous; NASAT: non-abdominal 
subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal. Differences 
before and after the 600 kcal supplement were analysed by paired Student’s t-test. 
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4.3.1.vii Changes in Liver Fat Content following 600 Calorie Overfeeding 
 
There was a trend for total IHCL content to decrease following the 600 kcal overfeeding 
intervention. There were also changes in regional IHCL content with small decreases in 
segments 1, 4 and 5&6, whereas IHCL content increased in segments 2&3 and 6&7, however 
none of these changes reached statistical significance, see Tables 4.2 and 4.3.  
 
An example of a subject with an increased in liver fat content is shown in Figure 4.0. In this 
volunteer, total IHCL content increased by 10% from baseline. 
Figure 4.0 Example of overfeeding variation of 600 kcal in 6 days in total liver fat  
A series of multi-echo (a & c) and corresponding heat-map images (b & d) from a 30 year old healthy male 
volunteer with a BMI of  25.60 kg/m² varying in levels of IHCL in the liver before & after overfeeding with 
600kcal.  
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Regional Changes are shown in Figure 4.1. In this example IHCL increased by 18.3 % in 
segment 1, 15.8% in segment 2&3, 2% in segment 4, 9% in segment 5&8 and 13.1% in segment 
6&7 from baseline during the 600kcal overfeeding. 
 
 
 
 
 
Figure 4.1 Example of overfeeding 600 kcal in 6 days in different segments of the liver 
Multi-echo at baseline and post overfeeding with 600kcal and corresponding heat-map liver segment images from 
a 30 year old healthy male volunteer with a BMI of 25.60 kg/m² varying in levels of ectopic fat (IHCL) in the 
different segments of the liver before & after overfeeding with 600kcal.  
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4.3.1.viii Changes in Pancreatic Fat Content following 600 Calorie Overfeeding 
 
There were no consistent changes in IPCL content following the 600kcal overfeeding 
intervention. There was a small increase in total IPCL (0.22 ± 0.71, p=0.48), but this did not 
reach statistical significance, see Tables 4.2 and 4.3.  
 
An example of a subject with an increase in total IPCL content of 23.5% from baseline is shown 
in Figure 4.2. 
 
 
Figure 4.2 Example of overfeeding variation of 600 kcal in 6 days in total pancreas 
A series of multi-echo (a & c) and corresponding heat-map images (b & d) from a 30 year old healthy male 
volunteer with a BMI of  25.60 kg/m² varying in levels IPCL before & after overfeeding with 600kcal.  
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There were also changes in regional IPCL content with an increase in Head (0.76± 1.62, 
p=0.30, Tables 4.2 and 4.3) and decreases in both the tail (0.20 ± 1.10, p=0.67) and body (0.83 
± 0.86, p=0.07) of the pancreas. 
 
An example of a subject with changes in regional in IPCL content is shown in Figure 4.3. In 
this example, IPCL increased by 1.8% in the Head, 1.2% ME Body IPCL, and a decreased by 
25.5% in the tail from baseline during the 600kcal overfeeding. 
 
 
 
Figure 4.3 Example of overfeeding variation of 600 kcal in 6 days in different regions of the 
pancreas 
Multi-echo at baseline and post overfeeding with 600kcal and corresponding heat-map pancreas region images 
from a 30 year old healthy male volunteer with a BMI of 25.60 kg/m² varying in levels of IPCL in the different 
regions of the pancreas before & after overfeeding with 600kcal.  
237 
 
4.3.1.ix Comparison of the Effects of 0 vs. 600 Calorie Overfeeding 
 
A comparison of the changes from baseline to follow-up in the 0 kcal group vs.600 kcal group 
is shown in Table 4.3. There were no significant differences between the groups following the 
intervention in any of the anthropometric measurements.  
 
4.3.1.x Comparison of the Effects of 0 vs. 600 Calorie Overfeeding on Adiposity 
 
Similarly there were no differences between the two groups in terms of changes in adiposity, 
although there was a non-significant trend for the 600kcal group to gain more adipose tissue 
compared with the 0kcal group. 
 
4.3.1.xi Comparison of the Effects of 0 vs. 600 Calorie Overfeeding on Liver Fat Content 
 
Paradoxically the 0kcal group appeared to have a tendency to increase their total and regional 
IHCL content, whereas the trend was for a corresponding reduction in the 600kcal group, 
although these differences did not reach statistical significance (Table 4.3). 
 
4.3.1.xii Comparison of the Effects of 0 vs. 600 Calorie Overfeeding on Pancreatic Fat 
Content 
 
There was a significant difference (p=0.03) in the response to the overfeeding intervention 
between the 0 kcal group and the 600 kcal group, in IPCL content in the body of the pancreas. 
This increased by 0.35 ± 0.75 in the 0kcal group and decreased by -0.83 ± 0.86 in the 600 kcal 
group (Table 4.3). There were no significant changes in total, head or tail IPCL content. 
Table 4.3 Impact of 0 vs. 600 kCal Supplementation on Body Composition 
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 0 kCal (n=6) 600 kCal (n=6)  
 Change from Baseline Change from Baseline p 
Anthropometric Variables  
Weight (kg) -0.30 ± 0.30 0.63 ± 0.92 0.06 
BMI (kg/m²) -0.10 ± 0.10 0.20 ± 0.30 0.06 
WC (cm) 5.22 ± 8.58 3.07 ± 6.35 0.63 
Hip (cm) 2.08 ± 3.90 -12.85 ± 33.21 0.32 
WHR 0.04 ± 0.07 0.005 ± 0.02 0.33 
WHtR 0.03 ± 0.05 0.06 ± 0.01 0.32 
Ectopic Liver Fat  
MRS IHCL 0.27 ± 0.26 -0.27 ± 0.81 0.18 
ME IHCL 0.01 ± 0.26 -0.16 ± 0.82 0.65 
Segment 1 0.22 ± 0.42 -0.13 ± 1.17 0.52 
Segment 2&3 -0.25 ± 0.28 0.06 ± 0.34 0.12 
Segment 4 0.18 ± 0.24 -0.02 ± 0.13 0.11 
Segment 5&8 0.19 ± 0.24 -0.14 ± 0.97 0.45 
Segment 6&7 0.24 ± 0.37 0.02 ± 0.68 0.51 
Ectopic Pancreas Fat  
ME IPCL 0.06 ± 0.55 0.22 ± 0.71 0.67 
Head -0.54 ± 1.17 0.76 ± 1.62 0.15 
Body 0.35 ± 0.75 -0.83 ± 0.86 0.03 
Tail 0.28 ± 1.87 -0.20 ± 1.10 0.60 
Adiposity Stores  
TAT (L) 0.21 ± 0.49 0.68 ± 0.84 0.28 
SAT (L) 0.19 ± 0.24 0.57 ± 0.54 0.17 
ASAT (L) 0.03 ± 0.11 0.14 ± 0.20 0.26 
NASAT (L) 0.17 ± 0.24 0.43 ± 0.55 0.33 
Internal (L) 0.02 ± 0.29 0.11 ± 0.43 0.67 
IAAT (L) -0.05 ± 0.12 0.006 ± 0.36 0.72 
NAIAT (L) 0.07 ± 0.19 0.11 ± 0.12 0.73 
IAAT/ASAT -0.04 ± 0.06 0.014 ± 0.07 0.46 
All data are presented as the mean ± SD of the change from baseline to follow-up for each group.WC: waist 
circumference; WHR: waist-to-hip ratio; WHtR: waist-to height ratio; IHCL: intra-hepatocellular lipid; IPCL: 
intra-pancreatocellular lipid, Adipose tissue deposits are in litres (l); TAT: total adipose tissue; SAT: 
subcutaneous; ASAT: abdominal subcutaneous; NASAT: non-abdominal subcutaneous; Internal: total internal; 
IAAT: intra-abdominal; NAIAT: non-abdominal internal. Differences between groups were analysed by unpaired 
Student’s t-test. 
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4.3.2 Study 2 - The Effect of Calorie Restriction on Body Composition 
 
Subjects were asked to fill in a 7-day diet diary which was subsequently used as the basis for 
individualised dietary counselling as part of the weight-loss strategy. This required for each 
volunteer to record all food items and drinks that they consumed over a period of 7 consecutive 
days (including a weekend). As part of the dietary assessment, volunteers were also asked to 
provide details regarding the method of food preparation and whether food was prepared at 
home or delivered/prepared, together with all available details of each brand, including 
packaging. Food diaries were analysed using DietPlan6 by a trained independent researcher 
competent in nutritional analysis. 
 
DietPlan6 is a database with full set of UK food tables - all the foods and nutrients from the 
5th and 6th Editions of McCance and Widdowson’s The Composition of foods plus all the 
published supplements, including Fatty acids and the Composition of Foods Integrated Data 
Set.   
 
The results from these analyses were subsequently used to advice each subject to reduce ~500 
calorie intake to achieve a desired weight loss. On average it was aimed for subjects to achieve 
a 3.0 kg reduction in weight at the end of a 12 weeks intervention period. Subjects were scanned 
at baseline and the morning after they concluded their intervention. 
 
Participants (19 females and 16 males) had a mean age of 51.8 ± 13.02 years, range of 18-65 
years. In addition to an overall BMI mean of 36.6 ± 8.4 kg/m2 (range 25.6-50.9 kg/m2) at 
baseline (Table 4.4). 
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There were significant reductions in most anthropometric measurements following the 12 week 
intervention, see Table 4.4. The mean weight loss was 6.4%, with a 6.2 % reduction in BMI, 
accompanied by reductions of 4.02 % in waist and 3.6% in hip circumferences (Table 4.4). 
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Table 4.4 Calorie Restriction Specific Variable Data in Whole Cohort 
 
 Baseline (n=35) Follow-up (n=35)  
 Mean ± SD Range Mean ± SD Range p 
Anthropometric Variables  
Age (years) 51.8 ± 13.02 18-65    
Weight (kg) 103.4 ± 22.4 68.6-151.1 96.8 ± 21.8 66.5-147.1 <0.001 
BMI (kg/m²) 36.6 ± 8.4 25.6-50.9 34.3 ± 8.2 22.7-49.2 <0.001 
WC (cm) 114.5 ± 17.7 77.0-145.5 109.9 ± 17.6 78.0-141.0 <0.001 
Hip (cm) 119.3 ± 14.4 98.2-147.0 115.0 ± 14.6 93.8-142.5 <0.001 
Height (cm) 169 ± 10.0 141-190    
WHR 0.96 ± 0.10 0.67-1.16 0.96 ± 0.09 0.75-1.14 0.91 
WHtR 0.68 ± 0.12 0.45-0.92 0.66 ± 0.12 0.49-0.89 <0.001 
Ectopic Liver Fat  
MRS IHCL 12.13 ± 14.88 0.15-60.54 7.84 ± 12.26 0.19-50.04 <0.001 
ME IHCL 9.31 ± 8.01 0.88-32.27 5.93 ± 6.20 0.53-26.7 <0.001 
Segment 1 8.37 ± 7.51 1.18-29.42 5.26 ± 5.85 0.46-26.89 <0.001 
Segment 2&3 8.50 ± 7.51 0.60-29.96 5.41 ± 5.69 0.78-25.23 <0.001 
Segment 4 9.32 ± 7.60 0.93-32.11 5.92 ± 5.81 0.29-25.88 <0.001 
Segment 5&8 9.62 ± 9.01 0.80-33.69 6.21 ± 7.16 0.39-29.15 <0.001 
Segment 6&7 9.78 ± 9.24 1.09-36.01 6.29 ± 7.59 0.18-33.28 <0.001 
Ectopic Pancreas Fat  
ME IPCL 8.01 ± 7.14 0.55-24.18 6.92 ± 5.67 0.24-20.88 0.21 
Head 6.75 ± 6.82 0.38-23.63 6.29 ± 5.57 0.52-21.16 0.66 
Body 7.62 ± 8.35 0.25-31.74 6.49 ± 5.86 0.32-25.29 0.28 
Tail 6.43 ± 5.86 0.27-25.29 7.73 ± 7.19 0.45-28.74 0.18 
Adiposity Stores  
TAT (L) 50.25 ± 19.55 16.49-87.67 46.04 ± 19.62 12.80-82.50 <0.001 
SAT (L) 41.22 ± 18.42 12.45-76.64 37.89 ± 18.07 9.88-72.84 <0.001 
ASAT (L) 13.23 ± 7.05 2.67-28.24 12.05 ± 6.93 1.91-27.33 <0.001 
NASAT (L) 28.00 ± 11.75 9.79-51.30 25.84 ± 11.49 7.97-48.86 <0.001 
Internal (L) 9.03 ± 2.68 4.04-13.53 8.15 ± 2.73 2.92-12.92 <0.001 
IAAT (L) 5.14 ± 1.83 1.82-8.73 4.50 ± 1.76 1.13-8.06 <0.001 
NAIAT (L) 3.89 ± 1.11 2.22-6.47 3.59 ± 1.12 1.79-6.31 0.001 
IAAT/ASAT 0.50 ± 0.32 0.17-1.57 0.48 ± 0.30 0.15-1.57 0.09 
All data are presented as mean ± SD. WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height 
ratio; IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid, Adipose tissue deposits are in litres 
(l); TAT: total adipose tissue; SAT: subcutaneous; ASAT: abdominal subcutaneous; NASAT: non-abdominal 
subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal. *Post calorie 
restriction ME total and regional IHCL (n=34), *WC (n=33), Hip (n=33), WHR (n=33) and WHtR  (n=33). 
Baseline versus post calorie restriction data was analysed by paired Student’s t-test 
 
 
242 
 
4.3.2.i Changes in Adiposity following Calorie Restriction 
 
There were significant reductions in all adipose tissue depots following the 12 week 
intervention, see Table 4.4 and Figure 4.4. There was a 8.4% reduction in TAT, 8.1% reduction 
in SAT, 9.7% in internal AT (see Figure 4.5) and a 12.5% reduction in IAAT, all p<0.001.  
 
 
 
 
Figure 4.4 Reduction in Subcutaneous Adipose Tissue Depots following Weight Loss 
Intervention. 
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Figure 4.5 Reduction in Internal Adipose Tissue Depots following Weight Loss Intervention. 
 
 
4.3.2.ii Changes in Liver Fat Content following Calorie Restriction 
 
Following the weight loss intervention there were large and highly significant reductions in 
both total and regional IHCL (all p<0.001), see Table 4.4 and Figure 4.6. In percentage terms, 
a greater proportion of IHCL was lost than adipose tissue, with a decrease in total IHCL of 
36.3% and decreases in regional IHCL of between 35.4-37.2%. 
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Figure 4.6 Reduction in Total and Regional IHCL Content following Weight Loss  
 
An example of a subject with a reduction in liver fat content is depicted in Figure 4.7. This 
subject had a decrease in total IHCL content of 24.3%.   
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Figure 4.7 Example of Calorie Restriction Variation in Total Liver Fat  
A series of multi-echo (a & c) and corresponding heat-map images (b & d) from a 62 year old female volunteer 
with a BMI of  35.65 kg/m² at baseline and 34.49 kg/m² post calorie restriction. Varying in levels of IHCL are 
seen across the liver. 
 
There were also significant regional changes in the same subjects, which can be seen in Figure 
4.8.  35.4% decrease in segment 1, 32% in segment 2&3, 12.3% in segment 4, 17.6% in 
segment 5&8 and 25.8% in segment 6&7 following weight loss. 
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Figure 4.8 Example Calorie Restriction Variations in Different Segments of the Liver 
Multi-echo at baseline and post  calorie restriction and corresponding heat-map liver segment images from a 62 
year old female volunteer with a BMI of  35.65 kg/m² at baseline and 34.49 kg/m² post calorie restriction varying 
in levels of ectopic fat (IHCL) in the different segments of the liver .   
 
 
4.3.2.iii Changes in Pancreatic Fat Content following Calorie Restriction 
 
Despite a trend for a reduction in total IPCL (8.01 ± 7.14 vs. 6.92 ± 5.67, p=0.21) following 
the weight loss intervention, these did not reach statistical significance (Table 4.4).  
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Similar changes were observed in the head and body regions of the pancreas, see Figure 4.9, 
however there was a slight increase in tail post calorie restriction, but again this did not reach 
statistical significance (p=0.18).  
 
 
 
Figure 4.9 Reduction in Total and Regional IHCL Content following Weight Loss  
 
 
An example of a subject with a reduction in total IPCL content is depicted in Figure 4.10. IPCL 
decreased by a substantial 74% in this subject.  
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Figure 4.10 Example of Calorie Restriction Variation in Total Pancreas Fat  
A series of multi-echo (a & c) and corresponding heat-map images (b & d) from a 65  year old male volunteer 
with a BMI of  27.91 kg/m² at baseline and 27.22 kg/m² post calorie restriction varying in levels of IPCL.  
 
 
 
Regional changes were also observed in this volunteer, see Figure 4.11. Head IPCL was 
reduced by53.2%, Body by 6% and Tail by 38.2%. 
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Figure 4.11 Example of Reduced Calories Variation in Different Regions of the Pancreas 
Multi-echo at baseline and post  calorie restriction and corresponding heat-map pancreas region  images from a 
65  year old male volunteer with a BMI of  27.91 kg/m² at baseline and 27.22 kg/m² post calorie restriction varying 
in levels of IPCL in the different regions of the pancreas.  
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4.3.2.iv The Impact of Gender and Weight Loss on Liver Fat Content 
 
Weight loss decreased in total IHCL by 33.9% from 8.03 ±1.72 to 5.31±1.32 (p<0.001) in 
females and by 37.2% from 10.55 ± 2.24 to 6.63 ± 1.73 (p=0.001) in male subjects, see Figure 
4.12. 
 
 
 
 
Figure 4.12 Reduction in Total IHCL in Female and Male Volunteers following Weight Loss.  
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4.3.2.v Relationship between Weight Loss and Total Liver Fat Content 
 
Interestingly, despite substantial reductions in both, there was no significant correlation 
between the reduction in IHCL and weight loss (female: r=0.18, P=0.49, male: r=-0.003, 
p=0.99), see Figure 4.13. 
 
 
Figure 4.13 Relation between the Absolute Change in Body Weight and IHCL in Male and 
Female Subjects. 
Relation between the absolute change in body weight and IHCL content for male (n=16) (open circles) and female 
(n=18) (closed circles) subjects. Spearman correlation coefficients for the relation between the absolute change in 
body weight and IHCL are (A) r=0.18 (p=0.49) for females and r=-0.003 (p=0.99) for males. 
 
 
252 
 
4.3.2.vi Relationship between Weight Loss and Regional Liver Fat Content 
 
There were significant reductions in regional IHCL content in all liver segments in both female 
and male volunteers (all p<0.001). Despite an apparent greater reduction in male subjects 
(Figure 4.14), there were no differences in IHCL content related to gender.   
 
 
 
Figure 4.14 Reduction in Regional IHCL Content in Female and Male Volunteers following 
Weight Loss.  
 
As in the case for total IHCL content there was no significant correlation between reduction in 
regional IHCL content and weight loss (Figure 4.15).  
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Figure 4.15 Relation between the Absolute Change in Body Weight and IHCL Content Male 
and Female Subjects in different Segments of the Liver 
Relation between the change in body weight and regional IHCL for male (open circles) and female (closed circles) 
subjects. Spearman correlation coefficients for the relation between the change in body weight and IHCL in 
segment 1 (B) (female: r=0.04, p=0.88, male: r=-0.15, p=0.59); segment 2&3 (C) (female: r=0.24, p=0.35, male: 
r=0.02, p=0.96); segment 4 (D) (female: r=0.24, p=0.33, male: r= -0.03, p=0.92); segment 5&8 ( E) (female: 
r=0.25, p=0.31, male: r=0.04, p=0.90); and segment 6&7 (F)  (female: r=0.05, p=0.85, male: r=0.10, p=0.70). 
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4.3.2.vii The Impact of Gender and Weight Loss on Pancreatic Fat Content 
 
Over all IPCL was reduced following weight loss by 0.71% (6.96 ±1.50 to 6.91±1.36, p=0.95) 
in female subjects and by 22% (8.87±2.03 to 6.92±1.44, p=0.13) in male subjects, although 
there was no significant effect of gender on the change in IPCL (p=0.21) (Figure 4.16).  
 
There was no consistent weight loss changes in IPCL related to gender, with both genders 
increasing, or decreasing IPCL in different regions of the pancreas. 
 
Interestingly there was a significant effect of gender (p=0.027) in the Head region, with an 
increase in IPCL in female, and a decrease in IPCL in male subjects.   
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Figure 4.16 – Reduction in Total and Regional IPCL Content in Female and Male Volunteers 
following Weight Loss.  
 
As with the liver, there was no significant relationship between change in total (Figure 4.17) 
or regional IPCL (Figure 4.18) and change in body weight following weight loss period.  
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Figure 4.17 Relation between the Absolute Change in Body Weight and that in Pancreas Fat 
content for Male and Female Subjects in total IPCL 
 
Relation between change in body weight and IPCL for male (open circles) and female (closed circles) subjects. 
Spearman correlation coefficients for the relation between the absolute change in body weight and IPCL are (A) 
r=0.17 (P=0.50) for females and r= 0.35 (P=0.19) for males. 
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Figure 4.18 Relation between the Absolute Change in Body Weight and IPCL Content for 
Male and Female Subjects in Variation in Different Regions of the Pancreas  
 
Relation between change in body weight and regional IPCL content for male (open circles) and female (closed 
circles) subjects. Spearman correlation coefficients for the relation between the absolute change in body weight 
and IPCL are: (B) Head: female r=-0.09, p=0.72, male r= 0.30, p= 0.26; (C) Body: female: r=0.14, p=0.57, male: 
r= 0.46, p= 0.08, (D) Tail: female: r=-0.03, p=0.90, male: r= 0.23, p=0.40. 
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4.3.3 Study 3 - Impact of Bariatric Surgery Study on Body Composition 
 
Morbidly obese subjects were scanned before and 6 months after undergoing bariatric surgery 
to determine its effect ectopic fat content and distribution and whether it would differ from 
conventional calorie reduction intervention.  
 
Besides the normal exclusion criteria, (Chapter 2) subjects were pre-selected based on their 
relative size due to the magnet-bore size. Subjects were scanned at baseline and 6 months 
following surgery. The standard protocol for bariatric surgery includes a short period of calorie-
restriction prior to surgery in this case between 2 and 6 weeks of a low calorie diet. Therefore 
the changes between baseline and follow-up include the combined effects of the dietary 
restriction and surgical intervention. 
 
Participants (83% female, 17% male) had a mean age range of 18-58 years with an overall 
mean BMI of 46.6 ± 2.6 kg/m2 (range 42.8 – 50.9 kg/m2) at baseline and a mean BMI of 34.0 
± 2.4 kg/m2 (range 30.4 – 37.2 kg/m2) 6 months post-surgery (Table 4.5).  
 
During the 6 months weight loss period after bariatric surgery, subjects lost 27% of their body 
weight, had a 27% reduction in BMI, as well as reductions of 19% in waist and 18.5% in hip 
circumferences (Table 4.5).  
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Table 4.5 Impact of Bariatric Surgery on Body Composition 
 Baseline (n=12) 6 months post-surgery (n=12)  
 Mean ± SD Range Mean ± SD Range p 
Anthropometric Variables  
Age (yrs) 43.3 ± 12.1 18-58    
Weight (kg) 127.3 ± 14.1 110.4-151.1 93.0 ± 11.9 72.7-115.5 <0.001 
BMI (kg/m²) 46.6 ± 2.6 42.8-50.9 34.0 ± 2.4 30.4-37.2 <0.001 
WC (cm) 132.7 ± 8.2 114.1-145.5 107.4 ± 9.9 94.0-122.0 <0.001 
Hip (cm) 135.9 ± 8.2 117.5-147.0 110.8 ± 6.7 101.0-128.0 <0.001 
Height (m) 165.2 ± 8.9 154-185    
WHR 0.98 ± 0.08 0.85-1.16 0.97 ± 0.10 0.86-1.12 0.81 
WHtR 0.80 ± 0.06 0.72-0.92 0.65 ± 0.06 0.57-0.78 <0.001 
Ectopic Liver Fat  
MRS IHCL 13.27 ± 16.13 2.01-60.54 3.30 ± 4.62 0.03-12.92 0.03 
ME IHCL 10.08 ± 7.34 3.98-30.0 3.89 ± 3.59 0.92-11.46 0.005 
Segment 1 8.63 ± 6.90 2.17-26.77 4.21 ± 3.89 0.58-12.61 0.03 
Segment 2&3 9.90 ± 6.83 3.57-28.1 3.15 ± 2.97 0.88-10.33 0.002 
Segment 4 9.79 ± 6.61 3.96-27.01 3.99 ± 3.83 0.68-12.77 0.006 
Segment 5&8 10.43 ± 8.42 2.95-33.53 3.81 ± 3.90 0.62-11.26 0.006 
Segment 6&7 10.69 ± 9.10 2.89-36.01 6.62 ± 9.29 0.74-33.28 0.27 
Ectopic Pancreas Fat  
ME IPCL 7.70 ± 6.72 1.26-21.62 8.29 ± 6.48 1.24-19.71 0.46 
Head 6.45 ± 6.17 0.59-17.56 7.94 ± 6.88 1.71-22.47 0.06 
Body 8.80 ± 9.43 0.32-31.74 8.65 ± 7.44 0.61-22.45 0.93 
Tail 5.21 ± 3.97 1.06-11.39 6.82 ± 6.53 0.77-20.59 0.35 
Adiposity Stores  
TAT (L) 73.80 ± 6.28 65.75-87.67 47.11 ± 6.82 31.92-55.83 <0.001 
SAT (L) 63.83 ± 6.24 53.21-76.64 39.93 ± 6.18 28.39-48.22 <0.001 
ASAT (L) 21.78 ± 2.81 18.38-28.24 13.11 ± 2.42 8.87-17.69 <0.001 
NASAT (L) 42.05 ± 5.56 34.83-51.30 26.82 ± 4.74 19.52-33.72 <0.001 
Internal (L) 9.97 ± 2.02 6.96-13.39 7.17 ± 1.95 3.54-11.33 <0.001 
IAAT (L) 5.34 ± 1.36 3.51-7.56 3.46 ± 1.04 1.31-5.14 <0.001 
NAIAT (L) 4.63 ± 0.90 3.21-6.47 3.71 ± 1.05 2.23-6.18 0.001 
IAAT/ASAT 0.25 ± 0.07 0.17-0.40 0.27 ± 0.09 0.15-0.43 0.05 
All data are presented as mean ± SD. WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height 
ratio; IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid, Adipose tissue deposits are in litres 
(l); TAT: total adipose tissue; SAT: subcutaneous; ASAT: abdominal subcutaneous; NASAT: non-abdominal 
subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal.  Baseline versus 
post-surgery data were analysed by paired Student’s t-test 
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4.3.3.i Changes in Adiposity following Bariatric Surgery 
 
There were significant reductions in adiposity 6 months after bariatric surgery. The mean 
reductions in adipose tissue were considerable, TAT 36.2%, SAT 37.4%, internal 28.1% and 
IAAT 35.2%, with the greatest percentage change in ASAT 39.8% (p<0.001 for all), see Table 
4.5.  
 
Interestingly there was a small increase in IAAT/ASAT ratio, it displayed a slight yet 
significant increase from 0.25 ± 0.07 to 0.27 ± 0.09 (p=0.05), reflecting the greater loss of 
ASAT compared with IAAT. 
 
 
4.3.3.ii Changes in Liver Fat Content following Bariatric Surgery 
 
There was a significant reduction in both total and regional IHCL content, see Table 4.5. Total 
IHCL was reduced by 61.4% (p<0.01) from 10.08 ± 7.34 to 3.89 ± 3.59.  
 
IHCL was also significantly reduced in all but one segment of the liver; this did not reach 
significance in Segment 6&7 (see Figure 4.19). 
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Figure 4.19 Changes in Total and Regional IHCL Content Baseline and Post-surgery 
 
 
An example of a subject with a significant reduction in IHCL is shown in Figure 4.20. In this 
individual, total IHCL content decreased by 70% from baseline.  
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Figure 4.20 Example of 6 Months Post-surgery Variation in Total Liver Fat 
A series of multi-echo (a & c) and corresponding heat-map images (b & d) from a 43 year old female volunteer 
with a BMI of  45.05 kg/m² at baseline and 35.49 kg/m² post 6 months surgery varying in levels IHCL.  
 
 
The same individual also showed significant reductions in regional IHCL content, see Figure 
4.21. IHCL reductions of 73% were observed in segment 1, 81.9% segment 2&3, 78.3% 
segment 4, 82.4% segment 5&8 and 73% segment 6&7 from baseline post 6 months after 
surgery. 
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Figure 4.21 Example of 6 Months Post-surgery Variation in Different Segments of the Liver  
Multi-echo at baseline and 6 months post-surgery and corresponding heat-map liver segment images from a 43 
year old female volunteer with a BMI of 45.05 kg/m² at baseline and 35.49 kg/m² post 6 months surgery varying 
in levels IHCL in the different segments of the liver.  
 
 
 
4.3.3.iii Changes in Pancreatic Fat Content following Bariatric Surgery 
 
Following bariatric surgery, there was a trend for IPCL content to increase, total IPCL by 7.1%, 
Head IPCL by 18.8% and ME Tail IPCL by 23.6%, those these changes did not reach statistical 
significance.  
 
A small non-significant decrease (1.7%) was observed in the Body pancreatic region (Table 
4.5, and Figure 4.22). 
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Figure 4.22 Changes in Total and Regional IHCL Content Baseline and Post-surgery 
 
 
An example of a subject with a reduction in IPCL content is depicted in Figure 4.23 and 4.24 
were total IPCL decreased by 16.1% from baseline and 19.4% in Body.  
 
There was an increase of 3.4% in Head IPCL and no alteration in the Tail from baseline to 6 
months post-surgery. 
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Figure 4.23 Example of 6 months Post-surgery Variation in Total Pancreas Fat 
 
A series of multi-echo (a & c) and corresponding heat-map images (b & d) from a 43 year old female volunteer 
with a BMI of  45.05 kg/m² at baseline and 35.49 kg/m² post 6 months surgery varying in levels of IPCL.  
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Figure 4.24 Example of 6 Months Post-surgery Variation in Different Regions of the Pancreas  
 
Multi-echo at baseline and 6 months post-surgery and corresponding heat-map pancreas region images from a 43 
year old female volunteer with a BMI of 45.05 kg/m² at baseline and 35.49 kg/m² post 6 months surgery varying 
in levels IPCL in the different regions of the pancreas.   
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4.3.3.iv Comparison of Changes in Body Composition following Weight Loss Induced by 
Dietary Restriction vs. Bariatric Surgery Study  
 
As previously mentioned the data in section 4.3.3 looking at the effects of bariatric surgery on 
weight loss also contained a period of calorie-reduction prior to surgery as part of the standard 
protocol.  
 
Therefore to determine whether diet and surgery resulted in different amounts or patterns of 
weight loss these individual were further examined at different time points – post diet but pre 
surgery, referred to as Baseline 2 and 6 months post-surgery (follow-up). This was compared 
with the changes pre and post caloric restriction in the wider cohort. 
 
There were significant differences in the degree of change in body composition between the 
calorie-restriction and surgical groups with a mean weight loss of 6.4% in the calorie-restricted 
vs. 22.5% in the surgical intervention group (p<0.001).  
 
Changes in waist circumference were also significantly different between the two groups with 
a mean weight loss of 4.02% in calorie restriction vs. 16.7% surgery p<0.001. Similar 
changes were seen for other anthropometric measurements (see Table 4.6).
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Table 4.6 Comparison of Calorie-Restriction and Bariatric Surgery on Body Composition 
 Caloric Restriction (n=35) Bariatric Surgery (n=12)  
 Baseline  Follow-up Baseline 2 Follow-up p 
Anthropometric Variables  
Age (yrs) 51.8 ± 13.02  43.3 ± 12.1   
Weight (kg) 103.4 ± 22.4 96.8 ± 21.8 120.0 ± 14.1 93.0 ± 11.9 <0.001 
BMI (kg/m²) 36.6 ± 8.4 34.3 ± 8.2 43.9 ± 2.8 34.0 ± 2.4 <0.001 
WC (cm) 114.5 ± 17.7 109.9 ± 17.6 129.0 ± 9.3 107.4 ± 9.9 <0.001 
Hip (cm) 119.3 ± 14.4 115.0 ± 14.6 131.2 ± 7.8 110.8 ± 6.7 <0.001 
Height (cm) 169 ± 10.0  165.2 ± 8.9   
WHR 0.96 ± 0.10 0.96 ± 0.09 0.99 ± 0.09 0.97 ± 0.10 0.67 
WHtR 0.68 ± 0.12 0.66 ± 0.12 0.78 ± 0.65 0.65 ± 0.63 <0.001 
Ectopic Liver Fat  
MRS IHCL 12.13 ± 14.88 7.84 ± 12.26 9.13 ± 12.74 3.30 ± 4.62 0.65 
ME IHCL 9.31 ± 8.01 5.93 ± 6.20 6.61 ± 6.57 3.89 ± 3.59 0.99 
Segment 1 8.37 ± 7.51 5.26 ± 5.85 5.60 ± 6.05 4.21 ± 3.89 0.53 
Segment 2&3 8.50 ± 7.51 5.41 ± 5.69 6.16 ± 5.86 3.15 ± 2.97 0.80 
Segment 4 9.32 ± 7.60 5.92 ± 5.81 6.12 ± 5.89 3.99 ± 3.83 0.74 
Segment 5&8 9.62 ± 9.01 6.21 ± 7.16 7.17 ± 8.33 3.81 ± 3.90 0.73 
Segment 6&7 9.78 ± 9.24 6.29 ± 7.59 7.76 ± 9.44 6.62 ± 9.29 0.71 
Ectopic Pancreas Fat  
ME IPCL 8.01 ± 7.14 6.92 ± 5.67 7.95 ± 6.71 8.29 ± 6.48 0.31 
Head 6.75 ± 6.82 6.29 ± 5.57 8.58 ± 6.91 7.94 ± 6.88 0.64 
Body 7.62 ± 8.35 6.49 ± 5.86 7.54 ± 5.88 8.65 ± 7.44 0.33 
Tail 6.43 ± 5.86 7.73 ± 7.19 8.60 ± 6.75 6.82 ± 6.53 0.06 
Adiposity Stores  
TAT (L) 50.25 ± 19.55 46.04 ± 19.62 69.32 ± 7.82 47.11 ± 6.82 <0.001 
SAT (L) 41.22 ± 18.42 37.89 ± 18.07 59.80 ± 7.09 39.93 ± 6.17 <0.001 
ASAT (L) 13.23 ± 7.05 12.05 ± 6.93 20.43 ± 2.97 13.11 ± 2.42 <0.001 
NASAT (L) 28.00 ± 11.75 25.84 ± 11.49 39.36 ± 5.85 26.82 ± 4.74 <0.001 
Internal (L) 9.03 ± 2.68 8.15 ± 2.73 9.53 ± 2.24 7.17 ± 1.95 <0.001 
IAAT (L) 5.14 ± 1.83 4.50 ± 1.76 5.02 ± 1.40 3.46 ± 1.04 0.002 
NAIAT (L) 3.89 ± 1.11 3.59 ± 1.12 4.50 ± 0.99 3.71 ± 1.05 0.06 
IAAT/ASAT 0.50 ± 0.32 0.48 ± 0.30 0.25 ± 0.07 0.27 ± 0.09 0.01 
All data are presented as mean ± SD. WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to height 
ratio; IHCL: intra-hepatocellular lipid; IPCL: intra-pancreatic cellular lipid, Adipose tissue deposits are in litres 
(l); TAT: total adipose tissue; SAT: subcutaneous; ASAT: abdominal subcutaneous; NASAT: non-abdominal 
subcutaneous; Internal: total internal; IAAT: intra-abdominal; NAIAT: non-abdominal internal. *Post calorie 
restriction ME total and regional IHCL (n=34), *WC (n=33), Hip (n=33), WHR (n=33) and WHtR  
(n=33),*Baseline 2 ME total and regional IHCL and IPCL (n=11),Differences between interventions were tests 
for using a student’s unpaired t-test on the difference between baseline and follow-up measurements for each 
group. 
 
269 
 
4.3.3.v Comparison of Changes in Adipose Tissue Content following Weight Loss Induced 
by Dietary Restriction vs. Bariatric Surgery Study  
 
Total and regional adipose tissue content were significantly reduced following both 
interventions, however, bariatric surgery resulted in a far greater loss of adipose tissue 
compared with calorie-restriction alone, see Table 4.6 and Figure 4.25. Total adipose tissue 
was reduced by -8.4% in the calorie-restricted group, compared with -32.0% in the surgical 
group (p<0.001). These differences were reflected in most other adipose tissue depots, apart 
from the non-abdominal internal adipose tissue, where the differences between groups did not 
reach significance.  
 
 
Figure 4.25 Comparison of Changes in Subcutaneous Adipose Tissue Depots following 
Calorie Restriction vs. Surgical Interventions 
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Figure 4.26 Comparison of Changes in Internal Adipose Tissue Depots following Calorie 
Restriction vs. Surgical Interventions 
 
 
4.3.3.vi Comparison of Changes in Liver Fat Content following Weight Loss Induced by 
Dietary Restriction vs. Bariatric Surgery Study  
 
Weight loss decreased total IHCL content by 36.3% from 9.31 ± 8.01 to 5.93 ± 6.20 following 
calorie restriction and by 41.2% from 6.61 ± 6.57 to 3.89 ± 3.59 following bariatric surgery, 
although the difference between interventions was not statistically significant (p=0.99), see 
Table 4.6 and Figure 4.27. A similar pattern was repeated for regional changes following both 
interventions. 
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Figure 4.27 Comparison of Changes in Liver Fat Content following Calorie Restriction vs. 
Surgical Interventions 
 
 
4.3.3.vii Comparison of Changes in Pancreatic Fat Content following Weight Loss 
Induced by Dietary Restriction vs. Bariatric Surgery Study  
 
Changes in IPCL content following both caloric restriction and bariatric surgery were less clear 
cut, and there was a high degree of variability in the results. 
 
Whilst caloric restriction resulted in a small decrease in total IPCL of  13.6% from 8.01 ± 7.14 
to 6.92 ± 5.67, bariatric surgery resulted in a small increase of 4.1% from 7.95 ± 6.71 to 8.29 
± 6.48, there was no significant difference between the two interventions (p=0.31), see Table 
4.6 and Figure 4.28 
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Figure 4.28 Comparison of Changes in Pancreatic Fat Content following Calorie Restriction 
vs. Surgical Interventions 
 
Regarding regional changes in IPCL, both interventions resulted in small decreases in the Head. 
 
The body and tail showed opposing changes with a decrease in the body and an increase in the 
tail following caloric restriction.  
 
The exact opposite was found following bariatric surgery, an increase in the body and a 
decrease in the tail. In each of these cases the difference between interventions was not 
significant. 
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4.4 Discussion 
  
 
4.4.1 Overfeeding study 
 
In this interventional study there was a mean increase in weight of 1kg for 600 kcal subjects 
and a significant increase in BMI (1%) in only 6 days. 
 
The composition of energy excess seems to have important effects on body energy storage, 
similar short term overfeeding studies found the same effect. (Diaz, Prentice et al. 1992, Klein 
and Goran 1993, Horton, Drougas et al. 1995) In fact, a study by Horton et al. (Horton, Drougas 
et al. 1995)  observed how the excess of carbohydrate in a diet affects energy and nutrient 
balances differently than fat excess in a diet, where fat leads to more body fat accumulation 
than carbohydrate. 
 
Although, some individuals seem better able to oppose weight changes with overfeeding. 
(Bouchard, Tremblay et al. 1990, Diaz, Prentice et al. 1992) This is possibly due to inter-
individual variations in weight gain.(Dulloo and Jacquet 1999, Bray, Smith et al. 2012) 
 
There were inconsistent changes in WC and hip circumferences in this study, where an increase 
of 6.2% was seen in the 0Kcal subjects and 3% was seen in the 600kcal subjects. As for Hip, 
an increase of 2.2% was seen in the 0Kcal subjects and a decrease of 11.4% was seen in the 
600Kcal subjects. This may also be due to measurement errors where there were two different 
individuals taking the measurements from participants at different time points in this study. 
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Though perhaps the 0 kcal overfed group which showed unpredictably an increase in fat 
content was due to the content of the 7up free drink, which contained sweeteners such as 
Aspartame and Acesulfame K. Aspartame, which are used as sweeteners in the beverage 
industry mainly in diet sodas and 0kcal drinks. (Ferland, Brassard et al. 2007) 
 
Observational studies showed that aspartame is almost 160 times sweeter than sugar and is 
absorbed from the intestine and metabolized by the liver to form phenylalanine, aspartic acid 
and methanol which can subsidize to weight gain, obesity, insulin resistance, and type 2 
diabetes mellitus. (Hofmann, Dong et al. 2002, Vlassara, Cai et al. 2002, Schulze, Manson et 
al. 2004, Dhingra, Sullivan et al. 2007, Ferland, Brassard et al. 2007, Fowler, Williams et al. 
2008) 
 
Therefore, whether subjects where overfed with either 600 kcal or 0kcal drink for 6 days, there 
seem to be a non-significant increase in most of the adiposity stores (p>0.05) except for SAT 
where it had a significant increase in the 600kcal group (p=0.05). 
 
IAAT had no significant effect or change in overfeeding. The variability of visceral fat during 
overfeeding has already been observed (Bouchard, Tremblay et al. 1990, Votruba and Jensen 
2011, Alligier, Gabert et al. 2013) and can be attributed to a higher resistance to the dietary 
intervention. 
 
Interestingly, IHCL content was affected differently in segments and in opposing ways whether 
subjects were overfed with the 600kcal drink or with the 0kcal drink. Segment 2&3 in the liver 
increased in fat content by 2% in 600kcal and 1 % in segment 6&7 in the liver while all other 
segments as well as total IHCL decreased with no significance. While in subjects having the 0 
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kcal drink, segment 2&3 in the liver decreased non significantly in fat content by 17% and 
increased in all other segments as well as in total IHCL with no significance. 
 
Consistent opposition was also seen in IPCL content between groups, especially in the Body, 
where there was a significance difference between a decrease in IPCL content in the Body in 
600kcal overfed participants by 26% and an increase of IPCL content in the Body in 0kcal 
overfed participants by 3% (p<0.05). 
 
This may be due to the 0Kcal consumption once again, where diet soda consumption was 
observed having an increased risk on fatty liver due to lipid peroxidation, hepatic inflammation, 
and being a source of glycation end products. (Assy, Nasser et al. 2008) This mirrors the effect 
of the 7up free overfeeding in liver in this study, perceiving an increase of ectopic fat in all 
segments except for the lateral part of the liver (segment 2&3). The reason for this is unknown 
and has not been stated or studied previously. 
 
Conversely, certain findings did not support that theory, and found no/ or a weight loss effect 
of diet sodas on fatness, ectopic fat, and metabolic factors. (Tordoff and Alleva 1990, Raben, 
Vasilaras et al. 2002, Maersk, Belza et al. 2012, Raben and Richelsen 2012). 
 
On the other hand when looking at the effect of excess calories in the 600kcal overfed group, 
the main fat synthesis seemed to be in the adiposity stores, liver played measurably a minor 
role. A study by Aarsland et al. showed similar results. (Aarsland, Chinkes et al. 1997).  
 
Once again, segment 2&3 in the liver was the only independent variable in liver fat content and 
increased with excess calories. The reason for this is unknown but a visible effect is seen in 
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these two segments depending on the type of excess energy in this study. Although, the 
inconsistent changes may partly be due to the small group in this study even with a 
reproducibility of <1% with the novel technique, this could be too small a challenge. 
 
Several studies have shown the effect of different types of fat and their correlation to liver fat 
increase (Kechagias, Ernersson et al. 2008, Sobrecases, Le et al. 2010, Sevastianova, Santos et 
al. 2012, Rosqvist, Iggman et al. 2014) suggesting that the type of overfeeding diet seems to 
be an important determinant of liver fat accumulation, fat distribution, and body composition. 
(Rosqvist, Iggman et al. 2014)  
 
Pancreas fat content, on the other hand, had a slight decrease in IPCL in its regions in the 
600kcal group during weight gain. But a slight increase in total fat content of the pancreas. 
 
The latest study by Rosqvist et al. (Rosqvist, Iggman et al. 2014) mirrored my results in the 
decrease of pancreatic fat during weight gain in a lean population, although the research did 
not look at regional variations. 
 
Conversely, an increase in total IPCL in my overfed cohort has also been observed by Rossi et 
al. (Rossi, Fantin et al. 2011) which associated pancreas and liver fat accumulation with fat 
intake. Similarly, Pinnick et al. (Pinnick, Collins et al. 2008) observed pancreas fatty acid 
accumulation and composition in mice fed with high-fat diet.  
 
In the 0kcal overfeeding intervention, the Head region decreased while total IPCL as well as 
the Body and Tail increased.  
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A study by El-Gamal et al. (El-Gamal 2012) in adult rats, observed a hyperstimulatory effect 
in β cells when administrated with aspartame, which may lead to the risk of the development 
of pancreatitis.  
 
In the pancreas, a visible effect is seen the Body region depending on the type of excess energy 
in this study. But once again similarly to IHCL the inconsistent changes may partly be due to 
the small group in this study even with a reproducibility of <1% with the novel technique, this 
could be too small a challenge. 
 
 
4.4.2 Calorie Restriction study 
 
 
In this intervention study, there was a mean weight loss of 6.4%, with a 6.2 % reduction in 
BMI and reductions of 4.02 % in WC and 3.6% in hip circumferences. Furthermore, I found a 
significant decrease in all adiposity stores (p<0.001), particularly in IAAT (12.5%).  
 
Visceral adipose tissue has been formerly perceived as more prone to weight reduction than 
subcutaneous adipose tissue. (Bjorntorp 1993) Adding that, all forms of weight loss affect 
visceral fat more than subcutaneous fat. (Armellini, Zamboni et al. 1991)  
In addition, IHCL had a significant and similar reduction in all segments as well as the total 
liver fat content, even more pronounced than that of adiposity stores (35.4-37.2% vs. 8-12.5%). 
 
Similar to my findings, previous studies addressing the effects of weight loss on liver fat have 
shown that even small decreases in body weight result in a considerable reduction in IHCL. 
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(Tiikkainen, Bergholm et al. 2003, Petersen, Dufour et al. 2005, Westerbacka, Lammi et al. 
2005, Larson-Meyer, Heilbronn et al. 2006, Sato, Tamura et al. 2007, Kantartzis, Thamer et 
al. 2009, Kirk, Reeds et al. 2009) 
 
A non-significant reduction in IPCL content was also observed in this study from the effect of 
weight loss, except for the Tail region, which paradoxically appeared to increase. But the  
decrease in ectopic fat content was more pronounced in the liver (average of absolute change 
= 3.22) than in the pancreas (average of absolute change = 2.02).  
 
Rossi et al. (Rossi, Fantin et al. 2012) also indicated how moderate weight loss can determine 
a significant decline in pancreas fat. Although, comparable to our study, he observed that the 
reduction of IHCL was greater than that of IPCL and visceral fat loss. This suggests that 
perhaps dietary restriction may mobilize more IHCL content than IPCL content.(Rossi, Fantin 
et al. 2012) 
 
The incline of hepatic fat loss showed no significant differences between men and women in 
my findings, as observed in a study by de Souza et al.(de Souza, Bray et al. 2012) 
 
In addition, according to Andersson et al., (Andersson, Sjostrom et al. 2010) women are more 
predominant in hepatic weight loss post the menopausal age ,as seen in this study, which add 
to a reduced ability to increase adipose tissue blood flow leading to a high incidence of liver 
steatosis in this group.  
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In the pancreas, IPCL content altered greatly in men and women, where the absolute change in 
pancreas fat content had a non-significant but more positive correlation in men in most regions 
to the absolute weight change. 
 
Pancreas fat loss in men decreased by 22% as for women, it was merely a reduction of 0.71%, 
showing once again a strong association between ectopic fat content in the pancreas and gender 
as seen in chapter 3. 
 
Interestingly, the Head region increased significantly in IPCL content in female subjects and 
decreased in males. (p<0.05) The reason for this is unknown especially that most of the women 
in this study are post-menopausal but a visible and significant effect with gender is seen. 
 
It is has been observed that the use of hormone replacement therapy in women post the 
menopausal age may elevate TG, (Rossouw, Cushman et al. 2008)which have been previously 
linked with increased risk of acute pancreatitis.(Lindkvist, Appelros et al. 2012) Exogenous 
oestrogen may also have harmful effects on the pancreas per se. as some cases stated oestrogen-
induced pancreatitis in the absence of gallstones and hypertriglyceridemia.(Mungall and Hague 
1975, Blake and Pitcher 2003) Unfortunately, hormone replacement therapy has not been 
reported in this intervention. 
 
Nonetheless, the slight increase in the Tail region in this intervention study echoes the variation 
of the pancreatic fat content seen in this region when compared to the other pancreatic regions.  
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4.4.3 Bariatric surgery study 
 
In this intervention study, there was a mean weight loss of 27%, with 27% reduction in BMI, 
as well as reductions of 19% in waist and 18.5% in hip circumferences. Furthermore, I found 
that bariatric surgery resulted in a far greater loss of AT when compared to calorie-restriction 
alone with significant and similar decrease in all adiposity stores post-surgery, (p<0.001) more 
so in ASAT (39.8%) than in IAAT (35.2%). This may be due to an original loss of IAAT post 
the induced diet before surgery, thus effecting ASAT changes secondarily. 
 
Although, diet-induced weight loss revealed to affect visceral fat favourably, whereas with 
larger degrees of weight loss such as in this bariatric surgery intervention, the effect tends to 
be similar for both visceral and subcutaneous fat.(Chaston and Dixon 2008) Though some 
previous studies have shown a preferential loss of visceral fat in the early phases after bariatric 
surgery. (Busetto, Tregnaghi et al. 2000, Phillips, Lewis et al. 2005) 
 
In this study we can see a significant increase in IAAT/ASAT ratio suggesting that body 
composition is not stable and may improve in time. In fact bariatric surgery is known to have 
favourable effects on appetite-mediating hormones and hunger, leading to a lower and healthier 
plateau of weight over time.(Sjostrom, Lindroos et al. 2004, le Roux, Aylwin et al. 2006) 
 
In addition, IHCL content had a similar and extremely significant reduction in all segments as 
well as the total IHCL (p<0.05) less so in segment 6&7 in the liver (p= 0.27). This may be due 
to the higher amount of IHCL in segment 6&7 at baseline when compared to total IHCL and 
other segments’ IHCL content. 
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Other reports have also seen a significant difference between the right and left lobes, with the 
left lobe showing a significantly larger increase in attenuation than the right lobe in obese 
subjects. (Nomura, Ohnishi et al. 1987, Benjaminov, Beglaibter et al. 2007)  
 
Similar to my findings, previous studies showed the beneficial effects of weight loss on 
NAFLD after bariatric surgery. (Klein, Mittendorfer et al. 2006, Furuya, de Oliveira et al. 2007, 
Mummadi, Kasturi et al. 2008) Although some studies have shown a decrease in inflammatory 
mediators following surgically induced weight loss as well as hepatic injury and liver failure. 
(Kooby, Fong et al. 2003, Clark, Alkhuraishi et al. 2005, Fujioka 2005, Mattar, Velcu et al. 
2005) 
 
Interestingly, there was an increase in pancreas fat content in all regions except for the Body 
were there was a non-significant slight decrease. 
 
In fact, an opposition was seen in total pancreas fat content (IPCL) decreasing in subjects with 
a diet induced weight loss but increasing in subjects that have undertaking surgery. The 
opposition persists in the different regions as well, with a non-significant increase in IPCL 
content in Body and a decrease in Tail post diet but an increase in Body and a decrease in Tail 
post-surgery.  
 
The lack of association between pancreas fat content and weight loss with bariatric surgery 
might be due once again to the ratio of   post-menopausal women to men in this study (83%), 
when taking into account the strong correlation of fatty pancreas with men seen in the previous 
chapter and the probable effect of hormone replacement therapy in women post the menopausal 
age. 
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In addition, the increase in pancreas fat content as opposed to an expected decrease might 
reflect a disturbance in pancreas metabolism. In fact, some studies have shown the possibility 
of pancreatic nesidioblastosis, (Chauhan, Vaid et al. 2010, Bal, Finelli et al. 2012) where the 
cause of hyperinsulinemic hypoglycemia is characterized by an acquired β cell hyperplasia 
most commonly found in patients post gastrointestinal surgery.(Clancy, Moore et al. 2006, 
Raffel, Krausch M et al. 2007) 
 
However, Kashyap et al. (Kashyap, Bhatt et al. 2010) indicated that bariatric surgery seems to 
uniquely restore pancreatic β cell function and resurrect a failing pancreas.  
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Chapter V: Summary 
 
The original motivation for this thesis was the inquisition of the accurate representation of the 
whole organ when assessing ectopic fat depots with current non-invasive methodologies. 
Unanswered questions surrounding the fat distribution of particular tissues and their effects 
behind their physiological patterns on certain chronic diseases captured my imagination and 
provided a focus for this work to be carried out. 
 
The work central to this thesis sought to add further insight on non-invasive methodologies in 
assessing ectopic fat, by implementing a surgical angle and taking into account the anatomy of 
a particular organ. 
 
In treating each region within the organ as a self-contained functional independent unit with 
specific vascularization and physiological patterns as well as using the novel MR-based 
method,  the series of studies in this thesis were undertaken to explore further the complexity 
and heterogeneity of fat distribution in the liver and pancreas in the adult. 
 
Key findings from the present thesis have demonstrated that: 
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1. The age range in my cohort (35-45 years) had the greatest increase in ectopic fat 
content in the liver and Age in general had a high correlation with IPCL in all 
regions especially in men. This may be due to the groups being skewed by small 
numbers. Although, aging is generally not only associated with increased adiposity, but 
also a redistribution in the pattern of adiposity.  
 
Subsequently, the  rises in liver and pancreas fat in my cohort may be due, in part, to an 
age-related deregulation of lipid metabolism in subcutaneous adipocytes, which leads to 
the accumulation of FFA in ectopic sites (Cree, Newcomer et al. 2004, Despres and 
Lemieux 2006, Li, Xie et al. 2011) before declining in older populations. (Carmelli, 
McElroy et al. 1991, Baumgartner, Stauber et al. 1995)  The reason for this lack of 
association in the elderly is unknown, undefined age-related mechanisms possibly have 
a greater contribution in fat accumulation. It has been observed that at older ages, 
subdued responses to oxidative stress and altered endocrine functioning may affect the 
mechanisms of fatty infiltration.(Lamberts, van den Beld et al. 1997, Paolisso, 
Tagliamonte et al. 1998) 
 
Furthermore, the available data suggests that there are effects of age and adiposity on 
pancreas volume. For example, anatomical studies reported decreased pancreas volume 
with aging in humans and histological studies report atrophy, fibrosis, and fatty 
infiltration of the pancreas in the aging population. 
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Saisho et al. (Saisho, Butler et al. 2007) observed that pancreatic fat volume increases 
with age in adults. In males, pancreatic fat volumes increase in the third and fourth 
decade and then remain constant until the seventh decade. In contrast, in females, 
pancreatic fat volumes remain remarkably unchanged.  
 
2. Height correlated greatly with total and regional ectopic fat content in the liver 
with a weaker association with total ectopic fat content in the pancreas in 
overweight participants (25-30 kg/m²). When looking at the data in this group we can 
see that it constitutes of mostly men who are normally taller, BMI does not accurately 
control for large differences in height between individuals, and it may be skewed by 
high muscle mass. 
 
Additionally, even though, that Height per se. is not usually seen as a biomarker for 
ectopic fat content in the liver, adult height do reflect the interaction of genetic and 
numerous early-life experiences and exposures (such as foetal, dietary, social and 
psychological circumstances) on several major adult-onset diseases.(Ben-Shlomo and 
Kuh 2002, Silventoinen 2003) 
 
Adult leg length has been considered as a biomarker of early childhood exposures, as 
leg growth justifies the increase in total height in the pre-pubertal period. (Gunnell 2002) 
A study by Fraser et al.(Fraser, Ebrahim et al. 2008) observed that leg length, a marker 
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of childhood nutrition, was inversely associated in women with adult levels of liver 
enzymes such as alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT) 
and Alkaline phosphatase (ALP) (ALT being the liver enzyme most closely associated 
with liver fat content).(Westerbacka, Corner et al. 2004) Therefore concluding that 
women with shorter legs may have an increased risk of liver disease. 
 
Alternative possibilities may be that linear skeletal growth in itself influences the 
development of the liver and better linear growth leads to a larger liver, resulting in 
lower levels of liver enzymes and a better ability to withstand liver insults.(Fraser, 
Ebrahim et al. 2008) In addition, low bone mineral density has been recognised as a 
potential health problem in both men and women suffering from the metabolic 
syndrome.(Yaturu, Humphrey et al. 2009, Kim, Choe et al. 2010, Jeon, Lee et al. 2011) 
 
Recent years have witnessed an increased awareness of the clinical and epidemiological 
association between liver fat and bone health in terms of reduced bone mineral density 
and an increased risk of osteoporosis in both children and adults.(Pirgon, Bilgin et al. 
2011, Campos, de Piano et al. 2012, Moon, Lee et al. 2012, Pardee, Dunn et al. 2012) 
Thus lipids and lipoproteins are evolving as important regulators of skeletal physiologic 
characteristics and have been shown to inhibit osteoblast and enhance osteoclast 
differentiation and survival.(Parhami, Tintut et al. 2001, Tintut, Morony et al. 2004) 
In fact, a recent study by Bredella et al. (Bredella, Gill et al. 2013), observed that IHCL 
is positively associated with bone marrow fat in young obese subjects, independent of 
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insulin resistance and exercise status. This supports the notion that ectopic fat content 
levels may exert negative effects on bone or are influenced by the same additional 
factors as the latter.  
 
3. Liver fat distribution is homogeneous overall but seem to variable opposite effects 
in different segments in the overfeeding intervention study depending on the type 
of energy excess. As seen in chapter 4, segment 2&3 appeared differently compared to 
other segments. This may be due to the higher amount of IHCL in segment 2&3 at 
baseline when compared to total IHCL and other segments’ IHCL content. Although the 
reason for the opposite reaction to the two different overfeeding drinks is unknown, but 
an effect is seen in the left lobe of the liver depending on the type of excess energy. This 
may be due to the anatomical position of these segments and the position of the left lobe 
in regulating and maintains body functions. (Sherlock and Dooley 2008, Couinaud 
1957)  
 
4. Total and regional pancreas fat content in my cohort was significantly correlated 
with men with and had opposite effects on the Body region in the overfeeding 
intervention study, depending on the type of energy excess. As mentioned in chapter 
3; this gender dimorphism has been observed previously.(Saisho, Butler et al. 2007) A 
recent study by Horng-Yih et al. (Ou, Wang et al. 2013) demonstrated that fatty pancreas 
was independently associated with β-cell dysfunction in males but not in females. In 
fact, pancreatic fat is not an important cause of β-cell dysfunction at the population level, 
288 
 
but it further increase  impaired insulin secretion compared to visceral fat in subjects 
with pre-diabetes.(Heni, Machann et al. 2010) 
 
Furthermore, Wong et al. (Wong, Wong et al. 2014)  observed that the fatty pancreas 
was affected by mild iron overload and high serum ferritin mostly in men. This 
phenomenon may clarify the very low occurrence of fatty pancreas in women. In effect, 
ferritin is an acute-phase protein and is upregulated by pro-inflammatory cytokines such 
as tumor necrosis factor-alpha (TNF) and nuclear factor kappa light-chain enhancer of 
activated B cells (NF-κB) (.(Kowdley, Belt et al. 2012) Moreover, iron overload is a 
well-known cause of pancreatic dysfunction and  may cause diabetes via 
hemochromatosis when the overload is extreme.(Pietrangelo 2007)  
 
As seen in chapter 4, the Body in the pancreas appeared differently compared to other 
regions. The reason for this is unknown but a visible effect is seen in this region 
depending on the type of excess energy. This may be due to its anatomical position and 
being the largest part of the pancreas, thus more affected. As seen in chapter 3 the Head 
and Body regions tend to be the fattiest in IPCL content. 
 
5. The Tail pancreatic region seemed to be and independent unit when compared to 
the Body and Head regions in the pancreas. It remained unaltered with exercise 
status, did not correlate with IAAT and increased in IPCL following weight loss. 
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This finding may not only be due to the distinct anatomical location and histological 
characteristics of the Tail,(Marchal, Verbeken et al. 1989, Jacobs, Coleman et al. 1994, 
Matsumoto, Mori et al. 1995, Kelsen 2008, Mulholland, Lillemoe et al. 2012) but also 
to the presence of a higher population density of islets in this region than in the head and 
body of the pancreas .(Hellman 1959, Wittingen and Frey 1974, Rahier, Guiot et al. 
2008) 
 
In fact, microscopically, IPCL is seen predominantly in the pancreatic 
parenchyma,(Olsen 1978) the islets of Langerhans are usually not affected by mild fatty 
infiltration. (Patel, Bellon et al. 1980, Hague and Amin 2006) This is perhaps the cause 
of a more focal fatty infiltration in the head and body pancreatic regions in my cohort, 
as seen in previous studies.(Atri, Nazarnia et al. 1994, Jacobs, Coleman et al. 1994, 
Matsumoto, Mori et al. 1995) However, an extreme degree of fatty infiltration may 
cause abnormal dilatation of the pancreatic duct, indicating an obstruction of the normal 
flow of pancreatic secretions found in symptoms such as acute pancreatitis and 
diabetes.(Patel, Bellon et al. 1980, Hadidi 1983, Lozano, Navarro et al. 1988, Chao, Lin 
et al. 2000)  
 
6. Increase in total and regional pancreatic fat content post 6 months of bariatric 
surgery and in the Head of the pancreas after weight loss in women. As mentioned 
previously in chapter 4, in addition to the post-menopausal effect or the occurrence of 
nesidioblastosis, participants in this intervention undertook a dietary restriction before 
the surgery and might still be in the process or have already lost some ectopic fat content. 
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A surgical restriction of the stomach, comprising the regulation of food intake, transit, 
and absorption by the gastrointestinal system, the liver, and the brain, may cause 
hormonal imbalances in the pancreas till weight loss stabilises.(Cummings and 
Overduin 2007). 
 
However, it has been proven that Bariatric surgery is a highly effective mean for 
restoring β-cell dysfunction and insulin resistance in very obese patients with type 2 
diabetes (Mingrone, Panunzi et al. 2012, Schauer, Kashyap et al. 2012),although, there 
has been no records on the time span of the ‘remission’ and if this his improvement in 
diabetes is simply attributable to weight loss or other mechanisms. 
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5.1 Limitations  
 
 
During the research of this thesis there were limitations. In addition to the limitations already 
mentioned in the discussion of the previous chapters, the lack of statistical significance in 
certain fat mass and ectopic fat contents throughout the thesis is limited by the relatively small 
number of subjects, and gender imbalance particularly in different BMI groups, overfeeding 
and bariatric intervention studies, which reduced the statistical power. 
 
In addition, changes in body weight are not good indicators of energy gains or losses over short 
periods. Intervention studies, in particular the overfeeding study, should have been extended 
for as long as possible in order to reduce the influence of methodological errors. Additional 
studies need to be performed to further describe the heterogeneity of fat distribution especially 
in lifestyle modifications. 
 
Measurements of ectopic fat content in the different segments and regions of the liver and 
pancreas measurements have not been correlated pathologically. Although it is unethical and 
invasive to conduct such tissue studies in healthy volunteers especially in the pancreas, it is 
possible to test the occurrence of the effect of IPCL on insulin resistance and β cell function, 
especially that we now recognize and uneven physiological pattern in this organ.  
 
Moreover, further longitudinal studies are needed using this novel MRI-based method to 
provide further insights on the authenticity of its measurement especially in a small and 
challenging organ such as the pancreas, where a time consuming difficulty was encountered in 
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determining the boundary between the body and tail of the gland, since there was no 
satisfactory landmark available for this division, although, CoV was very low (<1%).  
Additionally, these longitudinal studies may assist in determining the threshold at which 
pancreatic fat accumulation leads to adverse outcomes. 
 
Measurements of serum insulin level, blood lipids, and other metabolites including liver 
function tests and ferritin levels as an indicator of fatty pancreas would have been an important 
complement to findings of this thesis particularly in life style intervention studies. 
 
In addition, the importance of ethnic differences in the cut off threshold in fat distribution and 
ectopic fat deposition in addition to the effect of gestational age would have been a likely 
contribution to the regional heterogeneity in both organs. More studies on this topic are needed. 
 
I also acknowledge that an MRI slice thickness of 10 mm using the novel MRI-based method 
may not provide optimal spatial resolution for measurement of fat in the pancreas. While the 
spectral model of fat in human pancreatic tissue is likely to be similar to that in liver tissue, this 
has not yet been technically verified. A refinement for future studies will be the incorporation 
of a spectral model of fat derived from human pancreas in vivo if possible. 
 
3-dimensional (3D) techniques can also be developed using this novel MRI based method for 
estimating ectopic fat content in different segments and regions. One potential advantage of 
3D imaging for measuring pancreatic fat is that it may allow acquisition of thinner slices, which 
would reduce potential contamination. 
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